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Abstract 
Converging lines of evidence suggest that cocaine commandeers traditional reward-
related learning and memory pathways to instill pathologically persistent memories, which 
encode the association between stimuli in the drug use environment and the rewarding 
effects of the drug. When triggered, these maladaptive memories can recall the 
pleasurable effects of the drug, stimulate cocaine craving and precipitate relapse. 
However, the cellular and molecular adaptations that enable the maintenance of these 
memories during abstinence remain enigmatic.  
 
As outlined in Chapter 2, comparatively stable epigenetic modifications, such as DNA 
methylation, may function as a conserved means of perpetuating memory in the face of 
rapid transcriptional and proteomic turnover and degradation. Learning-induced 
modifications of DNA methylation have been implicated in the maintenance of contextual 
fear memories and may therefore also underpin the maintenance of cocaine-related 
memories. To investigate this possibility, we first established a novel next-generation 
sequencing technique (MBD Ultra-Seq) to probe genome-wide region- and cell type- 
specific changes in DNA methylation in individual animals (outlined in Chapter 3). I then 
applied this technique to identify genome-wide changes in DNA methylation in mice 
following chronic cocaine self-administration and passive (yoked) cocaine exposure, after 
1 or 21 days of forced abstinence (Chapter 4). Modifications of DNA methylation that 
regulate the maintenance of cocaine-related memories must arise from learned cocaine-
seeking and therefore be unique to the cocaine self-administration paradigm, in addition to 
being persistent, in order to be congruent with the enduring nature of memory. Overall, I 
identified 29 genomic regions that became persistently differentially methylated during 
cocaine self-administration and 28 regions that became selectively differentially 
methylated during abstinence, all of which may contribute to the maintenance of cocaine-
related memories.  
 
Functionally, persistent learning-induced changes in DNA methylation are thought to 
produce enduring modifications of gene expression, thereby altering the physiology of 
activated neurons and perpetuating memory. However, as posited in Chapter 2, 
experience-dependent variations in DNA methylation might also represent a form of 
genomic metaplasticity that is transcriptionally quiescent during memory storage and 
instead primes the transcriptional response upon subsequent neuronal or memory re-
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activation. As preliminary in vivo evidence of this hypothesis, I examined how the 
relationship between altered DNA methylation and the transcription of overlapped or 
proximal genes is regulated in response to memory reactivation (Chapter 4). In some 
cases cocaine self-administration induced changes in DNA methylation that had lasting 
transcriptional consequences, while in others a relationship between altered DNA 
methylation and the transcription of proximal genes was only evident following the explicit 
reactivation of cocaine-associated memories. This is the first evidence to suggest that the 
reactivation state of a memory may govern the relationship between learning-induced 
changes in DNA methylation and transcription. 
  
Taken together, these data constitute the first in vivo neuron-specific genome-wide profile 
of variations in DNA methylation associated with learned cocaine seeking and not simple 
drug exposure, where the former is more relevant to the development and persistence of 
addiction. Moreover, we demonstrate that the relationship between learning-induced 
modifications of DNA methylation and transcription is complex and mediated not only by 
the genomic location of DNA methylation, but also by the reactivation state of the relevant 
memory.
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1.1 Cocaine addiction as a pathology of reward-related learning and memory 
Dependence and withdrawal were once deemed the dominant features of addiction, 
however neither can explain its most baffling aspect: a life-long vulnerability to relapse that 
persists long after the physiological symptoms of withdrawal have subsided (O'brien et al., 
1998). Instead, converging lines of evidence indicate that addiction arises from a 
pathological appropriation of the neural pathways normally engaged by reward-related 
learning and memory (Hyman, 2005, Hyman et al., 2006, Kelley, 2004). During cocaine 
use, environmental cues (such as drug-related paraphernalia or a particular social milieu) 
become associated with the rewarding effects of the drug; these associations can be 
subsequently encoded as unusually salient and persistent cocaine-related memories. Re-
exposure to previously cocaine-paired cues or contexts during abstinence can precipitate 
relapse (Childress et al., 1999, Gawin & Kleber, 1986, O'brien et al., 1998), likely by 
promoting the retrieval of cocaine-related memories and prompting intractable cravings for 
cocaine (O'brien et al., 1998, Semenova & Markou, 2003). In animal models, 
pharmacologically disrupting the maintenance of memories for cocaine-cue associations 
decreases the reinstatement of cocaine seeking during abstinence (Lee et al., 2006) 
suggesting that cocaine-related memories are key motivators of continued drug seeking 
during abstinence. Moreover, unlike the transient neural plasticity associated with 
withdrawal and dependence, the neural adaptations underpinning cocaine-associated 
memories can last a lifetime and beget a life-long vulnerability to relapse. Thus, there is 
strong evidence to support the hypothesis that addiction arises from a pathology of 
reward-related learning and memory (Hyman et al., 2006, Kelley, 2004, Volkow et al., 
2004); however, the molecular features that support the maintenance of cocaine-related 
memories remain equivocal. 
1.1.1 Overlearning and the encoding of pathologically persistent cocaine-associated           
memories 
At the cellular level, memory is embodied in facilitated communication between select 
neuronal synapses, a phenomenon termed long-term potentiation (LTP). LTP is broadly 
contingent on two forms of cellular adaptation following neuronal activation: enhanced 
neurotransmitter release by the pre-synaptic neuron in response to subsequent neuronal 
stimulation and facilitated reception of these neurotransmitters by the post-synaptic 
neuron, due to altered densities of post-synaptic receptors. The actions of many 
neurotransmitters modulate LTP, although glutamate is widely recognised as being central 
to the induction of LTP at the majority of synapses (Lynch, 2004). Glutamate is an 
 
 
19 
excitatory neurotransmitter that activates both AMPA receptors (which mediate fast 
synaptic responses to glutamate) and NMDA receptors (which control slow responses to 
glutamate following sufficient AMPAR-mediate depolarisation), prompting neuronal 
depolaristation. However, the likelihood of LTP induction by glutamatergic transmission 
and its persistence are heavily influenced by the presence of other neurotransmitters, such 
as dopamine (Otani et al., 2003). Finally, the persistence of LTP is dependent on signal 
transduction and the production of gene products that encode for various components of 
the cellular machinery (eg. post-synaptic receptors) (Lynch, 2004).  
 
In addition, the cellular adaptations associated with learning and memory are localised to 
neurons of specific brain regions, which vary depending on the behaviour examined. In the 
context of reward-related learning, the mesocorticolimbic circuit (the ventral tegmental 
area (VTA), limbic areas (amygdala and the nucleus accumbens, Nacc), as well as diverse 
regions of the prefrontal cortex) features prominently. Unexpected reward (eg. cocaine) 
triggers activation of the VTA (D'ardenne et al., 2008), whose dopaminergic neurons 
project to the cortex and various limbic regions to ultimately establish and reinforce drug-
seeking behaviour. Less well characterised, though equally important are glutamatergic 
projections from the prefrontal cortex to the amygdala, Nacc and VTA, which are 
implicated in establishing learned associations between cues, behaviour and rewarding 
stimuli (Tzschentke & Schmidt, 2003), such as drugs of abuse. Though each structure 
plays an important role in reward-related learning and memory, the medial prefrontal 
cortex (mPFC) may be of particular importance in the context of long-lasting reward-
related memories. In cocaine users, as well as self-administering animals, this region is 
hyperactive upon exposure to cocaine-paired cues (Childress et al., 1999, Ciccocioppo et 
al., 2001), suggesting that it plays a key role in long-lasting cocaine-related memories. 
Moreover, the enduring contribution of the mPFC to drug-seeking behaviour is echoed in 
steadfast neuroadaptive changes in gene expression and the neuroproteome that persist 
for over 100 days of enforced abstinence in self-administering rats (Freeman et al., 2010a, 
Freeman et al., 2008, Lull et al., 2009). Finally, repeated exposure to cocaine induces 
lasting changes in the membrane excitability of prefrontal pyramidal neurons (Dong et al., 
2005), where changes in membrane excitability constitute a well-characterized measure of 
experience-dependent plasticity seen in learning (Zhang & Linden, 2003). Several 
investigations (Jasinska et al., 2015, Koya et al., 2009) have indicated that subregions of 
the mPFC, such as the ventral mPFC and dorsal mPFC, may mediate distinct aspects of 
cocaine-seeking behaviour. However, the plethora of contradicting results emerging from 
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these lines of investigation indicate that involvement of these regions in cocaine-seeking 
behaviour is quite nuanced and may instead reflect the actions of distinct sub-circuits 
within each region, rendering the absolute distinction between both unwise (Moorman et 
al., 2014).  
 
Notably, the pharmacological actions of cocaine are thought to over amplify many of 
aforementioned cellular changes to produce tenacious and compelling memories of the 
association between cocaine, its effects and cues that predict its availability (Hyman et al., 
2006, Kalivas & Mcfarland, 2003). Although cocaine and natural rewards act on the same 
mnemonic pathways, the self-administration of cocaine begets longer-lasting LTP in the 
VTA (Chen et al., 2008) and normally transient increases in neurotransmission become 
persistent in the presence of cocaine in vitro (Fole et al., 2013). Cocaine achieves a 
competitive advantage over natural rewards by directly altering the concentration of 
learning-related neurotransmitters in the synaptic cleft, which heightens neurotransmission 
(Hyman, 2005). Most prominently, cocaine produces an unusually prolonged and 
unregulated increase in synaptic dopamine by stimulating the exocytosis of reserve pools 
of dopamine-containing synaptic vesicles from dopaminergic neurons (Venton et al., 2006) 
and by inhibiting the reuptake of dopamine (Ritz et al., 1987). Originally it was posited that 
the overabundance of dopamine motivated cocaine seeking by creating an unprecedented 
hyper-hedonic state (Koob & Le Moal, 2001) yet, perplexingly, dopamine depletion does 
not influence how much an animal “likes” a reward (Berridge & Robinson, 1998, Robinson 
et al., 2005). Outside of drug abuse, dopamine release is particularly pronounced when 
learning about the cues that predict reward availability is extremely important, such as 
when food is presented following food deprivation (Wilson et al., 1995) or when a reward is 
delivered unexpectedly. The dopamine release provoked by rewards under such 
conditions potentiates on going learning and cements the association between the cues 
and reward availability, enabling cues to gain motivational salience (Berridge & Robinson, 
1998) and stimulate goal directed behaviour when encountered in the future. However, the 
atypical increase in extracellular dopamine prompts the brain to overlearn the association 
between cocaine-paired cues and drug availability and attribute excessive importance to 
such cues (Hyman et al., 2006), such that they are attended to at the expense of other 
stimuli. Moreover, dopamine is a powerful modulator of the cellular processes underlying 
memory formation and maintenance (Gonzalez et al., 2014, Gurden et al., 2000, Huang et 
al., 2004, O'carroll et al., 2006), which may further consolidate drug-seeking repertoires 
and accelerate the development of habitual cocaine seeking (Berke, 2003). The 
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exaggerated synaptic dopamine present following cocaine exposure may therefore 
produce exceptionally persistent memories for cocaine-cue associations leading to 
continued cocaine seeking during abstinence.  
 
Nevertheless, dopaminergic neurons project to a wide area and cannot account for a 
specific enhancement of the encoding of cocaine-related memories. Instead dopamine 
may consolidate ongoing learning-induced changes in glutamatergic neurotransmission 
(Otani et al., 2003, Sun et al., 2005). Within the PFC, dopamine- and glutamate-releasing 
terminals converge on the spines of pyramidal neurons, forming “synaptic triads” (Carr & 
Sesack, 2000). Within the dendritic spines of these neurons, dopamine (D1) receptors and 
N-methyl-D-aspartate (NMDA) receptors physically interact and D1 receptor activation 
potentiates NMDA receptor activity (Kruse et al., 2009), suggesting that dopaminergic and 
glutamatergic pathways directly interact to facilitate the encoding of cocaine-related 
memories. Moreover, within neurons of the PFC, D1 receptor activation facilitates the 
insertion of synaptic AMPA receptors, providing yet another mechanism by which 
dopamine may potentiate LTP induction and memory formation in the PFC (Sun et al., 
2005). Additionally, within the cortex, the application of D1 agonists facilitates the 
maintenance of NMDA-dependent LTP (Huang et al., 2004). Therefore, within the PFC, 
the combined actions of altered dopaminergic and glutamatergic signaling may be 
necessary to produce persistent cocaine-related memories. Increasingly, it is hypothesized 
that dopamine release, either in response to cocaine or to the presentation of a previously 
cocaine-paired cue, renders neurons of the PFC excitable (Lewis & O'donnell, 2000), and 
that subsequent excitation of these afferent neurons (projecting to the Nacc and 
amygdala) prompts drug-seeking behaviour (Kalivas et al., 2005).  
 
Altered glutamatergic neurotransmission is in and of itself required for the acquisition and 
expression of cocaine-seeking behaviour, as rats treated systemically with NMDA receptor 
antagonists fail to self-administer cocaine (Schenk et al., 1993). A particularly prominent 
site of glutamatergic plasticity is the PFC-accumbal pathway. Exposure to previously 
cocaine-paired cues activates glutamatergic PFC neurons that project to the Nacc and 
motivate relapse; such pronounced potentiation of this pathway is not seen when animals 
are exposed to a cue previously paired with a natural reward (Gipson et al., 2013). 
Interestingly, cocaine-induced dysregulation of glutamatergic neurotransmission is 
particularly prevalent in paradigms where animals learn to seek cocaine, such as the 
cocaine self-administration paradigm (Mcfarland et al., 2003). As opposed to passive 
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cocaine exposure, learned cocaine seeking induces the specific up-regulation of particular 
subunits of the glutamatergic NMDA receptor within the PFC (Pomierny-Chamiolo et al., 
2014), as well an increase in the ratio of AMPA/NMDA receptor expression in reward-
related brain regions, such as the VTA (Chen et al., 2008) and the nucleus accumbens 
(Conrad et al., 2008) which is indicative of enhanced synaptic transmission. Moreover, 
glutamatergic communication within these regions remains potentiated during abstinence 
(Conrad et al., 2008) and following the extinction of cocaine seeking behaviour (Chen et 
al., 2008) which may both enable the maintenance of cocaine-related memories and 
underlie the prolonged increased reactivity to cocaine paired cues that is observed in 
former users (Goldstein & Volkow, 2011).  
 
Increasingly the focus of altered glutamatergic transmission in response to cocaine has 
shifted to G protein-coupled metabotropic glutamate receptors (mGluRs), which modify 
neuronal activity by regulating NMDA receptor function (Pomierny-Chamiolo et al., 2014) 
and ionotropic receptor-dependent glutamate transmission (Ferraguti & Shigemoto, 2006, 
Schoepp, 2001). MGluR 2/3 receptors negatively regulate glutamatergic transmission and 
are downregulated following chronic cocaine exposure (Baker et al., 2003), which may 
remove the brake on glutamate neurotransmission and heighten reactivity to cocaine-
paired cues during abstinence. Indeed, restoring mGluR2/3 function in the Nacc prevents 
the cue-induced reinstatement of cocaine seeking behaviour (Baptista et al., 2004). In 
contrast, mGluR5 receptors positively modulate glutamatergic neurotransmission 
(Schoepp, 2001) and are required for the acquisition of cocaine self-administration 
(Chiamulera et al., 2001, Kenny et al., 2003). Correspondingly, mGluR5 activity is required 
for the cue-induced reinstatement of cocaine seeking (Kumaresan et al., 2009). 
Remarkably, the disruption of mGluR5 function has no effect on natural reward seeking 
(Chiamulera et al., 2001) or the maintenance of sucrose self-administration (Chesworth et 
al., 2013), which may indicate unique dysregulation of glutamatergic transmission in 
response to drugs of abuse.   
 
Lastly, chronic cocaine exposure affects future learning by promoting the formation of 
‘silent’ glutamatergic synapses where long-lasting changes in plasticity are more easily 
induced and maintained (Lee & Dong, 2011). AMPA receptors are absent or highly 
unstable at these synapses, which normally decline as the brain matures and are thought 
to contribute to the superior learning ability often seen in juvenile organisms (Groc et al., 
2006). During withdrawal from cocaine, ‘silent’ synapses are highly upregulated in both the 
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Nacc and PFC (Huang et al., 2009, Ma et al., 2014) and this may prime learning about 
cocaine-predictive cues upon repeat cocaine exposure, creating even more persistent 
cocaine-cue memories. Moreover, the disruption of inhibitory GABAergic tone by cocaine 
(Liu et al., 2005) may also prime the encoding of cocaine-related memories (Lee & Dong, 
2011).  
 
In sum, the pharmacological actions of cocaine prime the organism for learning and over 
amplify normal reward-related learning signals, which may underpin the enhanced 
encoding and persistence of cocaine-related memories. 
1.1.2 Not all roads lead to Rome: the importance of self-administration in   
establishing cocaine-related memories 
In examining the effects of cocaine in animals, many modes of administration may be 
used. The first is simple acute or chronic injections performed by an experimenter, during 
which the animal is not required to perform a specific behaviour to receive the drug. A 
second popular model is conditioned place preference (CPP), where animals are 
repeatedly administered cocaine and exposed to one of two contexts. When given the 
choice of exploring either of the two contexts, animals tend to prefer the cocaine-paired 
context. This paradigm provides a measure of drug-seeking behaviour, indicated by the 
amount of time an animal spends in the cocaine-paired context. A third popular model is 
cocaine self-administration, where animals learn to perform an operant response (typically 
a lever press) to receive an infusion of cocaine through an indwelling jugular catheter. The 
delivery of cocaine is often paired with an explicit cocaine-paired cue (such as a light). The 
latter, though technically more challenging than CPP, is considered to be a more 
ethologically valid model of cocaine seeking and taking. The self-administration paradigm 
produces similar neurobiological changes in the reward related neurocircuitry, though it 
does not necessarily lead to ‘addiction’ which is more accurately defined by continued 
drug-seeking and drug-taking despite negative consequences.  
 
The neurobiology of cocaine addiction is complex and the neural adaptions that arise 
during the transition to compulsive cocaine-seeking correspond to two distinct, but 
interacting pathways: the first is the neurobiological effects of the drug itself and the 
second is the adaptations associated with cocaine-related learning and memory formation. 
A substantial portion of research is devoted to studying the consequences of chronic non-
contingent cocaine exposure, though it is clear that the neurobiological consequences of 
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involuntary cocaine exposure do not faithfully parallel those produced by voluntary cocaine 
seeking. Motivated drug seeking and taking (seen in the CPP and self-administration 
paradigms) is key to the development addiction (Koob et al., 2004) whereas unpredictable 
involuntary exposure cocaine can be aversive and can retard the development of drug 
seeking (Twining et al., 2009). Moreover, the neural adaptations incurred during passive 
cocaine exposure may fail to produce the persistent cocaine-related memories that 
motivate continued cocaine seeking. Relative to self-administration, passive non-
contingent exposure to cocaine fails to induce an equivalent change in long-term 
potentiation (LTP) in the ventral tegmental area (VTA) (Chen et al., 2008, Martin et al., 
2006), or the same magnitude of increase in dopamine (Hemby et al., 1997) or 
acetylcholine concentration (Hemby et al., 1997, Mark et al., 1999). Furthermore, 
withdrawal from cocaine self-administration is associated with distinct neural adaptations, 
including the upregulation of calcium-permeable AMPA receptors (CP-APMARs) and an 
increase in the expression of brain-derived neurotrophic factor (BDNF), which may 
facilitate increased excitatory neurotransmission in response to cocaine-paired cues and 
contribute to the renewal of cocaine seeking during abstinence (Lu et al., 2010, 
Mccutcheon et al., 2011).  
 
The conditioned place preference (CPP) paradigm is often used to examine neural 
adaptations induced by cocaine and cocaine seeking as it is does not require extensive 
operant training, the surgical implantation of a jugular catheter and eliminates the 
differences attributable to variations in the rate and total intake of cocaine. While CPP has 
been widely adopted as a measure of drug seeking and is similar to cocaine self-
administration, there are some disparities that impart increased ethological validity to the 
cocaine self-administration paradigm, particularly when studying cocaine-related learning 
and memory. Firstly, the CPP model of cocaine seeking produces less robust cocaine-
associated memories than voluntary cocaine self-administration; higher doses of 
pharmacological agents are needed to promote the extinction of cocaine-seeking 
behaviour in self-administering animals (Thanos et al., 2011) and cocaine-related 
memories produced by self-administration are less prone to destabilisation following 
memory retrieval (Brown et al., 2008). Furthermore, in the self-administration paradigm, 
animals voluntarily develop extensive drug-seeking behavioural repertoires and learn 
about the cues that predict drug availability, in contrast to CPP, where the subjective 
effects of the drug are already present and initial administration of cocaine is involuntary. 
Therefore, the cocaine self-administration paradigm more faithfully replicates learned 
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cocaine self-administration in the natural environment and may provide a more accurate 
picture neural adaptations that support the formation and maintenance of cocaine-related 
memories.  
1.2 How are cocaine-associated memories maintained over time? 
Despite the ubiquity of long-term memory, little is known about the mechanisms that 
enable its persistence. The formation of memory requires precisely regulated programs of 
altered gene expression (Agranoff et al., 1967) and protein synthesis (Flexner et al., 1963) 
and several hundred molecules are known to be transcribed, translated or activated during 
memory formation (Sanes & Lichtman, 1999). However, these molecules undergo rapid 
turnover and have restricted half-lives and therefore cannot be the master modulators of 
memory. Even PKM-zeta, a constituently active protein kinase that is necessary and 
sufficient for the maintenance of several forms of long-term memory (see (Sacktor, 2012)), 
has a half-life of approximately 11 days (Sacktor, 2010) and therefore cannot maintain 
long-term memory on its own. Instead, neuroscience has long ignored the most obvious 
candidate for the repository of memory: the genome. 
 
DNA is the one cellular component that is present and largely intact for the lifetime of an 
organism and its long-term memories and was hypothesized to be the site of the self-
perpetuating modifications that support long-term memory several decades ago (Griffith & 
Mahler, 1969). Griffith and Mahler posited that the enzymatic modifications of nucleotides 
following learning could direct the changes in transcription and translation necessary for 
memory formation and maintenance. Furthermore, unlike mutations in the genome, these 
enzymatic modifications would likely be reversible, offering a degree of plasticity that is 
congruent with the dynamic nature of memory. Today, the collection of enzymatic 
modifications of genomic DNA forms the ‘epigenome’, where the prefix “epi” indicates that 
these modifications are above, outside of, or around the genome and do not alter the 
underlying genetic sequence.   
1.3 Epigenetics 
Traditionally, ‘epigenetics’ referred to heritable changes in gene function that were not 
produced by changes in genetic sequence (Bird, 2002). More recently, the requirement of 
heritability has been rescinded and epigenetics refers to any regulatory process, outside of 
genetic sequence variation, that serves to “register, signal or perpetuate altered 
transcriptional states” (Bird, 2007). Epigenetic processes include the modification of 
nucleotides (ie. DNA methylation and hydroxymethylation), histone modifications, 
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nucleosome remodelling and non-coding RNA among others. Epigenetic modifications 
regulate gene expression by controlling the conformation of DNA and chromatin or by 
recruiting further enzymatic modifiers or components of the transcriptional machinery. 
While epigenetic regulation was traditionally used to explain the development of stable 
differentiated cellular phenotypes from virtually identical genetic code, it is now clear that 
the epigenome is dynamically regulated across the lifespan in response to environmental 
stimuli. Moreover, the number of possible epigenetic modifications of DNA and histone 
proteins exceeds 100 (Hurd, 2010) and the summation and interaction of these enables an 
unprecedented level of transcriptional regulation in response to environmental stimuli.  
1.3.1 DNA methylation 
DNA methylation involves the addition of a methyl group to one or more nucleotides of 
DNA, typically a cytosine, to form 5-methylcytosine, although methylation of other bases 
has been observed in bacteria, plants and insects (Ratel et al., 2006). Amongst epigenetic 
modifications DNA methylation is comparatively stable as the methyl group is covalently 
bonded to the 5th carbon of the cytosine ring. Correspondingly, DNA methylation has been 
widely implicated in establishing and perpetuating stable transcriptional changes during 
genomic imprinting, cell differentiation and X-chromosome inactivation as well as in the 
stable repression of transposable elements (Ndlovu et al., 2011).  
 
1.3.1.1 Distribution of DNA methylation: hints at function 
Cytosine methylation occurs predominantly in the palindromic CpG dinucleotide context 
(where guanine follows a cytosine) (Lister et al., 2013); 46-90% of all 5-methylcytosines 
within the genome occur within this context (Bird, 1986, Guo et al., 2013, Lister et al., 
2013). The symmetric nature of the CpG dinucleotide (ie. 5’CpG/GpC5’) facilitates the 
propagation of DNA methylation during DNA replication and may have favoured the 
evolution of enzymes that preferentially methylated cytosine in the CpG dinucleotide 
context, which would explain why methylation is predominantly found in this context (Bird, 
2002). Nevertheless, CpG dinucleotides are conspicuously depleted from the genome, 
likely because methylcytosine is prone to spontaneous deamination to thymine, producing 
at T:G mismatch that is not efficiently recognised for repair (Kondrashov, 2003). Therefore, 
by examining the distribution of CpG dinucleotides and methylation throughout the 
genome we can identify regions where they might continue to play important regulatory 
roles.  
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Unmethylated CpG dinucleotides tend to cluster in CpG-rich islands (CGI) proximal to 
transcription start sites (TSS) of constitutively expressed genes (Bird, 1986, Edwards et 
al., 2010). About 70% of promoters co-localise with CGI (Larsen et al., 1992, Weber et al., 
2007) and methylation of these islands tends to be associated with the repression of the 
corresponding genes. As early studies of DNA methylation concentrated on promoter 
regions, a dogmatic notion that DNA methylation is associated with the stable repression 
of gene transcription arose (Jones, 2012). This dogma was reinforced by evidence that 
methylation of intragenic CGIs also represses transcription of the associated genes 
(Maunakea et al., 2010) in addition to the known function of DNA methylation in repressing 
retrotransposition (Rollins et al., 2006).  
 
The advent of powerful genome-wide sequencing technologies has given much greater 
resolution of the distribution of CpGs throughout the genome and revealed roles for DNA 
methylation that extend beyond its classical function in transcriptional repression. For 
example, CpG sites are concentrated at the 5’ and 3’ ends of internal exons (Edwards et 
al., 2010), which suggests that CpG methylation might regulate alternative splicing. 
Indeed, increased CpG methylation is observed at alternatively spliced sites, putative exon 
splicing enhancers and alternate exons (Anastasiadou et al., 2011, Choi, 2010, Maunakea 
et al., 2010), though interestingly it mediates exon inclusion (Maunakea et al., 2013), 
potentially by recruiting specialised methyl-binding proteins such as MeCP2 (Maunakea et 
al., 2013) or by altering the kinetics of transcriptional elongation (Lorincz et al., 2004). 
Likewise, gene body methylation is paradoxically a hallmark of actively transcribed genes 
(Feng et al., 2010b, Hellman & Chess, 2007). Finally, in regions of low CpG density, such 
as enhancers and gene bodies, DNA methylation is more prone to dynamic regulation 
(Schmidl et al., 2009, Wiench et al., 2011) and this may be a site of plasticity in the 
methylome following exposure to important environmental stimuli. Consequently, the 
relationship between DNA methylation and gene transcription has gained complexity, as 
the effects of DNA methylation on transcription are highly dependent on the context in 
which it occurs. 
 
1.3.1.2 Establishing de novo DNA methylation 
Establishing de novo methylation is a complex process mediated by an ever-growing 
number of factors. Largely, these factors belong to two categories: the enzymes that 
catalyse the addition of the methyl group to DNA and the factors that direct these enzymes 
to specific sites in the genome. 
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1.3.1.2.1 The enzymes: DNA methyltransferases  
In mammals, DNA methylation is established and maintained by DNA methyltransferases 
(DNMTs) that catalyse the addition of a methyl group to a nucleotide from a donor, 
typically S-adenosyl methionine (SAM). Until recently it was believed that the DNMT3 
family (DNMT3a and 3b and co-factor DNMT3L) conferred de novo methylation, whereas 
DNMT1 was thought to mediate the maintenance of DNA methylation, particularly during 
DNA replication (Auclair & Weber, 2012). However, there is now evidence that DNMT 1 
and 3a co-operate to mediate de novo methylation (Fatemi et al., 2002, Lin et al., 2002) 
and conversely that DNTM3a is necessary for the maintenance of DNA methylation (Feng 
et al., 2010a). More surprisingly, DNMT3a acts as a demethylase when SAM levels are 
low (Metivier et al., 2008). Therefore, although the DNMTs have a long been implicated in 
the regulation of DNA methylation, their functions are far from being well defined.    
 
1.3.1.2.2 Targeting DNMTs 
A second evolving area of enquiry is understanding how regions are marked for de novo 
methylation or demethylation by DNMTs and DNA demethylases. This is a complex 
question for several reasons: first, it is unclear if DNA methylation and demethylation are 
the cause or consequence of changes in transcription, and indeed they may be both. 
Should altered DNA methylation be the consequence of transcription, the transcripts 
initially produced by a specific locus could feedback to direct de novo methylation or 
demethylation, yet this does not explain how transcription arises from heavily repressed 
genes in the first instance. Second, there is the problem of specificity; how is the DNA 
methylation or demethylation machinery targeted to one CpG but not another? We have 
only begun to appreciate the dynamic regulation of DNA methylation in differentiated cells, 
but information derived from genome-wide sequencing suggests that several pathways 
bidirectionally influence DNA methylation, the most prominent of which are post-
translational modifications of histones and a myriad of non-coding RNAs.  
 
Post-translational modification of histones 
DNA methylation frequently co-localises with more transient modifications of histone tails, 
particularly certain forms of histone lysine methylation (Meissner et al., 2008). DNMTs may 
be recruited directly with histone lysine methyltransferases (Vire et al., 2006) and histone 
methylation at distinct sites can act to attract or repel DNMTs (Jin et al., 2011). Histone 
argine methylation can equally recruit DNMTs (Zhao et al., 2009). However, the interplay 
between histone modifications and DNA methylation is far from a one-way street as DNA 
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methylation may dictate the deposition of new histone modifications by recruiting histone 
methyltransferases and histone deacetylases (Jin et al., 2011). Nevertheless, most favour 
the hypothesis that histone modifications precede DNA methylation/demethylation (Cedar 
& Bergman, 2009), which serves as a more stable mark for transcriptional repression or 
activation. Regardless, this cannot explain how the epigenetic machinery is targeted to a 
specific locus in the genome; this role may fall to non-coding RNAs. 
 
Non-coding RNA 
One of the manners in which transcription might direct DNA methylation is through the 
production of non-coding RNAs that feedback to direct DNA methylation both locally and 
throughout the genome. Non-coding RNAs can bind to genomic loci proximal to the region 
from which they produced and form stem-loop structures that bait DNMTs and sequester 
them, shielding the locus from de novo methylation (Di Ruscio et al., 2013). Other classes 
of small non-coding RNAs, such as PIWI-interacting RNAs, may also be important for 
directing DNA methylation (Watanabe et al., 2011). While our understanding of RNA-
directed methylation is evolving, non-coding RNAs clearly offer a degree of specificity that 
is advantageous in promoting methylation or demethylation at specific loci.   
1.3.2 The dynamic nature of DNA methylation 
DNA methylation was once considered to be a relatively static epigenetic modification, 
renowned for its role in the long-term regulation of genomic imprinting, transposon 
silencing and X-chromosome inactivation, as well in cellular differentiation. Though DNA 
demethylation was observed in the early stages of embryonic development (Monk et al., 
1987) it was hypothesized that this stemmed from a passive, DNA replication-dependent 
process whereby newly synthesized daughter strands of DNA fail to acquire methylation at 
the appropriate sites. Despite the discovery of several DNA synthesis-independent 
demethylases (Gjerset & Martin, 1982, Ramchandani et al., 1999, Weiss et al., 1996), the 
possibility of active, replication-independent DNA demethylation remained controversial 
until recently, as the proposed reactions are thermodynamically unfavorable and the 
enzymes thought to mediate demethylation were inefficient at doing so (Cortazar et al., 
2007). However, rapid replication-independent demethylation was observed following 
fertilization (Oswald et al., 2000) and in non-dividing neurons (Martinowich et al., 2003) 
indicating that active DNA demethylation must be possible. Today we know that de novo 
DNA methylation and demethylation occur throughout the genome in response to 
environmental input, including neuronal activation (Guo et al., 2011a, Guo et al., 2011b, 
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Ma et al., 2009) and that this process is mediated by several enzymatic pathways (Li et al., 
2013).  
1.3.3 DNA methylation and neurons  
Though the epigenomes of all cells in the brain may be modified in response to learning 
and environmental input, neurons are conspicuously well suited to be the repository of 
long-lasting epigenetic modifications that perpetuate long-term memory. Unlike many other 
somatic cells, mature neurons do not undergo mitosis, which might prevent the 
disturbance of epigenetic marks that have been acquired during neuronal activity and 
learning (Griffith & Mahler, 1969). Furthermore, although glial cells contribute to synaptic 
remodeling (Perea & Araque, 2010, Todd et al., 2006), the cellular manifestation of 
memory is widely recognized as long-lasting changes in the transmission of signals across 
neuronal synapses.  
 
Though many were surprised to find that DNMT3a is expressed in mature neurons in 1994 
(Goto et al., 1994, Yu et al., 2011), seminal evidence of learning- and activity- induced 
changes in the neuronal methylome actually emerged two decades earlier. Shortly after 
Griffith & Mahler (1969) hypothesized that the enzymatic modification of DNA could form 
the physical basis of memory, Boris Vanyushin demonstrated that DNA methylation was 
modified in neurons following learning (Guskova Lv, 1977, Vanyushin, 1974). 
Unfortunately, this work received little recognition and it was not until 2003 that further 
evidence for the regulation of DNA methylation in response to neuronal activity emerged 
(Martinowich et al., 2003).  In the interim, several others capitalized and spruiked the idea 
that DNA methylation could support memory as their own (Crick, 1984, Holliday, 1999). 
 
DNA methylation in neurons is unique in several respects. Firstly, in most cells, intergenic 
regions are heavily methylated (Consortium, 2012), yet in neurons small regions of 
intergenic hypomethylation appear frequently (Hon et al., 2013). These regions might 
correspond to the distal regulatory elements that are the predominant site of neuronal 
activity-induced changes in DNA methylation (Guo et al., 2011a). Furthermore, the 
neuronal methylome appears to be inherently more plastic than that of other cell types; 
relative to glial cells, neurons have increased inter-individual variability in DNA 
methylation, which implies an enhanced propensity for plasticity (Iwamoto et al., 2011). An 
increased presence of non-CpG methylation (cytosine methylation outside of palindromic 
CpG dinucleotides) (Lister et al., 2013, Xie et al., 2012), and 5-hydroxymethylcytosine (5-
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hmC) in neurons may facilitate demethylation (Feng et al., 2010a, Guo et al., 2013) and 
the dynamic regulation of the neuronal methylome. Therefore, the unique features of the 
neuronal methylome leave it well equipped to responded to environmental stimuli and 
orchestrate the long-lasting changes in transcription and translation necessary for long-
term memory formation and maintenance.  
1.3.4 DNA methylation and long-term potentiation (LTP) 
Late long-term potentiation (L-LTP) is an increase in synaptic strength that gives rise to a 
long-lasting facilitation of neurotransmission across the synapse, and it is widely regarded 
as the cellular manifestation of memory (Lynch, 2004).  L-LTP arises when stimulation 
from the presynaptic neuron is sufficiently strong or occurs repeatedly. Under these 
conditions the response of the postsynaptic neuron becomes potentiated and it is more 
sensitive to future stimulation from the presynaptic neuron, which facilitates 
communication across the synapse. L-LTP requires a multitude of changes in the 
synapse, including a persistent increase in the number of glutamate-sensitive AMPARs on 
the postsynaptic membrane, increased exocytosis of neurotransmitters from the 
presynaptic neuron and host of changes in the architecture of the synapse. The 
persistence of these changes and L-LTP necessitates de novo transcription and protein 
synthesis (Abraham & Williams, 2003, Krug et al., 1984), though these must be 
orchestrated by a more enduring and self-perpetuating mark, such as neuronal activation-
induced changes in DNA methylation.  
 
Early experiments demonstrated that DNA methylation is altered within the promoter of 
Bdnf, (an important regulator of several memory-related processes) during the induction of 
LTP (Martinowich et al., 2003, Zhao et al., 2003) and that components of the DNA 
methylation machinery are critical for the induction of LTP (Zhao et al., 2003). However, it 
was Levenson and colleagues (2006) who first established that de novo DNA methylation 
is required for the induction of LTP in vitro by inhibiting DNMTs (Levenson et al., 2006). 
Originally these findings were restricted to the hippocampus, however, evidence that DNA 
methylation contributes to synaptic plasticity now extends outside the hippocampus; the 
induction of LTP in the mPFC and the lateral amygdala is impaired by the local application 
of DNMT inhibitors (Monsey et al., 2011, Sui et al., 2012). Moreover, this impairment 
cannot be attributed to the potentially toxic effects of DNMT inhibitors used in initial 
experiments, as mice lacking DNMT1 and DNMT3a in forebrain neurons have similar 
deficits in LTP induction (Feng et al., 2010a). Finally, appropriately regulated DNA 
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methylation is essential for the maintenance of altered neuronal network excitability 
following depolarization (Nelson et al., 2008), which hints at a role for DNA methylation in 
the long-term regulation of synaptic plasticity. 
1.3.5 DNA methylation and memory maintenance 
Although several persistent learning-induced changes in DNA methylation have been 
reported following contextual fear conditioning (Miller et al., 2010, Mizuno et al., 2012), 
there is limited causal evidence to implicate DNA methylation in the maintenance of 
memory once consolidation is complete or following the induction of LTP. In 2010, Miller & 
Sweatt released a paper titled “Cortical DNA methylation maintains remote memory”, 
which demonstrated that the application of DNMT inhibitors during memory maintenance 
disrupts the retrieval of remote fear memories (Miller et al., 2010). However, the DNMT 
inhibitors were applied within close proximity of the memory test (3x within the 24 hours 
period leading up to the remote memory test, including once at 1 hour prior to test) and 
therefore may have interfered with the retrieval of the memory trace rather than its 
maintenance. Disconcertingly, DNMT inhibitors interfere with the retrieval of other forms of 
memory (Han et al., 2010). Nevertheless, learning does produce persistent changes in 
DNA methylation, which is in turn perfectly poised to mediate the long-term changes in 
transcription and protein levels that are necessary for the maintenance of memory. The 
development of new tools that can directly manipulate learning-induced DNA methylation 
and examine its relevance to long-term memory maintenance will be key in advancing our 
understanding of how DNA methylation contributes to memory maintenance.   
 
Memory maintenance, however, is predicated not just on initial cellular modifications that 
are induced upon learning, but also by on-going modifications that arise from memory 
retrieval and reconsolidation. Following retrieval, memories can enter a labile state that 
permits the incorporation of new information and updating of the memory trace. The 
memory is returned to long-term storage through reconsolidation. Memory reconsolidation 
is thought to strengthen memory traces by increasing the persistence and specificity of the 
memory trace (Forcato et al., 2014), explaining why repeat experiences yield more 
persistent memories. There is strong evidence that DNMT activity is necessary for the 
reconsolidation of memory; infusion of DNMT inhibitors into the lateral amygdala (a region 
key to auditory fear memory) after the reactivation of an auditory fear memory disrupts the 
expression of reconsolidation-dependent long-term memory but not reconsolidation-
independent short-term memory (Maddox & Schafe, 2011). Therefore, de novo 
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methylation following memory retrieval may contribute to the maintenance long-term 
memory, which is of great relevance to addiction where cocaine-related memories are 
repeatedly reactivated and strengthened by re-exposure to external and internal cocaine-
paired cues.  
 
A further consideration is establishing in which cell-types learning and memory-related 
changes in DNA methylation might arise. Examining cell-type specific epigenetic 
modifications is extremely important as cell-type heterogeneity can confound epigenetic 
profiling attempts by producing spurious results following changes in cellular composition 
of the region (see Chapter 3). Additionally, it is likely that the epigenetic changes 
associated with a memory exist only within a discrete subset of neurons of the brain and 
these changes may be rendered imperceptible by examining heterogeneous regions. It 
would be desirable to examine changes in DNA methylation uniquely within neurons that 
are engaged by a memory trace or within a distinct subtype of neuron (ie. glutamatergic 
neurons), but at this time it is not possible to isolate such a population from a distinct 
region of an adult mouse brain and obtain sufficient DNA for analysis. 
 
Overall, the evidence of the distinct contribution of DNA methylation to memory 
maintenance is preliminary, but the presence of persistent changes in DNA methylation in 
the neuronal genome suggests that learning-induced changes in DNA methylation 
contribute to memory maintenance. The application of tools that can directly manipulate 
learning-induced changes in DNA methylation, such as transcription-activator like effector 
(TALE) – DNA demethylatase fusion proteins (Maeder et al., 2013b), will more 
convincingly elucidate the role of persistent changes in DNA methylation in long-term 
memory maintenance.  
1.4 DNA methylation and cocaine 
As learning-induced changes in DNA methylation are associated with the maintenance of 
other forms of memory, cocaine-induced changes in DNA methylation may equally 
underlie the maintenance of cocaine-related memories. A growing body of evidence 
suggests that exposure to cocaine gives rise to brain region-specific changes in DNA 
methylation. DNMT3a mRNA expression is altered in a region and time-dependent 
manner following cocaine exposure, self-administration and withdrawal (Anier et al., 2010, 
Laplant et al., 2010, Pol Bodetto et al., 2013, Tian et al., 2012), as are the levels of methyl 
binding proteins MeCP2 and MBD1 (Carouge et al., 2010, Cassel et al., 2006, Host et al., 
 
 
34 
2011, Im et al., 2010). Likewise, local and systemic manipulations of DNMT activity 
(Laplant et al., 2010) and methyl donor availability (Laplant et al., 2010, Tian et al., 2012) 
alter the expression of cocaine seeking in the cocaine conditioned place preference 
paradigm. Furthermore, several genes (CDKL5, PP1c, TACR3 and PP1Cβ) are 
differentially methylated following cocaine exposure (Anier et al., 2010, Barros et al., 2013, 
Carouge et al., 2010) and several of these changes are attenuated by the concurrent 
administration of DMNT inhibitors (Anier et al., 2010, Pol Bodetto et al., 2013). However, 
while these experiments provide a surfeit of evidence of dynamic regulation of the 
methylome in response to cocaine exposure, they fail to distinguish changes in DNA 
methylation that are attributable to learned cocaine-seeking from those that arise from 
simple drug exposure, where the former may be key to the development and persistence 
of cocaine-related memories and addiction. Chronic cocaine exposure and conditioned 
place preference do not require active cocaine seeking and/or repeated voluntary self-
administration of the drug, which are key to the malignant potentiation of the reward-
related neural circuitry. A single study has identified that forced abstinence from cocaine 
self-administration is associated with methylation of the SOX10 promoter in the corpus 
callosum of rats (Nielsen et al., 2012a) and one other suggests that DNMT3a mRNA 
expression is altered during withdrawal from cocaine self-administration (Laplant et al., 
2010), however this hardly sheds light on the changes in DNA methylation may be related 
to the maintenance of cocaine-related memories. Therefore, while there is sufficient 
evidence to suggest that DNA methylation is dynamically regulated in response to cocaine 
exposure, we must extend this level of profiling to identify changes in DNA methylation 
incurred by voluntary cocaine self-administration.   
1.5 Projects aims and rationale 
The overarching hypothesis of this project was that cocaine self-administration produces 
unique changes in DNA methylation that both persist and arise during forced abstinence, 
and which are associated with distinct changes in gene expression.  Overall, the aim of 
this project is to identify changes in DNA methylation that may be associated with the 
maintenance of cocaine-related memories. While epigenetic remodelling in response to 
chronic cocaine exposure and cocaine place preference conditioning has been reasonably 
well documented (Anier et al., 2010, Barros et al., 2013, Carouge et al., 2010, Chao et al., 
2014, Fragou et al., 2013, Han et al., 2010, Laplant et al., 2010, Nielsen et al., 2012b, Pol 
Bodetto et al., 2013, Pol Bodetto et al., 2014, Tian et al., 2012), changes in DNA 
methylation following voluntary cocaine self-administration have not. To identify changes 
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in DNA methylation associated with the maintenance of cocaine-related memories, it is 
necessary to distinguish those changes that are associated with learned cocaine seeking 
from those that arise as a result of simple drug exposure. Moreover, such changes must 
persist over time to be congruent with the enduring nature of memory. To address these 
and other issues, I have employed a mouse model of cocaine self-administration and 
yoked (simple) cocaine exposure to identify changes in DNA methylation that are unique 
to learned cocaine seeking. Additionally, I examined the persistence of identified learning-
associated modifications of DNA methylation during abstinence, to identify those changes 
that might underwrite the maintenance and reconsolidation of cocaine-related memories. 
Finally, I probed the relationship between altered DNA methylation and gene expression 
and questioned how this association is influenced by the retrieval of cocaine-related 
memories.  
 
To examine the overarching hypothesis, several aims had to be addressed:  
 
Aim 1: To determine if mice persistently seek cocaine after a period of prolonged 
abstinence. It is anticipated that cocaine self-administration training will lead to persistent 
cocaine seeking, as examined after 21 days of withdrawal. This is a common phenomenon 
within most animals trained to self-administer cocaine (Fuchs et al., 2008), however, it has 
not been established that mice continue to seek cocaine in our paradigm. Continued 
cocaine seeking (as indicated by a sustained preference for the previously cocaine paired 
lever) is indicative of the presence of enduring cocaine-related memories, which in turn 
require long lasting cellular and molecular adaptations in the brain. 
 
Aim 2: To develop a genome-wide sequencing method that can be used to identify 
changes in DNA methylation in a small amount of DNA derived from neurons of 
individual animals. As previously mentioned, examining epigenetic modifications in a 
region and cell-type specific manner may be key to their identification. Moreover, it is likely 
that animals vary in their preference for cocaine and this approach could be used to 
examine both generic changes in DNA methylation that arise from cocaine self-
administration, but also differences in methylation that contribute to variability in cocaine 
self-administration.    
 
Aim 3: To characterize DNA methylation in neurons of the mPFC of mice that have 
actively self-administered cocaine or been passively exposed to it. The mPFC is a 
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site of long-lasting changes in gene and protein expression following cocaine self-
administration and is necessary for the reinstatement of cocaine seeking following 
abstinence, which suggests that it plays a central role in enduring cocaine seeking 
behaviour and may harbor long-lasting epigenetic changes that drive cocaine-seeking 
behaviour. It is hypothesized that cocaine self-administration will induce changes in DNA 
methylation that are distinct from those induced by simple exposure to the drug, and 
equally that these changes in DNA methylation will vary over time.  
 
Aim 4: To characterize the transcriptional changes associated with altered DNA 
methylation. 
To exert an influence on behaviour, it is first necessary for altered DNA methylation to 
direct changes in gene transcription, that in turn give rise to the changes in cell physiology 
that direct behaviour. It is hypothesized that where the changes in DNA methylation are 
associated with known genes, the transcription of these genes will be altered. However, 
this is likely a complex relationship, which (as outlined in Chapter 2) may be mediated by 
the reactivation state of the cocaine-associated memories.  
 
Outcomes and significance 
In this thesis, I provide the first genome-wide profile of altered DNA methylation arising 
from voluntary cocaine-self administration and contrast these changes with those that are 
associated with passive cocaine exposure. Moreover, to identify these changes, I 
developed a genome-wide sequencing protocol that was recently published and which can 
be used to profile DNA methylation in a region- and cell type- specific manner (see 
Chapter 3). Furthermore, in considering how modified DNA methylation might contribute to 
memory maintenance, I recently posited that persistent modifications of DNA methylation 
might, in some cases, become functionally silent during memory storage and prime 
transcription when the corresponding memory is reactivated (see Chapter 2). Overall, 
cocaine self-administration yields unique persistent changes in DNA methylation in 
addition to a host of modifications of DNA methylation that arise during abstinence. 
Further, I find preliminary evidence of transcriptional priming by long-lasting changes in 
DNA methylation, though this remains an avenue for more rigorous investigation.  
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CHAPTER 2 
 
Dynamic DNA methylation: a prime candidate for genomic 
metaplasticity and behavioral adaptation 
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2.1 Preamble 
Prior to examining how cocaine IVSA-induced changes in DNA methylation affect the 
transcription of proximal genes (Aim 4), I first considered how DNA methylation and gene 
expression interact more generally in the context of long-term memory maintenance. 
Learning-induced modifications of DNA methylation are thought to propagate long-term 
memory by perpetuating long-lasting changes in transcription that in turn alter the synaptic 
physiology of affected neurons and give rise to ‘memory’, or a potentiation of 
communication between neurons. However, if all learning-induced modifications of DNA 
methylation induced enduring transcriptional changes, neurons might be pushed too far 
from homeostasis and be rendered aplastic and unable to respond to further stimulation. I 
therefore proposed that experience-induced modifications of DNA methylation might act as 
transcriptionally quiescent signatures of previous experience while memory is in storage 
and instead direct transcriptional responses to further neuronal stimulation or memory 
reactivation. This hypothesis was recently published as an opinion paper in Trends in 
Neurosciences and forms Chapter 2 and informed the selection of the experimental 
groups selected in Chapter 4. 
 
2.2 Dynamic DNA methylation: a prime candidate for genomic metaplasticity and 
behavioural adaptation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dynamic DNA methylation: a prime
candidate for genomic metaplasticity
and behavioral adaptation
Danay Baker-Andresen, Vikram S. Ratnu, and Timothy W. Bredy
Psychiatric Epigenomics Laboratory, Queensland Brain Institute, The University of Queensland, Brisbane, QLD, 4072, Australia
DNA methylation was once considered to be a static
epigenetic modification whose primary function was
restricted to directing the development of cellular phe-
notype. However, it is now evident that the methylome
is dynamically regulated across the lifespan: during de-
velopment as a putative mechanism by which early
experience leaves a lasting signature on the genome
and during adulthood as a function of behavioral adap-
tation. Here, we propose that experience-dependent
variations in DNA methylation, particularly within the
context of learning and memory, represent a form of
genomic metaplasticity that serves to prime the tran-
scriptional response to later learning-related stimuli and
neuronal reactivation.
Introduction
A range of epigenetic modifications, including the covalent
modification of DNA by cytosine methylation, confers the
transcriptional activity of a given gene. DNA methylation
was once considered to be a relatively static epigenetic
modification, with its primary function restricted to the
regulation of transcriptional programming during early
cellular development. However, a surge of recent studies
point to a continued role for DNA methylation across the
lifespan, particularly with respect to alterations in neuro-
nal gene expression that directly impact behavior [1–8].
Drawing from a conservative developmental perspective,
investigations into the function of DNA methylation in the
adult brain have predominantly explored instances where
learning- or activity-induced changes in methylation with-
in gene promoters correlate with changes in gene expres-
sion. Instances where basal levels of gene expression
remain unaltered following a change in DNA methylation
within the corresponding gene [9,10] have been largely
overlooked, which has led to a limited appreciation of the
functional variations in DNA methylation, both within
gene promoters and elsewhere in the genome. However,
recent advances in next-generation sequencing indicate
that the relation between DNA methylation and transcrip-
tional activity is more complex than previously realized. In
the adult brain, neuronal activity-induced changes in DNA
methylation frequently occur outside gene promoters [2],
and 5-hydroxymethylcytosine, a newly discovered base
derived from 5-methylcytosine that represents a functional
intermediary in the active demethylation process [11],
accounts for almost half of DNA methylation detected in
the brain [12]. Furthermore, DNA methylation can inter-
act with other epigenetic marks to jointly regulate tran-
scription [13,14]. However, the relevance of this expanded
repertoire of epigenomic modifications, particularly within
the context of behavioral adaptation across the lifespan,
remains to be determined.
One of the most remarkable features of the adult brain is
its plasticity in response to experience. To have a lasting
impact on behavior, learning-induced neuronal activity
must be accompanied by a functional reprogramming of
gene expression with corresponding modifications of protein
synthesis and synaptic connectivity [15]. However, sus-
tained changes in gene expression could severely constrain
plasticity and jeopardize the ability of a neuron to respond to
later stimuli. Instead, similar to the dormancy of memory
until recall, learning-related reprogramming of gene expres-
sion may be encoded in the genome and reflected in changes
in gene expression only when required, such as during
neuronal reactivation. This form of latent responsivity,
termed ‘metaplasticity’, or the plasticity of synaptic plastic-
ity, is a fundamental mechanism of behavioral adaptation
[16–18]. Experience-dependent metaplasticity allows prior
learning to register a signature that directs later plasticity
without disrupting cell homeostasis. For example, reward-
seeking behavior is governed by the induction of ‘silent’
synapses, which do not influence the basal efficacy of syn-
aptic transmission but are prominent mediators of plasticity
in response to later stimulation, the result of which is
enhanced behavioral sensitivity to subsequent exposure
to cues related to prior learning [18].
Although the existence of metaplasticity has been recog-
nized for some time, the molecular mechanisms underpin-
ning this adaptation are largely unknown. We propose that
activity-induced variations in DNA methylation, particular-
ly within the context of learning and memory, represent a
form of genomic metaplasticity that serves to prime the
transcriptional response to later neuronal activation. In
collaboration with other epigenetic marks, experience-de-
pendent changes in DNA methylation would direct later
transcription and plasticity in several ways, including the
regulation of alternative splicing [19] and transposable
elements [20], the development of bivalent chromatin marks
that render genes poised for transcriptional activity [21],
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or by directing nucleosome repositioning to bookmark re-
cently activated genes [22]. DNA methylation is intimately
related to the functional capacity of the genome and may
therefore contribute substantially to behavioral adaptation
across the lifespan through its direct effects on neural
plasticity and cognition.
Mechanisms of dynamic DNA methylation
The activity of three DNA methyltransferases, DNMT1,
DNMT3a, and DNMT3b, regulate cytosine methylation in
mammals. DNMT1 is considered to be a maintenance
methyltransferase, whereas DNMT3a and DNMT3b me-
diate de novo methylation. Although each of these enzymes
plays a crucial role in establishing genomic methylation
patterns during early neurodevelopment, only DNMT1
and DNMT3a are expressed in mature neurons, where
they appear to play a complementary role in regulating
synaptic plasticity [23] (Figure 1).
Active DNA demethylation permits the dynamic regu-
lation of the methylome in response to neuronal activity
[2,24,25] and learning [26]. Active demethylation involves
enzymatic removal of 5-methylcytosine and occurs via
several mechanisms, including: (i) deamination of 5-
methylcytosine to thymine by activation-induced cytidine
deaminase (AID) [27] and subsequent removal of a T–G
mismatch by the base excision repair pathway (Figure 2a);
(ii) conversion of 5-methylcytosine to 5-hydroxymethylcy-
tosine by the ten-eleven translocation 1-3 (Tet1-3) family of
DNA hydroxylases followed by base excision repair [24]
(Figure 2b); or (iii) nucleotide excision repair, which
involves Gadd45a [28] (Figure 2c). Moreover, it is likely
that these mechanisms act in conjunction with each other
to dynamically regulate DNA demethylation and the tran-
scriptional activity at a specific genomic locus.
DNA methylation and cellular differentiation
A tightly timed interplay between DNA methylation,
hydroxymethylation, and active demethylation regulates
gene expression and cellular differentiation in the devel-
oping nervous system [29–31]. Pluripotency is strongly
associated with high levels of 5-hydroxymethylcytosine
in embryonic stem cells [32,33] and the loss of 5-hydro-
xymethylcytosine and subsequent accumulation of 5-
methylcytosine corresponds with lineage commitment
[32]. Critical developmental stage-specific patterns of
DNMT expression further reflect the importance of DNA
methylation in directing early neurodevelopment [34]. For
example, active demethylation within the promoters of
several astrocytic markers [35,36] directs astrocyte lineage
commitment from pluripotent neural precursor cells. Fur-
thermore, epigenetic reprogramming via DNA methyla-
tion is required for the development of neural precursor
cells [37] and is associated with neuronal differentiation
[38]. Based on these observations, it is widely believed that
the induction, or loss, of DNA methylation during early
development drives unidirectional and sustained changes
in gene expression, which ultimately give rise to cellular
identity [30]. However, differentiating neurons retain a
comparatively high level of 5-hydroxymethylcytosine, in-
dicating that perhaps the neuronal methylome retains a
greater degree of plasticity throughout development [33].
In humans, neurons show significantly greater interindi-
vidual variation compared with non-neuronal cells of the
brain, supporting the idea that the neuronal methylome
may have an enhanced propensity for plasticity in response
to environmental cues [39].
The relation between DNA methylation and gene ex-
pression in development is also more complex than previ-
ously appreciated. For example, although promoter
methylation appears to be a key regulator of cell type-
specific programming [29,40], recent evidence suggests
that non-promoter DNA methylation also coordinates
the expression of neurogenic genes [41]. Moreover, the
association between promoter methylation and gene ex-
pression appears to be contingent on CpG density [42], and
there are instances where altered DNA methylation fails to
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Figure 1. DNA methylation across the lifespan. DNA methylation is mediated by two de novo DNA methyltransferases, DNMT3a and DNMT3b, and one maintenance
methyltransferase, DNMT1. The expression of these DNMTs varies across the lifespan: the expression of DNMT3b is restricted to embryonic development and corresponds
to a period of early neurogenesis, whereas an increase in DNMT3a expression coincides with early postnatal neuronal maturation [34]. DNMT3a and DNMT1 are expressed
in the CNS throughout the lifespan and may be important for synaptic plasticity [5,34]. Abbreviation: NPC, neural progenitor cell.
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coincide with gene expression [43]. This has prompted the
suggestion that DNA methylation does not directly regulate
transcription but rather serves as a signal for the long-term
maintenance of gene silencing [44]. Taken together, these
observations indicate the existence of context-specific
variations in DNA methylation and associated epigenetic
marks, the functional relevance of which has yet to be fully
revealed.
DNA methylation and early development
Stimuli in the pre- and postnatal environments have sig-
nificant effects on gene expression, which persist long after
the initial stimulus has dissipated. Dynamic regulation of
the methylome provides an underlying epigenetic signa-
ture of early-life experience that could support these sus-
tained changes in gene expression. In rats and mice,
prenatal stress [45], maternal cocaine exposure [46], and
parental enrichment [47] give rise to changes in promoter
methylation within a subset of genes in offspring, which
correlate with lasting changes in transcriptional activity.
Similarly, postnatal developmental perturbation, such as
infant maltreatment [48] or maternal deprivation [49–52],
results in corresponding changes in DNA methylation and
gene expression that persist into adulthood and are accom-
panied by enduring behavioral phenotypes. However, var-
iations in 5-methylcytosine levels incurred as a function of
early-life experience can be functionally reversed in rats
through methyl supplementation at later time points
[52,53]. Therefore, the evidence suggests that, in contrast
to the proposed role of static DNA methylation in deter-
mining cell fate, postnatal epigenetic reprogramming via
DNA methylation is an active process that is dynamically
regulated across the lifespan.
DNA methylation and behavioral adaptation in
adulthood
It has been proposed that long-term memory is contingent
on transcriptional regulation that is both stable and self-
perpetuating, two characteristics traditionally ascribed to
DNA methylation. Less than a decade ago, evidence
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Figure 2. Mechanisms of active DNA demethylation. Active demethylation occurs by several different mechanisms, including base excision repair (BER) pathways (a,b) and
nucleotide excision repair (NER) (c). (a) Deamination of 5-methylcytosine by AID/APOBEC yields thymine, which is excised by mammalian T–G-specific glycosylases (TDG,
SMUG1, or MBD4) through BER [27]. (b) 5-Methylcytosine can also be oxidized by the ten-eleven translocation (TET) family of enzymes to form 5-hydroxymethylcytosine
[24]. 5-Hydroxymethylcytosine can then be further oxidized to 5-formylcytosine and 5-carboxylcytosine, or converted to 5-hydroxymethyluridine by AID/APOBEC. Excision
of these intermediates is initiated by mammalian T–G specific glycosylases (TDG, SMUG1, or MBD4), resulting in replacement with an unmethylated cytosine. (c) GADD45
and cofactors can also remove 5-methylcytosine by NER [28]. Abbreviations: AID, activation-induced cytidine deaminase; APOBEC1–3, apolipoprotein B mRNA editing
enzyme-catalytic polypeptides 1–3; GADD45, growth arrest and DNA damage-inducible protein 45; MBD4, methyl-CpG-binding domain protein 4; SMUG1, single-strand-
selective monofunctional uracil-DNA glycosylase 1; TDG, thymine DNA glycosylase.
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emerged contradicting the prevailing model for an exclu-
sive role of DNA methylation in development: the expres-
sion of de novo DNMTs remained unexpectedly high in
post-mitotic neurons [34], early maternal care generated
persistent gene-specific changes in DNA methylation that
were associated with stress vulnerability in adulthood [51],
and neuronal activity-induced demethylation was ob-
served both in vitro and in the adult brain [54]. Together,
these findings indicated that the molecular machinery
driving variations in DNA methylation is present in the
postnatal brain and is responsive to experience and may
therefore be enlisted to perpetuate the learning-induced
changes in gene expression that underlie long-term mem-
ory. As summarized in Table 1, this possibility has become
the focal point of investigations into learning-related
changes in DNA methylation [7,8,23,55–57]. For example,
acute regulation of DNA methylation occurs as a function
of learning [8,26] and following the induction of long-term
potentiation (LTP) [58], the accepted cellular analog of
memory-related plasticity. DNMT3a expression is upregu-
lated in many learning paradigms [5,59], as well as follow-
ing the artificial induction of synaptic plasticity [57].
Furthermore, although transient learning-induced modi-
fications of DNA methylation occur in the hippocampus
following contextual fear conditioning [8], persistent
alterations develop within the prefrontal cortex following
an associative learning task [7]. Local inhibition of the
maintenance of altered methylation incurs memory defi-
cits, suggesting that cortical DNA methylation is enlisted
by the brain to preserve remote memories [7].
As a caveat, the role of DNA methylation in maintaining
memory may be structure and locus specific; within the
hippocampus both relatively persistent [57] and transient
[8] learning-induced changes in DNA methylation occur,
suggesting that this modification performs dissociable
roles in the formation and maintenance of memory. In
addition, DNA methylation is one component of the chro-
matin environment and can interact with other epigenetic
modifications to regulate transcription [13]. Furthermore,
concomittant changes in activating or repressing pathways
can obscure the relation between DNA methylation and
gene expression. Nevertheless, a primary consideration
within the context of memory maintenance is how a single
neuron, regardless of anatomical region, would cope with
enduring changes in the methylome that manifest in last-
ing cell-wide transcriptional consequences. We propose
that DNA methylation constitutes a mark of prior neuronal
and transcriptional activity that contributes to memory
maintenance by altering genomic responsivity to later
neuronal activation.
Dynamic DNA methylation as a mechanism for genomic
metaplasticity
Many theories of memory storage suggest that the same
network of neurons encodes multiple memories, which
retain their independence by enlisting distinct synapses
of each neuron. Consequently, cell-wide changes, such as
the persistent changes in gene transcription arising from
learning-induced changes in DNA methylation [7], would
be likely to perturb the maintenance of all memory traces
encoded by a given neuron, including those encoded during
prior learning. One possibility is that, rather than contrib-
uting to the maintenance of a unique memory, persistent
changes in DNA methylation alter the ability of a neuron to
respond to later stimuli, presumably through lasting tran-
scriptional changes [7,54,60]. According to this hypothesis,
enduring epigenetic marks would render a neuron aplastic
and stabilize synaptic weights through enduring changes
in the transcriptome, conferring responsivity to selective
inputs by modulating the degree of plasticity at all other
synapses [55]. However, this would both severely restrict
the storage capacity of the brain and entail a substantial
disruption of cell homeostasis. Instead, we propose that
experience-dependent variations in DNA methylation rep-
resent a form of metaplasticity that primes the genome for
response to later events by regulating transcriptional effi-
cacy in response to incoming inputs, rather than by medi-
ating enduring changes in gene expression (Figure 3).
Priming of the transcriptional response by active DNA
demethylation has been clearly demonstrated in mamma-
lian systems [61,62]. For example, in rat hepatic cells,
glucocorticoid stimulation can initiate the expression
Table 1. Examples of the dynamic regulation of DNA methylation in the adult rodent brain that have been associated with altered
behaviorsa
Behavior Impaired and/or enhanced Experimental manipulation Gene Locus 5-mC Brain region Refs
Fear-related learning and memory " WT PP1 Promoter " HPC [8]
Reelin Promoter # HPC
CaN Promoter " ACC [7]
BDNF Exon # HPC [57]
BDNF Promoter "/# HPC [26]
" DNMT3A overexpression N/a Euchromatin " HPC [103]
# DNMT inhibition N/a N/a N/a AMG [59]
N/a N/a # HPC [3]
N/a Fear conditioning Zif268 Promoter " HPC [14]
Drug-seeking and/or preference # DNMT inhibition N/a N/a # NAc [74]
Stress reactivity and/or anxiety " Maternal deprivation Crh Promoter # PVN [9]
Avp Enhancer # PVN [50]
" Maternal care Gr17 Promoter " HPC [51]
"/# Methionine and/or TSA Gr17 Promoter "/# HPC [52]
aAbbreviations: ACC, anterior cingulate cortex; AMG, amygdala; Avp, arginine vasopressin; BDNF, brain-derived neurotrophic factor; CaN, calcineurin; DG, dentate gyrus;
Era1b; estrogen receptor alpha 1-beta; Gr17, exon 1(7) glucocorticoid receptor; HPC, hippocampus; MPA, medial pre-optic area; N/a, not applicable; NAc, nucleus
accumbens; PVN, paraventricular nucleus; PP1, protein phosphatase 1; TSA, trichostatin A; WT, wild type.
Opinion Trends in Neurosciences January 2013, Vol. 36, No. 1
6
and demethylation of an enhancer region proximal to the
gene encoding liver-specific tyrosine aminotransferase
(Tat). Although this modification is stable for up to 3
months, the expression of Tat returns to basal levels upon
withdrawal of glucocorticoid stimulation. Nevertheless,
the capacity for transcriptional activity is primed by
DNA demethylation and, upon subsequent glucocorticoid
stimulation, the expression of Tat is three- to fivefold
greater than in previously unstimulated cells [61]. There-
fore, there is direct evidence of genomic metaplasticity by
active DNA demethylation. Demethylation-dependent
transcriptional priming is also evident in the nervous
system. In rats, maternal deprivation induces demethyla-
tion of corticotropin-releasing hormone (Crh) promoter.
However, this change in methylation is not reflected in
altered levels of Crh expression until the animals are
subject to acute stress, upon which Crh is significantly
upregulated [9]. As described below, DNA methylation
could contribute to genomic metaplasticity in a variety
of ways.
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Figure 3. Hypothetical model of the metaplastic priming and repression of gene transcription by changes in DNA methylation. (a) Priming: following a learning event (i) or
neuronal activation, the expression of a gene is elevated and learning is acquired. More transient epigenetic modifications, such as histone acetylation, may be responsible
for the initial burst in expression and DNA demethylation may occur subsequent to transcription. In contrast to current models, the expression of the demethylated gene
could return to baseline in the absence of the initial activating stimulus or when the memory is stored (ii). However, persistent DNA demethylation may prime gene
transcription upon reactivation of the neuron by memory retrieval or by new learning (iii), potentially enhancing expression relative to the response elicited by initial
activation and learning. The priming of a transcriptional response by active DNA demethylation has been clearly demonstrated in other mammalian systems [61,62] and in
the nervous system [9]. In the case of memory-enhancing genes, metaplastic priming could facilitate the encoding of new memories, although the priming of memory
suppressors could impair the formation of new associations by previously activated neurons. (b) Repression: (i) as in the case of priming, increased DNA methylation could
occur subsequent to learning- or activation-induced changes in gene transcription, driven by more rapid modifications, such as the binding of transcription factors or
histone modifications, which are known to work in concert with DNA methylation to regulate transcription [13]. Alternatively, rapid DNA methylation could promote
transcription by preventing the binding of a repressor protein. However, according to our hypothesis, while the memory is dormant and the neuron inactive (ii), a
methylation-mediated change in the transcriptional response is not evident and the expression of the inhibited gene returns to baseline. Nevertheless, in response to
further stimulation (iii), the transcriptional activity of the gene is suppressed by persistent learning-induced augmentation of DNA methylation, rendering the neuron
aplastic and unable to encode new associations. The methylation-induced blunting of the transcriptional response to subsequent stimulation has been observed in the
hypothalamic proopiomelanocortin (POMC) promoter, where overfeeding leads to hypermethylation and prevents the increase in transcription in response to high insulin
levels [101]. As a caveat of our hypothesis, the effect of DNA methylation or demethylation on the responsivity of the neuron would be locus and gene specific; for instance,
by giving rise to alternative splice variants, de novo DNA methylation could prime neuronal activity. Furthermore, DNA methylation may enhance transcription by
preventing the binding of a repressor protein. However, the primary difference with current models is that DNA methylation or demethylation does not result in persistent
changes in gene expression, but rather these changes in expression manifest at the time of neuronal reactivation and affect the ability of the neuron to encode new
associations.
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Regulation of alternative splicing
Alternative splicing contributes to the formation and main-
tenance of memory by fine-tuning receptor composition
and ion channel properties following neuronal depolariza-
tion [63,64], providing a subtle mechanism for regulating
synaptic strength. Moreover, the induction of alternative
splicing in response to prior events, such as exposure to
stress, modulates the acquisition of new learning and the
maintenance of memory by regulating LTP [65], providing
a clear example of metaplasticity. Unsurprisingly, a sig-
nificant percentage of neuronal activity-induced changes in
DNA methylation occur in intragenic regions of the genome
[2], which is consistent with a conserved role for intragenic
methylation in regulating alternative splicing [66].
DNA methylation directs alternative splicing by
manipulating the kinetics of RNA polymerase II, an enzyme
that catalyzes gene transcription (Figure 4a). In the context
of neuronal plasticity, one possibility is that learning-
induced changes in DNA methylation persistently up- or
downregulate the expression of alternative splice variants to
ultimately determine the responsivity of a neuron to new
stimulation. An important caveat of this is that enduring
changes in DNA methylation may not be reflected in an
overall change in the expression of a given gene, but instead
appear as an altered ratio of splice variant expression [26]. A
second possibility, in agreement with the idea of quiescent
metaplastic modifications, is that DNA methylation could
regulate the expression of various splice variants at specific
points in time, such as when the gene is retranscribed
following memory retrieval or during the formation of new
memories. The presence of different learning-induced splice
variants could determine whether novel information is
retained [65] by promoting or inhibiting the changes in
synaptic strength that underlie memory maintenance. Ac-
cordingly, by regulating alternative splicing, activity-in-
duced modifications of DNA methylation provide an
example of genomic metaplasticity that ultimately deter-
mines the responsivity of a neuron to future stimuli.
Key:
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Figure 4. Select mechanisms by which learning-induced variations in DNA methylation can direct genomic metaplasticity. Experience-dependent modifications of DNA
methylation could prime future transcription in several ways. (a) Alternative splicing: DNA methylation prompts the formation of alternative splice variants by manipulating
the kinetics of RNA polymerase II (RNA Pol II). De novo DNA methylation prevents CTCF binding and the CTCF-contingent pausing of RNA Pol II. In the absence of CTCF-
mediated RNA Pol II stalling, transcriptional elongation is impaired and the subsequent transcription of weak exons is inhibited [19]. Therefore, by preventing CTCF binding,
DNA methylation can yield alternative splice variants. (b) The regulation of retrotransposition: DNA demethylation may permit the transcription and insertion of L1
retrotransposons into various regions of the genome. Insertion of L1 copies affect gene length, where increased gene length is associated with reduced transcription [70].
(c) The development of bivalent domains: De novo DNA methylation resolves poised bivalent chromatin domains at promoter regions, leading to gene repression [32].
Bivalent domains are characterized by an activating histone mark (H3K4me3) and a repressive histone mark (H3K27me3), with RNA Pol II tethered at the domain by H2A
ubiquitination [102]. (d) Nucleosome repositioning: DNA methylation can induce the shortening of linker DNA, thereby increasing internucleosomal interactions and
priming clusters in interrelated genes. The addition of a methyl group at the 50 position of the cytosine decreases the flexibility of DNA, which prompts more DNA to be
trapped within the nucleosome, thereby shortening the linker region [90]. Abbreviations: CTCF, CCCTC-binding factor; DNMT, DNA methyltransferase; H3K4me3, histone
H3 lysine 4 trimethylation; H3K27me3, histone H3 lysine 27 trimethylation; L1, long interspersed nuclear element 1; MCEP2, methyl CpG binding protein 2.
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Regulation of transposable elements
Another example of experience-induced genomic meta-
plasticity is the movement of transposable elements.
The insertion or deletion of a single transposable element
can influence gene expression by introducing novel
alternative promoter regions, enhancer elements, tran-
scription factor binding sites, premature polyadenylation
[67], or by promoting the formation of heterochromatin
[68]. Equally, the insertion of several transposable ele-
ments can affect transcriptional efficacy by altering gene
and/or intron length [69] (Figure 4b), whereby reduced
gene length is associated with more highly expressed
genes [70]. Although it was previously thought that retro-
transposition occurred primarily during early embryogen-
esis [71], it has now been demonstrated that the
expression of a retrotransposon termed ‘long interspersed
nuclear element 1’ (L1) continues during adulthood and is
elevated in the brain [20,72,73]. L1 retrotransposition
occurs in response to a range of environmental stimuli,
including voluntary exercise and chronic cocaine exposure
[74,75], and it has recently been proposed to generate the
unique experience-dependent transcriptome profile of in-
dividual neurons [76]. L1 transcription is repressed by
region-specific DNA methylation in the 50 untranscribed
region (UTR) [77] and, accordingly, in neural precursors
and differentiated neurons, by the expression of methyl
CpG binding protein 2 (MeCP2) [20,78]. Furthermore,
L1 elements undergo an age-related depletion of
5-hydroxymethylcytosine in the hippocampus [12], which
may reflect reduced plasticity.
Perhaps the most interesting implication of the regula-
tion of transposable elements by DNA methylation is that, to
have an enduring and pervasive effect on gene transcription,
methylation or demethylation need only occur transiently
and allow the movement of transposable elements. In direct-
ing the movement of transposable elements, learning-relat-
ed changes in DNA methylation provide an excellent
illustration of genomic metaplasticity: the accumulation
of retrotransposons may generate a silent signature of prior
neuronal activity that affects memory maintenance and
later plasticity. The metaplastic modulation of memory-
related genes could be reflected by enduring up- or down-
regulation of the affected gene, or be revealed upon future
transcription, through alternative splicing (alternative pro-
moter insertion) and enhanced or weakened transcription
(insertion of enhancer or insulator elements, or decreased
and/or increased gene length), all of which would have
lasting consequences for memory maintenance.
Regulation of bivalent chromatin domains
Bivalent chromatin domains are characterized by the
presence of a repressive histone modification [trimethyla-
tion of histone H3 lysine 27 (H3K27me3)] interspersed
with active histone marks [trimethylation of histone H3
lysine 4 (H3K4me3)], which produce a silent but transcrip-
tionally poised state [21] that is characteristic of metaplas-
ticity (Figure 4c). Bivalent promoters are further
distinguished by the accumulation of 5-hydroxymethylcy-
tosine and a corresponding depletion of 5-methylcytosine
[79]. Traditionally, bivalent states occur within develop-
mental genes that are primed to respond to regulatory cues
and, during early development, de novo DNA methylation
resolves bivalent states to silence genes over time [30].
However, approximately 40% of bivalent domains are
retained in terminally differentiated neurons [30], which
suggests a continued propensity for this form of plasticity
in post-mitotic neurons. The greater degree of 5-hydroxy-
methylcytosine retained in neurons [33] may protect biva-
lent domains from becoming permenantly silenced by de
novo methylation, as it does in other cell types [80]. More-
over, activity-dependent demethylation could permit the
further reinstatement of bivalent chromatin domains, ren-
dering genes poised for future activation. In several model
cellular systems, pharmacologically induced demethyla-
tion by 5-aza-20 deoxycytidine, a DNMT inhibitor, allows
formerly hypermethylated genes to regain a bivalent state
by increasing the presence of H3K4me3 [81–83], although
this remains to be demonstrated in non-dividing cells.
These data further suggest that the processes regulating
DNA methylation function synergistically with post-trans-
lational modification of histones to promote genomic plas-
ticity, an idea that has been echoed in the context of
learning and memory [13,14]. Together with evidence for
an age-dependent change in DNA methylation at bivalent
domains [84], it appears that the experience-dependent
development of bivalent chromatin states, which occurs as
a function of active variations in DNA methylation, may
perform a metaplastic function by priming a gene for
activation without necessarily influencing basal levels of
gene expression.
Regulation of nucleosome positioning
Nucleosome repositioning is another mechanism by which
altered DNA methylation may prime a gene for transcrip-
tion. DNA coils around an octamer of condensed histone
proteins to form a nucleosome, with each nucleosome
separated by a 20–50-base pair (bp) linker region of
DNA. Nucleosomal arrangement within neurons is unique
in that the distance between nucleosomes is appreciably
shorter than that in other cells of the brain [85]. This
characteristic emerges at the point of neuronal maturation
[86] and may poise the neuronal genome for enhanced
plasticity, because reduced linker DNA length facilitates
internucleosomal interactions [87]. Consequently, a
change in the relative position of one nucleosome impacts
the positioning of neighboring nucleosomes to a greater
extent [87], potentially providing a mode of transcription-
ally priming or repressing clusters of interrelated genes.
In the aging rat brain, an increase in nucleosome repeat
length [88] coincides with a loss of DNA methylation [89],
which suggests a potential relation. Mechanistically, there
are multiple levels at which DNA methylation can influ-
ence nucleosome positioning. DNA methylation can de-
crease the flexibility of DNA to interfere with the
exaggerated bending of DNA required to form nucleosomes
[90], resulting in a further shortening of the regions of
linker DNA [91] (Figure 4d) that can alter the conforma-
tional space of a gene [92]. Moreover, activity-dependent
demethylation could regulate the relative position of a
recently transcribed gene within the nucleus. DNA de-
methylation can facilitate the incorporation of histone
variants, such as H2A.Z [22], which directly oppose DNA
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methylation [93] and also coordinate the repositioning of
nucleosomes associated with recently activated exons to
the nuclear periphery [94,95]. Although the regulation of
nucleosome repositioning by DNA methylation or demeth-
ylation has yet to be demonstrated in vivo, the relocation of
genes to a location within the nucleus could serve to either
prime or repression expression [96] upon subsequent stim-
ulation of the neuron. These observations point to a poten-
tial role for DNA methylation in the regulation of
nucleosome repositioning and experience-dependent geno-
mic plasticity, as a result of interactions with ATP-depen-
dent chromatin remodeling and the deposition of non-
canonical histone variants.
Genomic metaplasticity: the epigenome and beyond
The neuronal methylome is embedded within a complex
epigenetic environment, comprising many modifications,
including histone acetylation, methylation, and a myriad
other epigenetic marks. DNA methylation can act syner-
gistically with numerous epigenetic modifications [14,56]
to form an ‘epigenetic code’ that can regulate synaptic
plasticity [60]. Consequently, a learning-induced transcrip-
tional event would be encoded by the comprehensive epige-
netic environment surrounding a given gene [97], rather
than by the covalent modification of DNA in isolation.
However, to support genomic metaplasticity, an epigenetic
modification must be relatively enduring yet possess the
potential for plasticity; two key characteristics of DNA
methylation, the latter of which has only recently come to
light in the context of the nervous system [2,24,25,54]. These
recent discoveries suggest that the neuronal methylome is a
prime candidate for investigations into the molecular under-
pinnings of metaplasticity; however, the study of this adap-
tation should also include its relation with other epigenetic
mechanisms, as described in Box 1.
Concluding remarks
Investigations into the functional relevance of DNA meth-
ylation continue to reveal a role for dynamic regulation of
the methylome across the lifespan. However, the guiding
principles of these early studies have been based on a
developmental perspective, where DNA methylation is
thought to restrict plasticity and stabilize changes in gene
expression to give rise to cellular identity. By contrast, a
critical feature of the adult brain is continued plasticity,
which is predicated by an enduring capacity for dynamic
regulation in response to environmental stimuli. To date,
understanding of the adaptive significance of learning-
related changes in DNA methylation has been restricted
to the study of candidate genes that demonstrate concomi-
tant changes in DNA methylation and gene expression.
However, this approach affords limited insight into the
true plasticity of the methylome. Genome-wide sequencing
has revealed that a host of activity-modified CpGs occur
within regions of the genome that may not engender
persistent, cell-wide changes in transcription, but rather
prime the genome to respond to future stimuli.
Although direct demonstrations of DNA methylation-
mediated genomic metaplasticity within the context of
learning and memory are limited, emerging evidence sug-
gests that the priming of genomic capacity by epigenetic
modifications accompanies the development of certain
psychiatric disorders, such as drug addiction [98–100]. A
deeper understanding of the dynamic regulation of DNA
methylation and its associated epigenetic marks across the
lifespan is on the horizon, which will eventually lead to a
clearer picture of gene–epigenome–environmental interac-
tions and behavioral adaptation across the lifespan. It is
evident that this epigenetic mechanism has many funda-
mental biological and functional roles yet to be explained
and it may be within cognition, memory, and the fine-
tuning of genomic metaplasticity where the influence of
dynamic DNA methylation will be most significant.
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Box 1. Outstanding questions
! How do other epigenetic modifications interact with DNA
methylation to regulate genomic metaplasticity at a given locus?
Particular attention should be directed to enduring epigenetic
modifications, such as histone methylation, which is one of the
few histone modifications that has been shown to be modified in
an enduring fashion following learning [14,104]. Histone methyla-
tion may both direct DNA methylation and be reinforced by DNA
methylation by way of a positive feedback loop [105], and
therefore may jointly regulate long-term changes in gene
transcription. Noncoding RNAs may further contribute to the
maintenance of DNA methylation and demethylation [106].
Improved genome-wide sequencing techniques have become
available to elucidate the contribution of DNA methylation to
experience-dependent genomic metaplasticity. These include
approaches such as oxidative bisulfite-seq for the detection of 5-
hydroxymethylcytosine [107], RNA-capture approaches for asses-
sing retrotransposition events [108], bisulfite-seq on immunopre-
cipitated DNA to determine the contribution of DNA methylation
toward the development of bivalent chromatin domains [109], as
well as Nucleosome Occupancy Methylome sequencing (NOMe-
seq) to explore methylation-mediated nucleosome repositioning
[110]. Furthermore, some of these techniques are compatible with
the analysis of small amounts of DNA or RNA, which could reveal
the epigenetic signature of learning-induced neuronal activation
in vivo and yield better resolution of the alterations in DNA
methylation that support discrete memory traces
! Is genomic metaplasticity possible at all genes, throughout all
periods of development or do certain genes have an increased
propensity for plasticity at key periods in time?
! Is genomic metaplasticity dysregulated in neuropsychiatric
diseases (such as addiction) that are marked by decreased
cognitive flexibility? If so, is it possible to re-initiate plasticity to
alleviate symptoms?
Recent work has shown that cocaine exposure epigenetically
primes the expression of DFosB in response to subsequent
cocaine challenge [98], although the mechanisms supporting this
response require further investigation. Lasting gene-specific
changes in DNA methylation incurred during early development
have also been shown to prime gene expression and responsivity
to stress in adulthood in rodents [9].
! How is DNA methylation and/or demethylation directed to
specific sites in the genome?
Noncoding RNAs proximal to the recently transcribed genes
could direct DNA methylation or demethylation [106], although
this remains to be elucidated.
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3.1 Preamble 
As modifications of DNA methylation associated with cocaine self-administration (IVSA) 
likely arise within a distinct subset of neurons located in specific regions of the brain, 
performing whole genome analysis of DNA methylation on whole brain or whole region 
homogenates might prevent the detection of such discrete changes in DNA methylation. 
To facilitate the detection of IVSA-associated changes, I chose to examine modifications 
of DNA methylation within neurons of the mPFC. Unfortunately, I was first unable to 
achieve satisfactory labelling and sorting of neurons and I therefore drew from several 
methods to create a superior and easier method of labelling and sorting neuronal nuclei by 
fluorescent activated cell sorting (FACS). Secondly, the amount of DNA retrieved from the 
mPFC neurons of individual animals was insufficient for the application of existing 
genome-wide methods of identifying changes in DNA methylation. To apply existing 
techniques would have required the pooling of DNA from multiple animals and result in the 
loss of DNA methylation detection within individual animals. To circumvent this problem, 
myself and another student modified a DNA-barcoding technique, which assigns unique 
identifiers to strands of DNA from specific animals. Using this technique, we could pool 
DNA from multiple animals and use a methyl binding domain-based enrichment approach 
to isolate fragments of DNA possessing a moderate amount of DNA methylation. These 
fragments are then sequenced and the level of 5-methylcytosine enrichment is compared 
between groups, which identifies genomic loci that have been differentially methylated 
between conditions. The entire protocol, from the isolation of neuronal nuclei to the 
validation of sequencing results was recently published as a methods paper in Genes, 
Brain and Behaviour and is included as Chapter 3. MBD Ultra-Seq was subsequently used 
for the identification of IVSA-associated changes in DNA methylation in Chapter 4.  
3.2 MBD Ultra-Seq 
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Experience-dependent changes in DNA methylation
can exert profound effects on neuronal function and
behaviour. A single learning event can induce a variety
of DNA modifications within the neuronal genome,
some of which may be common to all individuals expe-
riencing the event, whereas others may occur in a
subset of individuals. Variations in experience-induced
DNA methylation may subsequently confer increased
vulnerability or resilience to the development of neu-
ropsychiatric disorders. However, the detection of
experience-dependent changes in DNA methylation
in the brain has been hindered by the interrogation of
heterogeneous cell populations, regional differences in
epigenetic states and the use of pooled tissue obtained
from multiple individuals. Methyl CpG Binding Domain
Ultra-Sequencing (MBD Ultra-Seq) overcomes current
limitations on genome-wide epigenetic profiling by
incorporating fluorescence-activated cell sorting and
sample-specific barcoding to examine cell-type-specific
CpG methylation in discrete brain regions of individuals.
We demonstrate the value of this method by character-
izing differences in 5-methylcytosine (5mC) in neurons
and non-neurons of the ventromedial prefrontal cortex
of individual adult C57BL/6 mice, using as little as 50ng
of genomic DNA per sample. We find that the neuronal
methylome is characterized by greater CpG methylation
as well as the enrichment of 5mC within intergenic loci.
In conclusion, MBD Ultra-Seq is a robust method for
detecting DNA methylation in neurons derived from
discrete brain regions of individual animals. This proto-
col will facilitate the detection of experience-dependent
changes in DNA methylation in a variety of behavioural
paradigms and help identify aberrant experience-induced
DNA methylation that may underlie risk and resiliency
to neuropsychiatric disease.
Keywords: DNA methylation, genome-wide, MBD, NeuN,
neuron, next-generation sequencing
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Experience-induced changes in DNA methylation are associ-
ated with the formation and maintenance of memory (Miller
& Sweatt 2007;Miller et al. 2010; Vanyushi et al. 1974), vulner-
ability to neuropsychiatric disorders following adverse early
life experiences (Chen et al. 2012; Labonte et al. 2012;Murga-
troyd et al. 2009; Weaver et al. 2004), as well as the develop-
ment of addiction (Anier et al. 2010; Day et al. 2013; Muschler
et al. 2010; Tian et al. 2012) and fear-related anxiety dis-
orders (Kang et al. 2013; Labonte et al. 2013). Accordingly,
epigenome-wide association studies stand to reveal a host
of novel biomarkers of susceptibility to psychiatric illness and
to shed light on common mechanisms of memory forma-
tion and maintenance. However, because of technical limita-
tions, genome-wide investigations of experience-dependent
changes in DNA methylation in vivo have predominantly
examined heterogeneous brain tissues (Day et al. 2013;
Grayson et al. 2005; Kang et al. 2013; Laufer et al. 2013;
Mill et al. 2008; Mizuno et al. 2012; Sabunciyan et al. 2012;
Simmons et al. 2012; Tian et al. 2012), which impedes the
discovery of disease- and learning-related changes in DNA
methylation (Guintivano et al. 2013).
Cellular heterogeneity confounds epigenetic profiling in
two ways (Guintivano et al. 2013; Heijmans & Mill 2012;
Michels et al. 2013). First, changes in cellular composition
within a region can produce spurious discoveries of changes
in DNA methylation (Guintivano et al. 2013). For example,
chronic stress induces microglial proliferation in the pre-
frontal cortex (Hinwood et al. 2012), which could be reflected
by global changes in DNA methylation if the entire cortex
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was examined, despite the absence of genuine intracellu-
lar changes in methylation. Secondly, if the change in DNA
methylation occurs within a distinct cell population, such
as recently activated neurons, even prominent changes in
5-methylcytosine (5mC) may be imperceptible because of
the relative underabundance of these cells in the regional
mosaic (Guintivano et al. 2013). Fortunately, several meth-
ods exist for isolating cells of interest from tissue, includ-
ing fluorescence-activated cell sorting (FACS) (Guez-Barber
et al. 2012; Iwamoto et al. 2011; Jiang et al. 2008; Kozlenkov
et al. 2013; Okada et al. 2011; Saxena et al. 2012), magnet
affinity cell sorting, laser-capture microdissection (Vincent
et al. 2002) and statistical correction for varying cellular com-
position (Guintivano et al. 2013). However, the amount of
DNA retrieved following the application of these techniques
is often insufficient for the preparation of next-generation
sequencing libraries that currently call for at least 1 μg
of DNA.
To sequence small amounts of DNA, tissue from multi-
ple biological replicates may be pooled or some form of
whole genome amplification employed. However, pooling
samples obscures inter-individual variation in methylation
that could govern differences in susceptibility to develop-
ing neuropsychiatric disorders, and whole genome amplifi-
cation has the potential to introduce bias and artefacts (Aird
et al. 2011; Warnecke et al. 1997). Furthermore, many proto-
cols become exceedingly labour-intensive and expensive if
applied to the large number of samples used in behavioural
paradigms. Here we describe a novel approach to determine
genome-wide CpG methylation in neurons derived from dis-
crete brain regions of individual animals by pairing FACS with
a modified MBD-Seq protocol. We have applied this tech-
nique using as little as 50 ng of DNA per animal to identify
differentially methylated regions (DMRs) within neurons and
non-neurons of the ventromedial prefrontal cortex (vmPFC)
of individual adult C57BL/6 mice. We find DMRs around sev-
eral neuron-specific genes and emphasize the importance of
using a cell-type-specific technique, as few of the regions of
5mC enrichment (RME) identified in neurons of the vmPFC
were also detected in a heterogeneous population of cells
derived from the vmPFC. We conclude that MBD Ultra-Seq
is a robust and cost-effective method for determining CpG
methylation on a genome-wide level in neurons and other
cell populations in individual animals. This technique will be
invaluable for identifying DMRs associated with learning and
memory, as well as for interrogating the neuronal epigenome
in neuropsychiatric disorders.
Materials and methods
Mice
Adult, male C57BL/6 mice (9-week-old, 20–25 g) were used for all
experiments. Mice were housed four per cage on a 12 h light:dark
cycle (lights on 0800h) in a humidity- and temperature-controlled
(22∘C) vivarium, with rodent chow and water provided ad libitum.
Mice were culled by cervical dislocation and whole brains were
snap frozen on liquid nitrogen and transferred to −80∘C storage.
All procedures were conducted according to protocols and guide-
lines approved by the University of Queensland Animal Ethics
Committee.
Dissection of the vmPFC
Ventromedial prefrontal cortices were microdissected by Palkovits
punch (Palkovits 1973). Briefly, whole brains were imbedded in
Tissue-Tek®O.C.T. compound (Sakura Finetek,MountWaverley, Aus-
tralia) and 300 μm coronal sections were serially cryosectioned from
2.96 to 0.26mm anterior to bregma. The vmPFC was retrieved using
a chilled brain punch (Stoelting, Wood Dale, IL, USA), with punches
of diameters 0.75–1.5mm, preselected according to the dimen-
sions of the vmPFC in each slice (Franklin & Paxinos 2007). Isolated
regions were placed immediately on dry ice and stored at −80∘C until
further use.
Isolation of neuronal and non-neuronal nuclei
Individual vmPFCs were dounce-homogenized on ice (Kimble Chase
Kontes, A pestle, K885300-0007, Murarie, Australia) in 1.5ml of
chilled nuclear extraction buffer (Jiang et al. 2008) [0.32M sucrose,
5mM CaCl2, 3mMMg(Ac)2, 0.1mM ethylenediaminetetraacetic
acid (EDTA), 10mM Tris–HCl (pH8), 1mM dithiothreitol (DTT), 1×
EDTA-free protease inhibitor cocktail, 0.3% Triton-X-100]. Nuclear
lysates were filtered through a 40-휇M cell strainer (BD Biosciences,
North Ryde, Australia) to remove clumps and centrifuged at 4∘C
for 7min at 700g. The supernatant was aspirated and nuclei were
gently resuspended in 550 μl of ice-cold 1× phosphate-buffered saline
(PBS). The blocking solution (5% bovine serum albumin, 10% normal
goat serum, 1× PBS) was prepared. The anti-NeuN antibody (1:1200,
Millipore, Kilsyth, Australia) was coincubated with the fluorescent
secondary antibody (1:1400 Alexa Fluor® 488, Invitrogen, Mount
Waverley, Australia) (Table 1, scale for number of samples) for 10min
at 4∘C on a rotating shaker; 50 μl was retained from each sample
and pooled for a secondary antibody-only control. Respective stains
were added to the nuclear solution and incubated for 1 h at 4∘C in
a dark room (see Table 1 for staining proportions). Prior to FACS,
the immunolabelled nuclei were centrifuged at 4∘C for 10min at
700g and gently resuspended on ice in ice-cold 1× PBS; 1 μl of
DAPI (Invitrogen) was added to the secondary-only control to identify
nuclei vs. debris. A BD FACSAria II (BD Biosciences) was used to
sort nuclei. Prior to sorting, 10 000 events from the secondary-only
control were used to gate events on the basis of their size, gran-
ularity and DAPI fluorescence (FITC) to isolate nuclei from debris
(Fig. 1a). From the selected nuclear population, we also established
non-specific labelling by Alexa488 (Fig. 1b). Prior to the sorting of
each NeuN-stained sample, 10 000 events were examined to verify
the position of the gates, as a distinct population of NeuN+ events
is easily recognizable (Fig. 1c). On average, the NeuN+ population
accounted for approximately 60% of the population, or approximately
80 000 events (Fig. 1).
DNA extraction
Nuclei were lysed overnight at 55∘C in lysis buffer (100mM Tris–HCl,
pH8.0, 5mM EDTA, 0.2% sodium dodecyl sulphate (SDS), 200mM
NaCl, 300 μg/ml proteinase K) (Gu et al. 2011). An equal volume
of phenol:cholorform:isoamyl alcohol (25:24:1) was added to each
sample and mixed by vortexing for 2min. Samples were centrifuged
at 14 000g for 5min at room temperature and the supernatant
was carefully isolated and transferred to a new tube; 2.5 sample
volumes of ice-cold 100% ethanol, 1 μl of glycogen (20mg/ml) and
NaCl (final concentration 250mM) were added to each sample. DNA
was precipitated for 4 h at −30∘C. Following precipitation, DNA was
centrifuged at 15000g for 30min at 4∘C. Pellets were washed with
ice-cold 70% ethanol and subject to further centrifugation (10min,
15 000g, 4∘C). Ethanol was removed and the pellets were dried by
vacuum centrifugation at 45∘C, then resuspended in 75 μl of ultrapure
H2O overnight. To maximize recovery, we recommend heating the
solution to 37∘C in a thermomixer for at least 30min to overnight.
Quantification of DNA was performed by Qubit dsDNA HS assay
(Invitrogen). We have found that spectrophotometry (i.e. Nanodrop;
Thermo Fisher Scientific, Waltham, MA, USA) is unreliable with
low amounts of DNA and can result in as much as a sevenfold
overestimation of the quantity of DNA. Qubit is robust in the presence
of phenol and salt contamination and provides reliable quantification;
70 000 events yield approximately 400 ng of genomic DNA (gDNA).
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Table 1: Nuclear staining of neuronal and non-neuronal samples
Reagent Anti-NeuN (μl) Alexa488 (μl) Blocking buffer (μl) 1× PBS (μl) Nuclear solution (μl)
Staining solution 0.6 (1:1200) 0.5 (1:1400) 50 150 500
Secondary control – 0.5 50 150 500
Staining solution in the proportion that is added to 500 μl of nuclei to identify NeuN+ and NeuN− nuclei. A secondary-only control is
used to account for background fluorescence.
Figure 1: Isolation neuronal and
non-neuronal nuclei by FACS. (a) The
population of nuclei (green and purple) was
gated based on size (FCS-A), cell granu-
larity (SSC-A) and fluorescence (DAPI, not
shown). (b) A secondary-only control was
used to gate NeuN− samples. (c) Neurons
(green) were identified using anti-NeuN
preconjugated to a fluorescent secondary
antibody (Alexa488). Approximately 80 000
events were identified as NeuN-positive,
constituting approximately 60% of all
events.
Library preparation
DNA fragmentation and concentration
DNA was randomly sheared by sonication (Covaris S2, North Mel-
bourne, Australia) to create fragments of approximately 300 bp in
length. For each sample, 50 ng of DNA was resuspended in 130 μl of
ultrapure H2O (Invitrogen), transferred to microTUBEs (Covaris) and
sonicated with the following settings: bath temperature: 4∘C, duty:
10%, intensity: 6, cycle/burst: 100, time: 180 seconds. Fragment size
was verified by Agilent 2100 Bioanalyzer DNA High Sensitivity Assay
(Fig. 2). Although generally robust for varying quantities of DNA, soni-
cation of low amounts of DNA requires optimization on a per lab basis.
Following sonication, samples were placed in a new microcentrifuge
tube and DNA was vacuum concentrated (Eppendorf concentrator
plus, Eppendorf, Hauppauge, NY, USA, V-AQ, 45∘C) to a final volume
50 μl.
End repair
Sonication generates fragments with varying 3′ and 5′ overhangs that
may also lack a phosphate group at the 5′ end, which renders them
incompatible with A-tailing and adapter ligation. End repair uses a
combination of polymerases with 3′ to 5′ exonuclease activity and
5′ to 3′ polymerase activity to remove 3′ overhangs and fill in 5′
overhangs respectively, as well as a polynucleotide kinase to add the
5′ phosphate group. All of these are contained in the End Repair Mix
(Illumina TruSeqTM DNA V2, San Diego, CA, USA).
The Resuspension Buffer and End Repair Mix were thawed on ice.
Samples were transferred to 200 μl thin-walled DNAse/RNAse-free
PCR tubes (Axygen, Wembley, Australia), and 10 μl of Resuspension
Buffer and 40 μl of End Repair Mix were added to each sample
of fragmented DNA. Samples were mixed thoroughly by gentle
pipetting and incubated in a thermal cycler (Bio-Rad, Hercules, CA,
USA) for 30min at 30∘C (lid 100∘C). After incubation, all samples
were spun briefly and transferred to 1.7ml low-bind microcentrifuge
tubes (Maxymum Recovery®; Axygen); 160 μl of AMPure XP beads
(Beckman Coulter, Brea, CA, USA) (1.6:1 beads:sample ratio) was
added to each sample and DNA was purified as prescribed in the
Illumina® V2 TruSeq sample preparation guide.We recommend using
1.7ml microcentrifuge tubes and a DynaMag (Invitrogen or similar
strength magnet) to facilitate handling. Samples were eluted in 17.5 μl
of Resuspension Buffer (vortex 15 sec, incubate at room temperature
for 30min, place onmagnetic stand for 5min) and 15 μl of supernatant
from each sample was transferred to new DNAse/RNAse-free PCR
tubes for A-tailing.
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Figure 2: Quantification of the size of DNA fragments fol-
lowing sonication. After sonication, fragment size was ver-
ified using using a Bioanalyzer with a High Sensitivity DNA
chip (Agilent Technologies). The majority of fragments were
approximately 300 bp in length.
A-tailing
The addition of an overhanging dA allows the ligation of the adapters,
which carry a complementary overhanging dT; 15 μl of end-repaired
DNA was mixed with 2.5 μl of Resuspension Buffer and 12.5 μl of
A-tailing Mix by gentle pipetting and incubated at 37∘C for 30min
in a preheated thermal cycler (lid 100∘C, temperature 37∘C). Trou-
bleshooting note: poor A-tailingmay cause inefficient adapter ligation.
The addition of fresh dATP may be helpful in resolving this issue.
Adapter ligation
The addition of adapters with sample-specific barcodes prior to
MBD pull-down allows multiple samples to be pooled for a robust
pull-down, while retaining sequence information pertaining to indi-
vidual animals. The dilution of adapters for low-input samples is key
to avoiding adapter dimers that would be sequenced and reduce the
coverage of the samples being sequenced.
Adapters were thawed and diluted (1:40) in Resuspension Buffer
(we recommend optimizing this dilution for specific quantities of
DNA and confirming the presence or absence of adapter dimers by
Bioanalyzer); 2.5 μl of Resuspension Buffer, 2.5 μl of ligation buffer
and 2.5 μl of the designated diluted adapter were added to individual
samples and mixed thoroughly by gentle pipetting. All samples were
incubated at 30∘C for 10min in a preheated thermal cycler. After
incubation, 5 μl of Stop Ligation Buffer was added to each sample
and mixed by pipetting. After ligation, samples were purified using
AMPure XP beads in a 1:1 v/v ratio according to TruSeq V2 guidelines.
Ligated DNA was eluted in 67 μl of ultrapure H2O. Please note that
Illumina has discontinued the V2 kit, andwe recommend the adapters
used in the latest HT kit or independent synthesis as an alternative.
We detected some adapter dimers by Bioanalyzer and therefore
repeated purification with AMPure XP beads in a 1:1 ratio, eluting in
67 μl of ultrapure H2O and retaining 65 μl of eluate in a new DNA
low-bind tube. We confirmed by Bioanalyzer that the amount of
adapter dimers was negligible in all samples. A 1:1 beads:sample
ratio removes a greater number of small fragments (size is less than
100bp) compared to the standard 1.6:1 ratio and this eliminates the
need for gel-based size selection.
Checking ligation efficiency
We determined that the percentage of remaining DNA that was
well-ligated by employing the Qubit dsDNA HS assay for total DNA
quantification, and the SYBR Fast Illumina Library Quantification Kit
(Kapa Biosystems, Thebarton, Australia) to determine the amount of
well-ligated DNA in each sample. Each sample was diluted 1:1000 in
Library Dilution Buffer prior to use of the Library Quantification Kit,
according to the manufacturer’s instructions.
Once the size-adjusted concentration of ligated sample in pM was
determined, we converted to ng/ml using the following formula:
ng∕ml = (concentration in pM ×molecular weight) ∕106
Molecular weight =
(
average length of fragment
+ adapter × 607.4) + 157.9
We then determined how many ng of well-ligated DNA was
present in each sample as a percentage of the amount (ng) from
Qubit. Typically 50–60% of fragments were well ligated.
Pooling and MBD pull-down
Within each group (vmPFC, NeuN+ cells, NeuN−cells) we pooled
12.5 ng of well-ligated DNA from each biological replicate (n=8) for a
total of 100 ng in a final volume of 10 μl. It is preferable to pool an equal
number of animals from each group in each pull-down, to account for
differences inMBDpull-down efficiency. To facilitate handling, we rec-
ommend using sterile 1.7ml microcentrifuge tubes and the DynaMag
magnetic stand (Invitrogen) in lieu of the items provided. In cases of
prolonged storage, it is often best to validate the kit using the included
controls prior to use. Methyl CpG binding domain pull-downs (Methyl-
collector Ultra; Active Motif, Karrinyup,, Australia) were performed as
per the manufacturer’s directions, under high salt (high stringency)
binding conditions. The captured methylated DNA was eluted in
100 μl of complete elution buffer. The methyl-enriched fraction was
then purified using AMPure XP beads (1.6:1 ratio, beads:sample) and
the enriched sample was eluted in 20 μl of Resuspension Buffer.
Amplification
Following MBD pull-down, 10 cycles of polymerase chain reaction
(PCR) were used to amplify well-ligatedmethylated DNA. The primers
provided anneal to a sequence common to all adapters and preserve
the sample-specific barcodes during amplification. Each pool was
amplified independently; 20 μl of each sample was transferred into
DNAse/RNAse-free PCR tubes and 5 μl of primer cocktail and 25 μl
of PCR master mix was added to the sample. PCR was performed
by initially denaturing for 30 seconds at 98∘C, followed by 10 cycles
of denaturation at 98∘C for 10 seconds, 30 seconds of annealing at
60∘C and 30 seconds of elongating at 72∘C, then a final 5min at 72∘C,
with the lid at 100∘C for the duration of thermocycling. PCR products
were purified using a 1:1 ratio of AMPure XP beads as previously
described, and eluted in 32.5 μl of Resuspension Buffer; 30 μl of
eluate was transferred to 0.6ml DNA low-bind tubes (Maxymum
Recovery; Axygen). If there is primer dimer contamination, another
AMpure XP beads purification step is required.
Final QC and sequencing
The final concentration of the PCR-enriched libraries was determined
by quantitative polymerase chain reaction (qPCR) against a reference
library of known cluster density using the Library Quantification Kit
(Kapa Biosystems) and Stratagene Mx3000P qPCR instrument (Agi-
lent Technologies,Mulgrave, Australia). The distribution of library frag-
ment size was determined using a Bioanalyzer with a High Sensitivity
DNA chip (Agilent Technologies). Each final library was adjusted to
8 μM and loaded into one lane of a HiSeq v.3 flow cell (Illumina) follow-
ing cluster generation on the Illumina c-Bot instrument and paired-end
(101 bp) sequencing was performed using a HiSeq 2000 (Illumina)
according to standard manufacturer’s instructions.
Bioinformatics
High-throughput DNA sequencing
Paired-end (PE) libraries were sequenced using the Illumina
HiSeq2000 sequencing platform with the read length of 101 bp*2,
image processing was performed using the standard Illumina
Genome Analyzer software and pipelines developed in house.
CASAVA software (v1.8.2) was used to demultiplex the samples.
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Aligning short reads to reference genome
PE reads were aligned to the reference genome of mouse (mm9)
using BWA (v0.6.2) (Li & Durbin 2009). Samtools (v0.1.17) (Li et al.
2009) was then used to convert ‘.sam’ files to ‘.bam’ files, sort and
index the ‘.bam’ files and remove duplicate reads. If the same library
was sequenced in different Illumina runs or lanes, we merged these
‘.bam’ files using Samtools before the step in which duplicates were
removed. Readswith lowmapping quality (Q<20) or that did not align
to the reference genome were excluded from the downstream peak
calling analysis.
Calling peaks
Model-based analysis of Chip-Seq (MACS; v1.4.2) (Zhang et al. 2008)
was used to call peaks for each sample with the parameter setting
‘-f BAM --keep-dup= all --nomodel --shiftsize 100 -gmm -p 1e-5--bdg’.
MACS is a popular peak calling software program used to identify
areas in a genome that have been enriched with aligned reads (or
peaks) as a consequence of performing next-generation sequencing.
In the case of MBD-Seq, these peaks correspond to regions with
increased methylation. MACS uses a dynamic Poisson distribution
to capture local biases effectively in the genome sequence and
evaluates the significance of enriched regions. ‘--keep-dup= all’ was
used because duplicate PE reads had been previously removed using
Samtools. ‘-p 1e-5/ was set as a default value of the P value cut-off for
peak detection relative to background. ‘--nomodel --shiftsize 100’ was
used to avoid model-based estimation of fragment size and instead
shift forward and reverse tags by 100bp to identify the midpoint of
the region of enrichment. ‘-gmm’ was set for mouse reference and
‘-bdg’ was set to save extended fragment pileup at every position into
a bedGraph file, which is helpful for plotting peaks.
All peak summits identified by MACS were then collected to get a
full list of potential methylation sites. CustomPERL script was applied
to parse the number of fragments (hereafter referred to as counts)
that covered the peak summit in each sample. Here fragments refer
to DNA fragments in the library that was used for sequencing. Thus,
each pair of properly aligned PE reads represents one fragment. The
total counts in each sample were normalized to 10 million, after which
the normalized counts for each summit were compared between
conditions using two-sided Student’s t-test. Peaks with P <0.05
and the mean of normalized counts in at least one group >5 were
considered as differentially methylated peaks between conditions.
Peak summits located within 600bp were grouped together and
treated as the same peak using a custom PERL script. The analysis
pipeline ‘Differentially Methylated Sites Analyzer (DMSA)’ is shown
in Appendix S5, Supporting Information and all PERL scripts used in
DMSA can be downloaded from https://github.com/Qiongyi/DMSA/.
Candidate DMR selection
We did not apply multiple testing corrections, choosing instead to
attempt validation of a number of DMRs with varying characteristics
in order to determine a criterion of real peaks vs. false positives as
others have done (Li et al. 2013). We took note of the P value and
fold change between groups as well as the read coverage, as others
recommend 5× coverage for identifying true DMRs (Trimarchi et al.
2012).
A 300bp region surrounding the peak summit of each candidate
DMR (n=16) was retrieved using UCSC’s genome browser (mm9),
and primers (Appendix S6) were designed (Primer3) to amplify a
120–200bp amplicons overlapping the peak summit. Primer speci-
ficity was tested using the NCBI blastn suite and optimized using
1 ng/μl sonicated gDNA, in 10 μl reactions [5 μl 2×Sybr, 1 μl primers
(forward+ reverse, 10 μM), 2 μl gDNA, 1 μl upH20].
Validation by MBD-qPCR
To provide both biological and technical validation, we generated
another cohort of neuronal and non-neuronal gDNA and performed
MBD pull-downs (Methylcollector Ultra; Active Motif) on individual
animals according to the manufacturer’s directions. Briefly we frag-
mented 300ng of gDNA by sonication and retained 14 μl as the
input DNA and to verify the fragment size using the Bioanalyzer. The
remaining DNA was vacuum concentrated to a volume of 10 μl prior
to MBD pull-down (high salt conditions). The methyl binding reac-
tion was incubated overnight at 4∘C on an end to end rotator. DNA
was purified by phenol chloroform extraction and EtOH precipitation
for 4 h at −30∘C. Methyl-enriched DNA was resuspended in 60 μl of
ultrapure H2O and incubated at 37∘C for 3 h to maximize dissolution.
Both input (in a final volume of 80 μl) and methyl-enriched DNA (in
60 μl) were stored at −30∘C in DNA low-bind tubes (Maxymum recov-
ery; Axygen). Quantitative polymerase chain reaction was performed
in duplicate using a Rotor Gene Q (Qiagen, Chadstone Centre, Aus-
tralia), and replicated if therewas any uncertainty. Relative enrichment
was calculated by normalizing to input, then using the delta-delta ct
method with the NeuN−group set as the control.
Results
Isolation of neuronal and non-neuronal nuclei from
the vmPFC
Immunolabelled neuronal (NeuN+) and non-neuronal
(NeuN−) nuclei were purified from whole vmPFCs by FACS
(Fig. 1, a–c). Approximately 60% of nuclei were neuronal (or
positive for NeuN); the remaining 40% was designated as
non-neuronal (or NeuN−) (Fig. 1c).
Neurons exhibit greater 5mC enrichment than
non-neurons
Neurons derived from the vmPFC have a distinct CpGmethy-
lation profile compared to non-neurons from the same region
or whole vmPFC (Fig. 3). On average, in each individual,
we identified significantly more RME (enriched relative to
background) in neurons (178±28 RME) than in non-neurons
(121±25 RME) or total vmPFC (128±48 RME) (F2,18 =7.72,
P <0.01, Tukey’s post-hoc test, neurons vs. non-neurons,
P <0.01, neurons vs. vmPFC, P <0.01, Fig. 4). Furthermore,
there were significantly more properly paired reads aligned in
neuronal samples (mean: 20083228 reads) than non-neurons
(mean: 10980756 reads) (t11 =2.74, P <0.05), which sug-
gests that this is because of more CpG methylation and not
a facilitated discovery of peaks in a homogeneous neuronal
population. However, only 43 of 113 significant DMRs (as
identified by Student’s t-test, Appendix S1)were hypermethy-
lated in neurons. This is consistent with a previous report of
global hypomethylation in neurons (Iwamoto et al. 2011). We
reconcile these observations by proposing that neurons have
more CpG methylation overall (Kozlenkov et al. 2013; Li et al.
2013; Lister et al. 2013) but are hypomethylated in CpG-rich
regions that are preferentially examined by the LUminomet-
ric Methylation Assay (LUMA) assay (Iwamoto et al. 2011)
and the high-stringencyMBD pull-downwe employed (Karimi
et al. 2006; Nair et al. 2011).
CpG DNA methylation is enriched in the 3′UTRs
of neurons
As expected, most regions of differential methylation (in neu-
rons vs. non-neurons) were located within intergenic regions
(Fig. 5a); collectively, these regions comprise the majority of
the genome. However, after normalizing for the cumulative
length of each region, we found an unexpected enrichment
of CpGmethylation in the 3′untranslated region (UTR) of neu-
rons (Fig. 5b). In contrast, there was significant enrichment of
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Figure 3: Neurons derived from the vmPFC have distinct
CpG DNA methylation compared to non-neurons or bulk
vmPFC. For each grouped differentially methylated region (see
Fig. 5), the number of biological replicates displaying significant
5mC enrichment (as detected by MACS) was considered. White
indicates that none of the samples (n=6–8/group) showed sig-
nificant enrichment; red indicates that all samples had significant
enrichment (displayed as ratio of all samples in the group, referred
to as ‘Value’ in this figure).
5mC in the 5′UTRs of non-neurons (Fig. 5b). There is exten-
sive lengthening of 3′UTRs in the mammalian brain, particu-
larly in neurons (Miura et al. 2013), which may be regulated
by differential DNA methylation. For example, methylation
of CpG islands in the mouse H13 and Herc3/Nap1l5 genes
promotes the use of downstream alternative polyadenylation
sites that result in the production of longer transcripts for
these genes (Cowley et al. 2012; Wood et al. 2008). There-
fore, hypermethylation of the 3′UTR in neurons may regulate
the lengthening of 3′UTRs in the mammalian brain, which
could in turn affect the stability of these transcripts (Miura
et al. 2013). It should be noted that each identified peak was
used for downstream analysis (for illustration, see Fig. 6),
rather than grouping peaks in close proximity, hence the dis-
crepancy between the average number of regions of 5mC
enrichment identified in individuals and the total number of
cell-type-specific DMRs (Appendix S2).
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Figure 4: Neurons display greater CpG methylation than
non-neurons or bulk vmPFC. On average more regions of
5mC enrichment are identified in neurons derived from the
vmPFC (178±28) than in non-neurons from the same region
(121±25) or bulk vmPFC (128±48), F2,18 =7.72, P <0.01,
Tukey’s post-hoc test, neurons vs. non-neurons, **P <0.01,
neurons vs. vmPFC,**P <0.01.
Validation of cell-type-specific methylation
A total of 16 DMRs were selected for confirmatory analysis
by MBD-qPCR (Appendix S3, Appendix S4). Candidate loci
varied in statistical significance, in fold difference in methy-
lation between cell types, in coverage of the region and in
the number of samples that were initially identified as having
the RME. A wide range of genomic loci were selected in an
attempt to identify the characteristics of DMRs that reliably
validate. We found that the DMRs identified by sequencing
must be covered by at least a mean of PE 5 reads (herein
referred to as 5× coverage, following normalization to 10 mil-
lion reads) in at least one cell type in order to validate reliably
by qPCR. Of the DMRs with 5× coverage in at least one
group, 10 of 12 candidates were validated byMBD-qPCR (see
Fig. 7 for select examples). As expected, we were unable to
validate similar DMRs with <5× coverage (four candidates,
see Appendix S3). These DMRs were marked by substantial
inter-individual variability, with regions of enrichment iden-
tified in only one or two biological replicates. While these
may reflect individual differences in methylation, they are not
reflected in consistent group differences. Correspondingly,
DMRs must be initially identified in at least half (3/6) of the
biological replicates in order to be validated as reliable group
differences byMBD-qPCR.We further caution that at this low
level of coverage (<5×) these DMRs may be misalignments
or artefacts of normalization. On the basis of our experience,
we recommend selecting candidates of the following charac-
teristics: P <0.02, fold difference >1.2, mean reads >5 and
present in at least half of all biological replicates. A minimum
of 5× coverage is key, as the ability to identify differences
between groups is strongly affected by enrichment levels
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Figure 5: Distribution of the genomic
locations of the regions of 5mC enrich-
ment. (a) When the number of peaks
is not normalized for the length of the
genomic region over 50% of regions of
5mC enrichment are found in the inter-
genic region, as this region is substan-
tially longer than all others. (b) When the
number of peaks is normalized for the rel-
ative length of the region, the neuronal
genome has a pronounced enrichment of
5mC in 3’UTRs of genes.
Figure 6: Individual regions of enrichment (S1–S4) vs. a
grouped region of 5mC enrichment. All individual regions of
5mC enrichment (S1–S4) were used in downstream analysis,
although thesemay occur within one broad region of 5mC enrich-
ment (grouped region of 5mC enrichment). Using all regions for
analysis is preferable as it avoids equally weighting DMRs that
are only defined by one or two biological replicates.
surrounding the locus, because of the fact that greater enrich-
ment results in greater depth of sequencing (Robinson et al.
2010; Trimarchi et al. 2012).
Discussion
To date, investigation of neuronal DNA methylation has been
restricted to candidate loci (Labonte et al. 2012; Matrisciano
et al. 2013; Nishioka et al. 2013; Schor et al. 2013), reduced
representations of the genome (Guo et al. 2011, Oh et al.
2013), or a meagre number of samples pooled from a num-
ber of individuals (Guo et al. 2013; Lister et al. 2013). These
methods are not amenable to the analysis of changes in DNA
methylation in response to learning and other environmental
experiences, where experiments necessitate the use of dis-
crete brain regions and cell types (i.e. neurons), as well as
numerous samples. MBD Ultra-Sequencing is well-suited for
such experiments, and the increase in resolution afforded by
the use of neurons and individuals, as well as the ability to
use as little as 50 ng of input DNA, will facilitate the discovery
of changes in DNA methylation related to memory formation
and maintenance.
The strength of MBD Ultra-Seq derives from several
improvements to existing protocols. First, we have increased
the yield of nuclei from tissue by eliminating the use of a
sucrose cushion when isolating nuclei (Jiang et al. 2008).
Moreover, the FACS procedure is applicable to other cell
types with distinct nuclear markers (i.e. TBR1 for pyrami-
dal neurons, unpublished observations) or to transgenic mice
with nuclear reporters. Barcoding individual samples using
sample-specific indices (Illumina Truseq V2) prior to MBD
pull-down also enabled the detection of inter-individual vari-
ability in DNA methylation from ‘pooled’ samples. Pool-
ing samples during MBD pull-down reduces the variabil-
ity attributed to differences in handling and pull-down effi-
ciency, particularly where low amounts of DNA are consid-
ered. Sample-specific barcodingwas also recently used in the
construction of reduce-representation bisulphite sequencing
(RRBS) libraries (Boyle et al. 2012).
When the size of the genomic region is not considered,
we find that the majority of differences in DNA methyla-
tion between neurons and non-neurons occur within inter-
genic regions. As most neuronal activity-induced changes
in DNA methylation are likewise located intergenically (Guo
et al. 2011), the use of MBD-based enrichment approaches
is preferable to RRBS, which does not provide coverage of
intergenic regions or 3′UTRs outside CpG islands (Wang et al.
2013).
Limitations
MBD Ultra-Seq provides one of the few methods for pro-
filing genome-wide methylation in a large number of sam-
ples; however, it is subject to certain limitations. Firstly,
messenger RNA (mRNA) cannot be extracted simultane-
ously from neurons, and consequently the direct relationship
between altered DNA methylation and gene expression can-
not be explored. There are a handful of protocols for iso-
lating whole neurons from adult brains (Guez-Barber et al.
2012; Lobo et al. 2006; Saxena et al. 2012); however these
suffer from reduced yield (120 000 NeuN+ events from an
entire mouse frontal cortex) and the RNA obtained may be
degraded (unpublished observations).
Secondly, unlike whole-genome bisulphite sequencing
(WGBS) (Guo et al. 2013; Lister et al. 2013), MBD Ultra-Seq
cannot be used to profile non-CpG methylation as MBD
2B/3 L binds exclusively to methylated cytosines in the CpG
dinucleotide context. However, in neurons, CpG methy-
lation accounts for 46–75% of all methylated cytosines
(Guo et al. 2013; Lister et al. 2013) and exhibits greater
inter-individual variability than non-CpG methylation (Lis-
ter et al. 2013), which may be indicative of an increased
Genes, Brain and Behavior (2014) 13: 721–731 727
 
 
59 
 
 
 
Li et al.
Gene symbol Kctd16 
Peak summit Ch18: 
40467865
Fold difference 
(N-/N+) 1.39
P-value 0.009
Mean NeuN+ 47
Mean NeuN- 66 40467500 40468000 404
0
20
40
60
0
20
40
60
NeuN+
NeuN-
N+ N
-
0.0
0.5
1.0
1.5
2.0
***
Gene symbol Cdk8
Peak summit  Ch5:   
147072760
Fold difference 
(N-/N+) 2.63
P-value 0.003
Mean NeuN+ 5.13
Mean NeuN- 13.44
0
4
8
12
0
4
8
12
000 147072500 147073000 147
NeuN+
NeuN-
N+ N
-
0.0
0.5
1.0
1.5
2.0
**
Gene symbol NCAM 
Peak summit Ch6: 
103599191
Fold difference 
(N-/N+) 1.37
P-value 0.014
Mean NeuN+ 5028
Mean NeuN- 6692
0
20
00
50
00
0
30
00
60
00
98500 103599000 103599500
NeuN+
NeuN-
N+ N
-
0.0
0.5
1.0
1.5
2.0
**
Gene symbol N/A 
Peak summit Ch6: 
15137969
Fold difference
(N+/N-) 9.87
P-value 0.008
Mean NeuN+ 0.3
Mean NeuN- 2.96 15137500 15138000 15138500
0
1
2
3
0
1
2
3
NeuN+
NeuN-
N+ N
-
0.0
0.5
1.0
1.5
2.0
N+ -
0.0
0.5
1.0
1.5
2.0
**
N+ N-
0.
0.5
1.0
1.5
2.0 ***
N+ N-
0.0
0.5
1.0
1.5
2.0
**
N+ N-
0.0
0.5
1.0
1.5
2.0
-
0.0
0.5
1.0
1.5
2.0
0
Figure 7: Candidate DMRs. Sequencing results (table) are derived from the average of all individual peaks within the grouped DMR.
The plot is indicative of the normalized reads surrounding the locus, whereas the graph shows the relative enrichment as determined
by MBD-qPCR.
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propensity for experience-induced changes in methyla-
tion. Moreover, to identify differential methylation, WGBS
requires 15- to 30-fold more coverage of the genome than
MBD-Seq (Stevens et al. 2013) and is consequently unsuited
for behavioural paradigms that require a large number of
animals, and for which individual animal resolution may be
required.
Alternatively, MeDIP-Seq can be used to assay non-CpG
methylation, and protocols optimized for low amounts of
DNA and numerous samples have been developed (Taiwo
et al. 2012). However, within the CpG dinucleotide context,
methylated DNA immunopreciptation (MeDIP) suffers from
reduced sensitivity and specificity compared to MBD, gen-
erating a high degree of background ‘noise’ (De Meyer et al.
2013) that may impede the detection of DMRs. Nevertheless,
although MeDIP-Seq suffers from additional technical limita-
tions, such as the use of single-stranded DNA, it is a viable
alternative for thosewishing to explore non-CpGmethylation.
As a final limitation, we find that, although MBD 2B/3L is
highly efficient at enriching for fragments with seven or more
methylated CpGs (De Meyer et al. 2013), CpG-rich regions
receive greater coverage, which facilitates the discovery of
DMRs in these areas.
Conclusion
MBD Ultra-Seq is a novel approach for identifying DNA
methylation in neurons and non-neuronal populations derived
from discrete brain regions of individuals, using as little as
50 ng of DNA. We find that the neuronal methylome is
unique and that CpG-rich regions are hypomethylated.
Differences in DNA methylation between neurons and
non-neurons are predominantly localized to intergenic
regions, which emphasizes the importance of using
genome-wide methods to examine this region of the
genome. However, when the size of the genomic region
is accounted for, the greatest proportionate difference in
methylation between neurons and non-neurons is in the
3′UTR, which may be related to the lengthening of 3′UTRs
in the neuronal transcriptome of the mammalian brain.
We find that DMRs with >5× coverage validate reliably,
demonstrating the utility of this method. Overall, MBD
Ultra-Seq provides a tool that can be used to examine
and detect neuronal DNA methylation with individual ani-
mal resolution in a large number of biological replicates,
which should greatly facilitate the detection of differen-
tial methylation related to learning and neuropsychiatric
disorders.
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Appendix S1: The ‘summits’ of regions of 5mC enrich-
ment in individuals (S1–S4, Fig. 6) are often separated by a
small distance. Regions of 5mC enrichment identified in indi-
viduals that were within 600 bp of each other were grouped
together to explore the overall degree of methylation of
the vmPFC, neurons and non-neurons and the sequencing
results are available here.
Appendix S2: Regions of differential DNA methylation
between neurons and non-neurons (individual). To avoid fail-
ing to detect any cell-type-specific differences in DNAmethy-
lation, we compared methylation in all biological replicates at
each region of 5mC enrichment (i.e. S1–S4 in Fig. 6) rather
than at grouped DMRs. Significant individual regions of 5mC
enrichment are listed here.
Appendix S3: Candidate DMRs for validation by
MBD-qPCR. MBD Ultra-Seq information for candidate
differentially methylated loci for validation (16). Position of
the peak summit is the median value for the grouped peak
summit derived from all individual peaks surrounding the
loci. The number of samples with peak refers to the number
of samples initially identified as having the peak by MACS,
which remained statistically significant (P <0.05) after a
Student’s t-test. For example, a region of 5mC enrichment
may have been identified by MACS in all NeuN− samples
(n=7) for Chr 6 ∼ 15137969; however the enrichment was
only significant at one of the seven peaks identified.
Appendix S4: MBD Ultra-Seq data for candidate
cell-type-specific RME. The original data are available here.
Appendix S5: Differentially Methylated Sites Analyzer
(DMSA) analysis pipeline.
Appendix S6: Primers used for validation of candidate
DMRs by MBD-qPCR. List of primers used for the validation
of candidate DMRs by MBD-qPCR.
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Additional file 3. Candidate regions that are differentially methylated in neurons and non-neurons (MBD qPCR validation) 
Chr Peak 
summit 
Genomic 
location 
# of 
samples 
NeuN+ 
mean 
NeuN- 
mean 
P-
value 
Fold 
difference 
Overlapped 
gene 
Right gene 
(distance) 
    Left gene 
    (distance) 
5 33080729 CDS 6 10.58 20.67 0.01 1.96 Pisd Yes1 
 
C330019G07 
Rik  
5 147072761 Intron 3 5.13 13.44 0.003 2.63 Cdk8 Rnf6 Wasf3  
6 49186533 5’UTR 2 4.67 10.43 0.02 2.25 N/A Igf2bp3  
(22065 bp) 
Tra2a  
(8211 bp) 
6 103599191 Intron 6 5028 6892 0.01 1.37 NCAM Cntn3  Cntn6 
8 14306933 Intron 2 6.41 12.03 0.02 1.88 Dlgap2 Erich1  Cln8  
8 56208439 Intergenic 4 10.42 22.33 0.002 2.15 N/A Gpm6a  
(64157 bp) 
Adam29 
(2141514 bp) 
11 108873349 Intergenic 4 6.74 19.54 0.007 2.90 N/A Axin2  
(62640 bp) 
Rgs9  
(213653 bp) 
13 3372785 Intergenic 6 59.22 84.89 .0007 1.43 N/A N/A Gdi2  
(164760 bp) 
15 74917258 Intergenic 6 223 360 .0000
6 
1.61 N/A Ly6c1  
(38319 bp) 
Ly6c2 
(21855 bp) 
17 39984652 Intergenic 6 43.38 81.98 .002 1.69 N/A Esp23 
(772314 bp) 
Pgk2 
(359752 bp) 
18 40467865 Intron 6 47.53 65.91 0.01 1.39 Kctd16 Yipf5  Prelid2 
19 61275693 Intergenic 4 5.14 21.01 0.02 4.09 N/A Gm7102  
(23828 bp) 
Csf2ra  
(25344 bp) 
Chr Peak 
summit 
Genomic 
location 
# of 
samples 
NeuN+ 
mean 
NeuN- 
mean 
P-
value 
Fold 
difference 
Overlapped 
gene 
Right gene 
(distance) 
    Left gene 
    (distance) 
 2 
 
 
4496971 Intergenic 1 2.04 0.2 0.000
2 
10 - Gm 13476 
(1114 bp) 
Acvr2a 
(3700501 bp) 
5 24309239 CDS 1 1.83 0 0.01 NC N/A Crygn  
(45580 bp) 
Rheb  
(245 bp) 
6 5055404 Intron 1 0 2.94 0.02 1.67 Ppp1r9a Peg10 Pon1  
6 15137969 5’UTR 1 0.3 2.96 0.008 9.87 N/A Ppp1r3a  
(43272 bp) 
Foxp2  
(8992 bp) !
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Additional file 6.  Primers used for validation of candidate DMRs by MBD qPCR 
Peak summit of DMR Left primer Right primer 
Chr 2: 4496971 CCACTTCCCAGGGGATTTT GCATCCTCAAATTTGGCTGT 
Chr 5: 33080729 GGATACGGATAGAGCCCACA GGCTCTGAGCAGAAAGTAGCA 
Chr 5: 24309239 GCCGATAAAATTCTTGGTCA TGAAAGATGTCATTTGGGTCAG 
Chr 5: 147072761 CTCTTCCTGGAGTCGGATTG TTCACGCCCTCTTGAACTCT 
Chr 6: 5055404 CTCAGGCCGTAGCTCAGAGT TGCATGGTTAGCTTCATTGC 
Chr 6: 15137969 CCCTGGCAATTTTCTGTTTT CCCAATTCTGCTAATGAAGAGTG 
Chr 6: 49186533 CCAACCCCAAGAGTTATCCA 
 
TGTCAGGGAGGACAGAAACC 
Chr 6: 103599191 AATTCCCGTTTCCAACGAAT CAAGCAATCTTTCAAGCAAGG 
 
Chr 8: 14306933 AAAATGAGAAGGCTCCATCC TCTGTGAACCTCACAATGCAC 
Chr 8: 56208439 CAGGACTTTGGCTTGGAGAA 
 
ATTTTCGGCTCTGGCTTAGG 
 
Additional file 6.  Primers used for validation of candidate DMRs by MBD qPCR 
Peak summit of DMR Left primer Right primer 
Chr 2: 4496971 CCACTTCCCAGGGGATTTT GCATCCTCAAATTTGGCTGT 
Chr 5: 33080729 GGATACGGATAGAGCCCACA GGCTCTGAGCAGAAAGTAGCA 
Chr 5: 24309239 GCCGATAAAATTCTTGGTCA TGAAAGATGTCATTTGGGTCAG 
Chr 5: 147072761 CTCTTCCTGGAGTCGGATTG TTCACGCCCTCTTGAACTCT 
Chr 6: 5055404 CTCAGGCCGTAGCTCAGAGT TGCATGGTTAGCTTCATTGC 
Chr 6: 15137969 CCCTGGCAATTTTCTGTTTT CCCAATTCTGCTAATGAAGAGTG 
Chr 6: 49186533 CCAACCCCAAGAGTTATCCA 
 
TGTCAGGGAGGACAGAAACC 
Chr 6: 103599191 AATTCCCGTTTCCAACGAAT CAAGCAATCTTTCAAGCAAGG 
 
Chr 8: 14306933 AAAATGAGAAGGCTCCATCC TCTGTGAACCTCACAATGCAC 
Chr 8: 56208439 CAGGACTTTGGCTTGGAGAA 
 
ATTTTCGGCTCTGGCTTAGG 
 
Additional file 6.  Primers used for validation of candidate DMRs by MBD qPCR 
Peak summit of DMR Left primer Right primer 
Chr 2: 4496971 CCACTTCCCAGGGGATTTT GCATCCTCAAATTTGGCTGT 
Chr 5: 33080729 GG TACGGATA A CCCACA GCT TGAGCAGAAAG AGCA 
r 5: 2 30 23  CCG TAA ATTCTTGGTCA T AAAGAT TCATTTGGGT G 
r : 147072761 CTC T CTGGAGTCGGATTG TC C CC T GAACT T 
hr 6: 5055404 AGG CGT CTCAGAGT GCAT GTTAGCTTC T GC 
Chr 6: 15137969 C T AA TTTCTGTTTT CC ATTC GCTAATGAAGAGTG 
Chr 6: 49186533 AACC C AGAGTTA CCA 
 
TGTC GGGAGG CA ACC 
Chr 6: 103599191 AATTCCCGTTTCCAACGAAT CAAGCAATCTTTCAAGCAAGG 
 
Chr 8: 14306933 AAAATGAGAAGGCTCCATCC TCTGTGAACCTCACAATGCAC 
Chr 8: 56208439 C GGACTTTG CT GG GAA 
 
AT T CGG TCTGGCT AGG 
 
Peak summit of DMR Left primer Right primer 
Chr 11: 108873349 CTCT GATTTGGGGATCTGA GAACTTT AAG CCGAA TG 
Chr 13: 3372785 TTGTTTTCCTGGAGGTGTGG 
 
CCCGACAGGTGAGGATGTAG 
 
Chr 15: 74917258 CCAAAGCGACCTGAAACAAT 
 
GCACATTGACCTCACCAAGA 
 
Chr 17: 39984652 CTTGTAAGCGTCGAGGTGCT 
 
CTCAGACACAAACGGGAAGG 
 
Chr 18: 40467865 TGGAGCCTTCCTCTTTCTGT 
 
GCCAGAAGTCCGTGAGTGAT 
 
Chr 19: 6127569 CACTCACGCACACATGACAG 
 
TGATTTCGCCTGTTTTCACA 
 
 
Peak summit of DMR Left primer Right primer 
hr 11: 108 7 349 TCTG T GGATCTG  GAACTTTGAAG GAA TG 
r 3: 3372 85 T TTTCC A G G 
 
CCCGACAGGT AG T AG 
 
Chr 15: 74917258 CCAAAGCGACCTGAAACAAT 
 
GCACATTGACCTCACCAAGA 
 
Chr 17: 39984652 CTTGTAAGCGTCGAGGTGCT 
 
CTCAGACACAAACGGGAAGG 
 
Chr 18: 40467865 TGGAGCCTTCCTCTTTCTGT 
 
GCCAGAAGTCCGTGAGTGAT 
 
Chr 19: 6127569 CACTCACGCACACATGACAG 
 
TGATTTCGCCTGTTTTCACA 
 
 
Peak summit of DMR Left primer Right primer 
Chr 11: 08873349 CTCTG TTT GGATC GA GAAC TTGAAGGCCGAAGTG 
Chr 13: 3372785 TTGTTTTCC GA TGTGG 
 
CCCGACA GT A GATGTA  
 
r 5: 7491 2 8 CCAAAGCGACCTGAAACAAT 
 
G AC TT ACCTCACCAAGA 
 
hr 17: 39984652 TTGTAAGCGTC AGGTGCT 
 
CTCAGACACAAA GGGAAGG 
 
Chr 18: 40467865 TGGAGCCTTCCTCTTTCTGT 
 
GCCAGAAGTCCGTGAGTGAT 
 
Chr 19: 6127569 CACTCACGCACACATGACAG 
 
TGATTTCGCCTGTTTTCACA 
 
 
Peak summit of DMR Left primer Right primer 
Chr 11: 108873349 CTCTGGATTTGGGGATCTGA GAACTTTGAAGGCCGAAGTG 
Chr 13: 3372785 TTGTTTTCCTGGAGGTGTGG 
 
CCCGACAGGTGAGGATGTAG 
 
Chr 15: 74917258 CCAAAGCGACCTGAAACAAT 
 
GCACATTGACCTCACCAAGA 
 
Chr 17: 39984652 CTTGTAAGCGTCGAGGTGCT 
 
CTCAGACACAAACGGGAAGG 
 
Chr 18: 40467865 TGGAGCCTTCCTCTTTCTGT 
 
GCCAGAAGTCCGTGAGTGAT 
 
Chr 19: 6127569 CACTCA GCACACA GACAG 
 
TGATTTCGCCTGT TTCACA 
 
 
Peak summit of DMR Left primer Right primer 
Chr 11: 108873349 CTCTGGATTTGGGGATCTGA GAACTTTGAAGGCCGAAGTG 
3: 3372 85 T GTTTTCC A GTGTGG 
 
CC GACAGGTGAGGATGTAG 
 
Chr 15: 74917258 CCAAAGCGACCTGAAACAAT 
 
GCACATTGACCTCACCAAGA 
 
Chr 17: 39984652 CTTGTAAGCGTCGAGGTGCT 
 
CTCAGACACAAACGGGAAGG 
 
Chr 18: 40467865 TGGAGCCTTCCTCTTTCTGT 
 
GCCAGAAGTCCGT AGT AT 
 
r 9: 6127569 CACTCA GCACACA GACAG 
 
TG TTTCGCCTGTTTTCACA 
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consequences of cocaine self-administration 
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4.1 Abstract 
To date, most investigations have focussed on the epigenetic consequences of repeated 
involuntary cocaine exposure. However, the neural adaptations arising from forced 
cocaine exposure differ significantly from those incurred by voluntary cocaine self-
administration and may not be representative of the plasticity produced by cocaine 
consumption in the natural environment. A fundamental difference is that cocaine self-
administration produces memories for the association between cocaine-paired cues, drug 
availability and the rewarding effects of the drug; when reactivated during abstinence, 
these cocaine-related memories can incite cocaine craving and precipitate relapse. The 
enduring presence of cocaine-related memories is one of the primary reasons that the 
treatment of cocaine addiction is largely unsuccessful, and therefore, in identifying the 
cellular adaptations that mediate the maintenance of cocaine-related memories, we may 
provide valuable targets for treatment. One possibility is that long-lasting modifications of 
DNA methylation are produced by cocaine self-administration and underpin the 
maintenance of cocaine-related memories, as enduring changes in DNA methylation beget 
the maintenance of memory in other paradigms. To this end, we used MBD Ultra-Seq, a 
technique developed to detect region- and cell type- specific modifications of DNA 
methylation in individual animals, to identify changes in DNA methylation in neurons of the 
mPFC that occur as a result of cocaine self-administration. We identified 29 genomic 
regions that were persistently differentially methylated following cocaine self-administration 
but not passive cocaine exposure, and 28 regions that became differentially methylated 
during abstinence, all of which may contribute to the maintenance of cocaine-related 
memories. These differentially methylated regions (DMRs) were predominantly located 
within or proximal to annotated genes (coding and non-coding). Gene-associated DMRs 
primarily arose within introns or non-coding loci. Abstinence-associated DMRs were 
curiously enriched within nuclear lamina-associated domains. Functionally, gene-
associated DMRs regulate the expression of co-localising genes in an isoform-specific 
manner. Finally, preliminary evidence suggests that the reactivation state of cocaine-
associated memories further modulates the relationship between differential methylation 
and gene expression. Together this body of work provides the first in vivo profile of 
neuron-specific changes in DNA methylation that are uniquely produced by voluntary 
cocaine self-administration rather than simple drug exposure. Moreover, it yields cursory 
examples of the metaplastic priming of gene expression by long-lasting learning-induced 
changes in DNA methylation, as described in Chapter 2. 
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4.2 Introduction 
A key feature of cocaine addiction is the pathological overlearning of the association 
between cues in the environment and the rewarding effects of the drug. Memories of these 
associations are extraordinarily persistent and, when reactivated, can trigger overpowering 
cocaine craving and relapse despite prolonged abstinence (Childress et al., 1999). 
However, how cocaine-associated memories are perpetuated in the brain in the face of 
rapid transcriptional and proteomic degradation remains enigmatic.  
 
Accumulating evidence suggests that persistent learning-induced epigenetic modifications 
may support the maintenance of long-term memories (Miller et al., 2010). In particular, 
relatively stable epigenetic modifications, such as DNA methylation, have been implicated 
in the maintenance of contextual fear memories (Miller et al., 2010) and arise in response 
to neuronal activity (Vanyushin, 1974) and the induction of synaptic plasticity (Levenson et 
al., 2006). Moreover, dysregulated DNA methylation is associated with several disorders of 
memory formation and maintenance (Matijevic et al., 2009, Yu et al., 2015). Therefore, 
enduring learning-induced variations in DNA methylation may function as a conserved 
mechanism of memory maintenance and underlie the preservation of cocaine-related 
memories. In support of this hypothesis, recent investigations indicate that cocaine self-
administration results in long-lasting changes in DNA methylation in the nucleus 
accumbens and that local inhibition of DNMTs within this region abolishes cue-induced 
cocaine-seeking (Massart et al., 2015). 
 
To maximize the probability of detecting and correctly identifying learning-induced 
changes in DNA methylation it is first necessary to determine where these changes are 
prone to develop. Firstly, the brain region(s) that mediate the maintenance of cocaine-
related memories are likely the regions in which persistent memory-associated 
modifications of DNA methylation reside. The medial prefrontal cortex (mPFC) is required 
for the reinstatement of cocaine seeking during abstinence (Capriles et al., 2003, Di Pietro 
et al., 2006, Fuchs et al., 2007, Mcfarland & Kalivas, 2001, Mclaughlin & See, 2003), 
which suggests that it is necessary for the maintenance of cocaine-related memories. 
Befittingly, steadfast modifications of gene expression, histone acetylation and the 
neuroproteome occur in the mPFC following intravenous cocaine self-administration 
(IVSA) and persist for up to 100 days of enforced abstinence (Freeman et al., 2010b, 
Freeman et al., 2008, Lull et al., 2009). However, these molecules and modifications are 
subject to rapid degradation and unable to support the maintenance of cocaine-related 
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memories. Instead, IVSA-induced modifications of DNA methylation within the mPFC may 
sustain enduring cocaine-related memories.  
 
Cell type-specific profiling is equally vital to the identification of IVSA-associated changes 
in DNA methylation. Discrete, self-administration-induced changes in DNA methylation will 
occur in a select population of cells or neurons that are engaged by this behaviour and 
these limited changes may be indiscernible if methylation is analysed at the whole brain or 
whole region level. Furthermore, regional changes in cellular composition may occur 
following cocaine exposure (Bowers & Kalivas, 2003, Ciccarelli et al., 1997) and could 
produce artefactual changes in DNA methylation, as outlined in Chapter 3. To avoid these 
confounds, I have explored cocaine-induced modifications of DNA methylation in mature 
NeuN+ neurons. NeuN recognizes FOX-3, a neuron-specific splicing factor present in the 
nuclei of most neuronal subtypes of the cortex (Kim et al., 2009) Experience-induced 
variations in neuronal DNA methylation are particularly relevant to the maintenance of 
long-term memory, as neurons are fundamental to learning and have the peculiar property 
of not dividing, which might prevent the disturbance of acquired information stored in their 
DNA (Griffith & Mahler, 1969). Therefore, the maintenance of cocaine-associated 
memories might be predicated on experience-induced changes in DNA methylation in 
neurons of the mPFC. Repeated cocaine exposure induces LTP at excitatory synapses of 
layer V neurons of the mPFC (Huang et al., 2007), which suggests that neurons in this 
region contribute to the maintenance of cocaine-related memories. In addition, withdrawal 
from cocaine self-administration produces morphological abnormalities in layer V 
pyramidal neurons of the mPFC (Rasakham et al., 2014). It is further possible that distinct 
epigenetic changes arise in the subtypes of neurons within the mPFC (glutamatergic, 
GABAergic, dopaminergic etc.) however these cannot be isolated in sufficient number and 
quality by FACS, due to the lack of nuclear markers.  
 
Finally, one must consider where in the genome experience-induced changes in DNA 
methylation are likely to occur, as this determines which methods are suitable for their 
detection. Traditionally, investigations have concentrated on CpG-rich promoter regions, 
however these regions are relatively resistant to experience- and cocaine- induced 
changes in DNA methylation (Guo et al., 2011a, Laplant, 2010). Therefore, I elected to 
explore genome-wide changes in DNA methylation, using MBD Ultra-Seq (see Chapter 3).  
While previous investigations determined that components of the DNA methylation 
machinery and DNA methylation itself are regulated in response to cocaine exposure 
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(Anier et al., 2010, Barros et al., 2011, Carouge et al., 2010) and mediate the rewarding 
effects of the drug (Laplant, 2010, Massart et al., 2015, Tian et al., 2012), they fail to 
distinguish the changes in DNA methylation that arise from simple cocaine exposure from 
those that are associated with voluntary cocaine self-administration. This distinction is 
important because passive involuntary cocaine exposure fails to produce the persistent 
changes in long-term potentiation (Chen et al., 2008, Martin et al., 2006) and sharp rise in 
extracellular dopamine (Hemby et al., 1997) and acetylcholine (Mark et al., 1999) that may 
underlie overlearning and the extreme persistence of cocaine-associated memories, as 
well as the development of addiction. In addition, involuntary exposure to cocaine is 
strongly aversive and retards the acquisition of cocaine self-administration (Twining et al., 
2009). We therefore employed a mouse model of intravenous cocaine self-administration 
(IVSA) that contrasts learned cocaine self-administration with passive yoked cocaine 
exposure to identify modifications in DNA methylation that are uniquely associated with 
learned cocaine-seeking and enduring cocaine-seeking during abstinence. 
 Likewise, little is known about the persistence of changes in DNA methylation that arise 
from cocaine self-administration (Nielsen et al., 2012a), though persistence is a critical 
indicator of an epigenetic modification’s ability to contribute to memory maintenance. 
Therefore, the aim of this body of research was to identify modifications of DNA 
methylation that are exclusively produced by voluntary cocaine self-administration and to 
examine the persistence of these modifications over time, in order to identify changes in 
DNA methylation that may contribute to the maintenance of cocaine-related memories.  
 
I sought to identify persistent and abstinence-associated modifications of DNA methylation 
that arise in neurons of the mPFC following cocaine self-administration. Age-matched 
yoked controls accounted for the changes in DNA methylation produced by simple passive 
cocaine exposure. Genome-wide modifications of DNA methylation were identified by 
MBD Ultra-Seq, a next-generation sequencing technique outlined in Chapter 3. Following 
the statistical selection of DMRs, differences in DNA methylation between naïve and self-
administering animals were confirmed by MBD qPCR in an independent biological cohort.  
 
A common functional output of altered DNA methylation is a change in the expression of 
proximal or co-localising genes. Persistent learning-induced changes in DNA methylation 
may direct enduring modifications of gene expression, or, as I hypothesize in Chapter 2, 
provide a quiescent signature of memory and prime transcription upon subsequent 
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memory or neuronal reactivation. To provide in vivo evidence of the latter possibility, I 
examined the relationship between persistent differential methylation and gene expression 
in animals that underwent a brief relapse test after 21 days of abstinence and those that 
were simply sacrificed. Re-exposure to the self-administration chamber and cocaine-
paired cues during the relapse test reactivates cocaine-related memories (as evidenced by 
continued cocaine seeking) whereas cocaine-related memories likely remain dormant in 
mice that have been simply sacrificed after prolonged abstinence. In the absence of 
differences in DNA methylation between relapsed and non-relapsed mice, altered gene 
expression unique to either group indicates that the reactivation state of memory 
modulates the relationship between IVSA-associated modifications of DNA methylation 
and gene expression. Moreover, a change in the expression of proximal genes provides 
preliminary evidence of a functional role for cocaine IVSA-associated changes in DNA 
methylation.  
 
Collectively, this body of work yields the first in vivo neuron-specific genome-wide profile of 
changes in DNA methylation associated with learned cocaine seeking and not simple drug 
exposure, where the former may be more relevant to the development and persistence of 
addiction. Moreover, it provides the first demonstration of the modulation of the 
relationship between learning-induced modifications of DNA methylation and transcription 
by the reactivation state of a memory, suggesting that the function of persistent 
modifications of DNA methylation extends beyond the enduring regulation of transcription. 
4.3 Methods 
 
4.3.1 Operant cocaine self-administration in mice 
 
4.3.1.1 Animals 
Adult male C57BL/6 mice (8-9 weeks of age at the start of experiments, 20-24 g) were 
singly housed under a 12 hr reverse light-dark cycle (lights off 7 am) under standard 
housing conditions (ad libitum standard rodent chow and water, upon cat litter with tissue 
nesting material) unless otherwise specified.  
 
4.3.1.2 Ethics statement 
All experiments were performed in accordance with the Prevention of Cruelty to Animals 
Act (1986), under the guidelines of the National Health and Medical Research Council 
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Code of Practice for the Care and Use of Animals for Experimental Purposes in Australia 
(Florey Animal Ethics Committee approval number: 10-079). 
 
4.3.1.3 Intravenous self-administration (IVSA) 
Operant self-administration training was conducted in mouse operant chambers (model 
ENV-370W, Med Associates) housed in individual ventilated sound- and light- attenuating 
cubicles. Two retractable levers (ENV-312M, Med Associates), one paired with reward 
delivery (active lever) and the other with no programmed consequence (inactive lever), 
were present either side of a fluid receptacle (ENV-303LP, Med Associates) outfitted with 
a contact lickometer (ENV-250, Med Associates). A stimulus light (conditioned stimulus, 
CS) was located over the active lever and illuminated for 5 sec concomitant to reward 
delivery. A vanilla-scented olfactory cue (discriminative cue) placed beneath the reward-
paired lever. Responses were registered in a separate room on a computer running Med-
PC IV software (Med Associates).  
 
Self-administration training was conducted in the dark photoperiod. Animals were 
acclimated to single housing and the reverse light dark cycle for 7 days, after which point 
access to standard laboratory chow was restricted  (7g/day, unless body weight fluctuated 
more than 2g). The instrumental response (lever press) and discrimination between the 
active and inactive levers was established using 10% w/v oral sucrose (Coles) under a 
FR1 schedule. Each active lever press resulted in the presentation of a 5-sec light cue and 
the concurrent delivery of 5 µl of sucrose to the fluid receptacle over a 1.7 s period. The 
instrumental response was considered to be acquired if animals performed >100 lever 
presses per 2 hr session with >75% discrimination between the reward-paired and inactive 
levers over the last 3 days of training. Licking events were recorded by a contact 
lickometer to ensure that lever pressing during cocaine self-administration was not due to 
continued sucrose seeking. Yoked control animals received equivalent amounts of 
sucrose, under the control of their paired self-administering counterparts.  
 
Following sucrose training, all mice were anaesthetized with isofluorane (5% induction, 
1.5-1.8% maintenance in air, Rhodia Organic Fine Ltd.) and implanted with a custom built 
indwelling jugular catheter (Brown et al., 2009). Mice received analgesic (meloxicam, 3 
mg/kg, i.p., Boehringer Ingelheim) and were allowed to recover for two days prior to 
cocaine self-administration training. During the recovery period, catheters were flushed 
with 0.03 ml of 0.9% physiological saline containing heparin (90 U, CSL) and neomycin 
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sulphate (4 mg/ml, Delta Veterinary Laboratories). During IVSA training catheters were 
flushed with 0.03 ml of 10 U heparinized saline with antibiotic prior to each session and 
0.03 ml of 90 U heparinized saline after each training session.  
 
Mice self-administered cocaine intravenously under an FR1 schedule over 12 daily, 2-hour 
sessions in the first half of the dark phase of the photoperiod. Responses on the reward-
paired lever resulted in the infusion of 0.5mg/kg of cocaine hydrochloride (Sigma Aldrich, 
in 0.9% physiological saline) over 1.7 s (infusion volume of 19 µl) and the concurrent 
presentation of a 5-sec light cue. To minimize the risk of overdose, cocaine was 
unavailable during the presentation of the light cue and a within session maximum of 80 
cocaine-paired lever presses was applied. Lever presses during the timeout period were 
recorded. Yoked animals received cocaine contingent on the response of a paired self-
administering animal. Subsequent to self-administration training, animals were assigned to 
groups (1 day of abstinence + relapse test; IVSA 1, 21 days of abstinence + relapse test; 
IVSA 21 or IVSA 21 R, 21 days of abstinence + no relapse test; IVSA 21 NR) 
counterbalanced for cocaine-seeking behaviour (determined by the average number of 
active lever presses over the final 3 days of cocaine self-administration). 
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Group Conditions Experiments 
Naïve Caged during experiments      Two cohorts 
- Next-gen sequencing 
- MBD qPCR, mRNA 
analysis 
 
Sacrificed at same time 
point as IVSA 1 animals 
IVSA Day 1  
(IVSA 1) 
12 days cocaine IVSA  Two cohorts 
- Next-gen sequencing 
- MBD qPCR, mRNA 
analysis 
 
1 day forced abstinence 
1 hour relapse test  
IVSA Day 21 
(IVSA 21/IVSA 21 R) 
12 days cocaine IVSA  Two cohorts 
- Next-gen sequencing 
- MBD qPCR, mRNA 
analysis 
 
21 days forced abstinence 
1 hour relapse test 
IVSA Day 21 NR 
(IVSA 21 NR) 
12 days cocaine IVSA      One cohort 
- MBD qPCR, mRNA 
analysis 
 
21 days forced abstinence 
NO relapse test 
Yoked 1 12 days yoked cocaine      One cohort 
- Next-gen sequencing 
 1 day forced abstinence 
1 hour context re-exposure 
Yoked 21 12 days yoked cocaine One cohort 
- Next-gen sequencing 
 21 days forced abstinence 1 hour context re-exposure 
 
Table 4.1 Behavioural conditions 
4.3.1.4 Abstinence 
During abstinence, all mice were returned to their home cages. Periods of abstinence were 
either short (1 day) or long (21 days). In rats, self-administration of cocaine or natural 
rewards (food, sucrose) potentiates glutamatergic signalling in the VTA, however only 
following cocaine self-administration does this potentiation persist beyond 21 days (Chen 
et al., 2008), which suggests that this time point may be used to identify long-lasting 
persistent epigenetic changes that are unique to cocaine self-administration.  
 
4.3.1.5 Continued cocaine seeking during abstinence 
With the exception of IVSA 21 NR mice, self-administering animals were subject to a 1-
hour relapse test in the absence of cocaine after either 1 or 21 days of forced abstinence 
to examine the persistence of cocaine-seeking behaviour. Active lever presses resulted in 
the presentation of the previously cocaine-paired light cue and the activation of the syringe 
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pump. Cocaine-seeking behaviour was measured as the sum of all active lever presses 
over the course of the hour, including those performed during the timeout period. Yoked 
animals underwent simple contextual re-exposure for 1 hour. Animals used for next-
generation sequencing were sacrificed by cervical dislocation immediately after relapse 
test, whereas those employed for the validation of the differentially methylated regions and 
gene expression analysis were sacrificed 2 hours after the end of the relapse test. Brains 
were removed following cervical dislocation, snap-frozen on liquid nitrogen and stored at -
80C.  
 
4.3.2 Identification of genome-wide changes in DNA methylation by MBD Ultra-Seq 
Neuronal genomic DNA was isolated from the mPFC of individual animals, as described in 
Chapter 3. Next-generation sequencing was performed by MBD Ultra-Seq (Chapter 3), 
with two minor modifications: 75 ng of gDNA from each animal was used for library 
preparation and the final pooled, amplified, methyl-enriched libraries for each treatment 
group was loaded into two lanes, to prevent the production of artificial differences by inter-
lane discrepancies. Regions of methylation enrichment (RMEs, or peaks) were identified 
as per Chapter 3.  
 
4.3.3 Candidate DMR selection 
To identify differentially methylated regions, RMEs covered by a minimum of 5 normalised 
reads in at least one of the treatment groups were selected. From this selection, RMEs 
within 600 bp of each other were grouped and defined as a single RME. Student’s t-tests 
were performed to compare the relative level of 5mC enrichment (as measured by the 
normalised read counts) between naïve and cocaine-treated animals (IVSA 1, IVSA 21, 
Yoked 1, Yoked 21) at each grouped RME. The Benjamini-Hochberg false discovery rate 
multiple testing correction was used to calculate adjusted p-values, allowing for a false 
discovery rate of 10%. The level of 5mC enrichment was considered significantly different 
between groups if the FDR-adjusted p-value was less than 0.1 (Ellis et al., 2012, Non et 
al., 2014). Persistently differentially methylated regions (persistent DMRs) arising from 
cocaine self-administration are those that are significantly different in the IVSA 1 and IVSA 
21 groups, but not in the yoked cocaine controls relative to naïve animals. Abstinence-
associated DMRs are significantly different to naïve animals after 21 days of abstinence 
from cocaine self-administration. As the MBD2b/3L1 complex captures DNA fragments 
containing a minimum of 5 methylated CpGs (Active Motif), I ensured that the genomic 
region (RME summit +/- 150 bp) surrounding each DMR of interest contained at least 5 
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CpG dinucleotides. Finally, I confirmed the 300 bp region overlapping each DMR 
corresponded to a unique location in the mouse reference genome (mm9) to avoid 
artefacts produced by poor mapping of repetitive regions. 
 
4.3.4 MBD quantitative PCR (MBD qPCR) 
MBD pull downs were performed using 150 ng of neuronal DNA derived from the mPFCs 
of individual animals from a second cohort of animals. Genomic DNA was extracted as 
described in Chapter 3, except that two 250 µl aliquots were retained for the analysis of 
gene expression following the disruption of the tissue in the douncing buffer. Genomic 
DNA was sheared by sonication in 130 µl of ultrapure H20 (Covaris S2, bath temperature: 
4°C, duty: 10%, intensity: 6, cycle/burst: 100, time: 180 seconds) to fragments of ~300bp 
in length, as verified by Bioanalyzer HS (Agilent) and 13 µl of fragmented DNA was diluted 
in a total volume of 80 µl of DNAse/RNase free TE buffer (pH 8) and retained as input to 
control for slight variations in the amount of DNA used in each pull down. MBD pull downs 
were performed according to manufacturer’s protocol (Methylcollector Ultra, Active Motif). 
Captured methylated fragments were eluted in 60 µl of TE buffer (pH 8).  
 
A 300 bp region surrounding each candidate DMR was retrieved (UCSC genome browser, 
mm9) and primers (Table 4.2) were designed using Primer3 (Untergasser et al., 2012) to 
amplify 120-300 bp regions overlapping the peak summit of select candidate DMRs. qPCR 
was performed in duplicate using a Rotor gene Q (Qiagen) in 10 µl reactions (5 µl 2X Sybr, 
1 µl 10 µM primer (F+R), 3 µl H2O, 1 µl MBD DNA/input DNA). Ct values for methyl-
enriched DNA were normalised to input and the relative enrichment between groups was 
calculated using the delta-delta ct method.  
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DMR Forward primer Reverse Primer 
KCTD16-
associated 
AGGGCGAGGCTTCTAGTGA TCCTTTCAGGTCCACCTTTG 
GOLGB1-
associated 
GCAGTCGTACGAGAACGTGA ATCCTGCAGCTGCTTCTCTC 
SNW1-proximal ACTTTTTCCCCTCCATCGAC ACTACTGAGAGCCCCGGAAT 
GLRa1-associated GAGCAGCAGGTGAGTGACAG AGAGAGATGGAGGAGGTGAGG 
CDH13-assocatied TGCCTACCTGTGCGTATGAG TTTCCAGGCTCCTGTCCTAA 
Gm10375-proximal TGGAACCCAGTGGAAGTCTC CCCTCCTCAGCGATTACAAA 
 
Table 4.2 Primers used for the validation of DMRs by MBD qPCR 
4.3.5 Analysis of gene expression 
4.3.5.1 RNA extraction and cDNA synthesis 
250 µl of whole mPFC homogenate was retained from each animal in the second 
biological cohort following homogenisation of the brain punches in nuclear lysis buffer. 
RNA was extracted by Trizol LS (Invitrogen) according to the manufacturers protocol and 
quantified by spectrophotometry (Nanodrop). 250 ng of RNA was reverse transcribed 
(QuantiTect Reverse Transcription, Qiagen). cDNA was diluted to approximately 100 ng/ul 
prior to qPCR (Nanodrop). Whole mPFC homogenate was used because it is not possible 
to obtain neuronal mRNA from neuronal nuclei (mRNA resides in the cytoplasm and 
attempts at sorting whole neurons have been unsuccessful).  
 
4.3.5.2 Quantitative PCR (qPCR)  
Primers (IDT) for gene expression quantification were designed using Primer3 
(Untergasser et al., 2012), AutoPrime (Wrobel et al., 2004) or obtained from PrimerBank 
(Wang et al., 2012) (Table 4.3). In select cases, the expression of multiple isoforms of the 
gene of interest was examined. qPCR was performed in triplicate using a Rotor gene Q 
(Qiagen) in 10 µl reactions (5 µl of 2X Sybr, 2 µl of 5 µM primer (Foward+ Reverse), 2 µl 
H2O, 1 µl 100 ng/ul cDNA). Relative expression was quantified using the delta-delta Ct 
method, normalised to dynein expression, which was the most consistent of 5 
housekeeping genes tested (B-actin, PPIA, PGK, 18S and dynein).   
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Gene 
(isoform) 
Forward primer Reverse primer 
Cdh13 (all) CCTGTCCTAAACTTGACC GAGTTCTGCCATGTCTTC 
Cdh13 
(001, 003-
006 
CTGCTGTCCCAGGTGCTC TGAAGGTCAAGTTTAGGACAGG 
Cpeb4 (all) AGGATAAACCAGTGCAGATCC GAGCCATCCATCACAAAGTC 
Cpeb4 
(201,203, 
002) 
GCGAAGGAGAGGTCAGTC CTGGTGAGTGAAGCAGTGAG 
Glra1 (all) CGGAATGGCAATGTCCTCTAC GAGTTGCATGATACACGTCTGT 
Golgb1 (all) CTTCCTCAGACGCTGACTC CAGCTCCACCACTAACTTCT 
Kctd16 (all) TCTTCTATCGTGAGCCTTCC CAGGTCACTTTTCCGCCTCAT 
Mctp1 (all) CCACAAGAACCTAAATCCTGTGT AAAGGCTGAGCCCATAAAGTC 
Mctp1 
(001) 
CAGGCTCTGCAGAAGGACAT CTGGTACATTCCGGGATCAG 
Nkain3 (all) TGCTCGCTGGTCTGTCTCT ACACCATGATGTAACGTGGTCTA 
Snw1 (all) GCTCACCAGCTTTTTACCTGC GCTCCCTTCGAGAGGAGAC 
Dynenin GGACATTGCTGCCTATATCAAGAAG CGTGTGTGACATAGCTGCCAA 
 
Table 4.3 Primers used for quantification of mRNA expression by qPCR.  
Primers were designed by Primer3, AutoPrime or retrieved from PrimerBank. In the case 
of isoforms, “all” refers to the fact that the primer amplifies all the isoforms of the gene 
overlapped by the corresponding DMR, but not necessarily all isoforms of the gene itself. 
Isoforms are numbered according to Ensembl Build 37 of the mouse reference genome. 
 
4.3.6 Statistical analysis 
4.3.6.1 Intravenous cocaine self-administration 
A two-way analysis of variance (ANOVA) was performed with factors ‘lever’ (cocaine-
paired or inactive) and ‘days of abstinence’ (1 or 21 days) in Prism 6.0. A Holm-Sidak 
posthoc test was used to examine the significant main effect of ‘lever’. A Kruskal-Wallis 
test followed by Dunn’s multiple comparison post hoc tests was used to examine 
differences the number of lickometer contacts, as this data was non-parametric. 
Lickometer contacts indicated as mean contacts ± standard error of mean. 
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4.3.6.2 Heatmap 
All regions of methylation (RMEs) were identified by MACS, as described in Chapter 3 
(calling peaks). If enrichment for methylation was identified in greater than 50% of 
biological replicates in either the Naïve, IVSA 1 or IVSA 21 groups, that RME was retained 
and illustrated in the heatmap for all groups. The colour of each tile indicates the number 
of biological replicates within each group that displayed enrichment at a given RME (red = 
all biological replicates, white = no biological replicates).    
 
4.3.6.3 Quantitative PCR (MBD qPCR and gene expression analysis) 
For each candidate DMR or gene, a one-way ANOVA was used to examine variance, 
followed by Holm-Sidak multiple comparison post hoc tests if the overall ANOVA was 
significant. In instances where the homogeneity of variance assumption was violated, 
Welch’s one-way ANOVA test was used, followed by Games-Howell post hoc tests if the 
overall ANOVA was significant. Where data was non-parametrice, a Kruskal-Wallis test 
was used, followed by Dunn’s multiple comparison post hoc tests. For all tests, the 
significance confidence limit was set at 95%. Statistical analysis was performed using 
GraphPad Prism version 6.0.  
 
4.4 Results 
4.4.1 Mice persistently seek cocaine during protracted abstinence 
Enduring cocaine-related memories are a prerequisite for continued cocaine seeking 
during abstinence; conversely, this behaviour indicates the presence of such memories. 
We therefore sought to establish that our paradigm produces continued cocaine seeking 
during abstinence. Cocaine-seeking behaviour manifests as a sustained and significant 
preference for the previously cocaine-paired lever relative to the inactive lever. In our 
paradigm, mice trained to self-administer cocaine continue to seek cocaine during 
abstinence, pressing the previously cocaine-paired lever significantly more than the 
inactive lever after 1 and 21 days of abstinence, (F1,62 = 84.35, p<0.0001, Figure 4.1). The 
number of responses on the previously cocaine-paired lever did not differ across the 
period of enforced abstinence mice do not press the previously cocaine-paired lever 
significantly more following 21 days of abstinence, as compared to 1 day of forced 
abstinence (Holm-Sidak’s post hoc, ns, Figure 4.1). Moreover, it is unlikely that continued 
lever pressing is due to continue sucrose-seeking (following the use of sucrose self-
administration in establishing the instrumental response) as the mean number of contacts 
with the lickometer was significantly less during cocaine self-administration (1.56 ± 0.69 
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contacts), the relapse test after 1 day of abstinence (0.43 ± 0.43 contacts) and during the 
relapse test after 21 days of abstinence (10 ± 4.55 contacts) than during sucrose self-
administration (4185 ± 282 contacts), (H4,57 =42.82, p<0.0001, Dunn’s post hoc tests: 
cocaine IVSA vs. sucrose SA, p<0.0001, IVSA 1 vs. sucrose SA, p<0.001, IVSA 21 vs. 
sucrose SA, p<0.05). Importantly, continued cocaine seeking during abstinence suggests 
that mice ‘remember’ the cues, stimuli, context and behaviours associated with cocaine 
availability and denotes the presence of long-lasting cocaine-related memories. This 
model of cocaine self-administration is therefore appropriate for the examination of the 
neural adaptations that underlie the maintenance of cocaine-related memories during 
abstinence. 
 
 
 
Figure 4.1 Mice persistently seek cocaine during protracted abstinence.  
Mice pressed the previously cocaine-paired lever significantly more than the inactive lever 
after 1 and 21 days of forced abstinence, F1,62 = 84.35, p<0.0001 (n=18 and 15, 
respectively). There was no difference in the number of cocaine-paired lever presses 
performed after 1 or 21 days of forced abstinence (Holm-Sidak’s post hoc, ns). Data 
displayed as mean lever presses ± SEMs. 
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4.4.2 Altered DNA methylation following cocaine self-administration  
DNA methylation was identified by MBD Ultra-Seq (Li et al., 2014) using neuronal DNA 
derived from the mPFCs of naïve animals (n=5), cocaine self-administering mice sacrificed 
after either 1 or 21 days  of abstinence (n= 7 and 6 respectively) and yoked cocaine 
controls sacrificed at the same time points (n=3 and n=4). The mean total intake of 
cocaine across self-administration (IVSA 1: 40.85 ± 1.73 infusions, IVSA 21: 43.01± 2.14 
infusions) or yoked cocaine exposure (Yoked 1: 39.64 ± 3.32 infusions, Yoked 21: 45.69 ± 
2.87 infusions) did not differ between groups (F3,44 = 1.05, ns). MACS (Zhang et al., 2008) 
identified 46,464 regions of methylation enrichment (RMEs) across the genome. 
Preliminary inspection of a heatmap of RMEs identified in at least half the biological 
replicates of either the naïve, IVSA 1 or IVSA 21 groups (Figure 4.2), reveals that both 
cocaine exposure and cocaine self-administration produce distinct patterns of 5mC 
enrichment.  
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                           Naïve             IVSA1         IVSA 21         Yoked 1        Yoked 21 
                  
Figure 4.2 Representative heatmap of 5mC enrichment 
All RMEs that were supported by enrichment (relative to background genomic coverage) in 
at least 50% of biological replicates in naïve (n=6), IVSA 1 (n=7) or IVSA 21 (n=6) animals 
are plotted. White indicates that no biological replicates displayed enrichment for 5mC, 
while dark red indicates that all biological replicates had enrichment for 5mC at the given 
genomic locus. 
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4.4.3 Persistent modifications of DNA methylation following cocaine self-
administration  
Modifications of DNA methylation that arise during cocaine self-administration and persist 
over time are consistent with the enduring nature of cocaine-related memories and 
consequently more prone to be implicated in their maintenance. 29 genomic regions were 
persistently significantly differentially methylated (relative to naïve animals) following the 
self-administration of cocaine but not passive cocaine exposure (p<0.1 in IVSA 1 and 
IVSA 21 animals, p>0.1 in Yoked 1 and Yoked 21 animals, FDR-adjusted p-values relative 
to naïve animals following Student’s t-tests). The genomic coordinates of the persistent 
DMRs and associated or proximal genes are listed in Table 4.4. Five persistent DMRs 
were demethylated following cocaine self-administration; the remainder were subject to 
increased methylation.  
 
The genomic distribution of persistent IVSA-associated DMRs was examined using 
EpiExplorer (Halachev et al., 2012), a web-based tool that identifies genes and regulatory 
features overlapped by user-defined genomic regions. 15 of 29 DMRs overlap genes and 
a further 5 are located within less than 10 kB of a gene (NCBI Ensembl Build 37). 
Therefore, a chief function of persistent IVSA-associated changes in DNA methylation may 
be the regulation of the transcription of proximal genes, both coding and non-coding. 
Interestingly, gene-associated DMRs are predominantly located with intronic regions or 
non-coding loci; only 3 of these DMRs overlap principal promoter regions (-5kb to 1kb from 
TSS) or exons. The most common regulatory feature associated with persistent DMRs is 
repetitive elements (19 of 29 DMRs overlap repetitive elements identified by 
RepeatMasker). However, repetitive elements tend to be heavily methylated and it is 
easier to discern changes in DNA methylation at these loci (Hardcastle, 2013). 
Nevertheless, as cocaine exposure leads to repetitive element unsilencing (Maze et al., 
2011), it is possible that persistent changes in DNA methylation following cocaine self-
administration oversee the regulation of repetitive elements. Persistent DMRs further 
consort with DNase I hypersensitive sites (13 of 29 DMRs overlap DNase HS sites). 
DNase I hypersensitivity is characteristic of open chromatin and classically associated with 
transcriptional activity (Weintraub & Groudine, 1976), which further advocates for a role of 
persistent IVSA-associated changes in DNA methylation in the regulation of the 
transcription of proximal genes. Additionally, 5 persistent DMRs overlap active enhancer 
regions (defined by an enrichment of histone H3 lysine 4 methylation and histone H3 
lysine 27 acetylation (Creyghton et al., 2010)). Finally, 5 persistent DMRs are located 
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within regions of the genome that are ordinarily anchored to the nuclear lamina (LADs). 
LADs regulate chromosomal architecture and comprise approximately 35% of the genome 
(Meuleman et al., 2013). In sum, cocaine self-administration leads to distinct persistent 
modifications of the neuronal methylome and a primary function of these changes in DNA 
methylation is likely the regulation of the transcription of proximal genes, possibly through 
the modulation of several genomic features.   
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Chr Location 
 
Overlapped 
gene 
Left gene 
(distance) 
Right gene 
(distance) 
Genomic 
region 
4 
 
3010811 
 
None 
 
N/A 
(centromere) 
Vmn1r2-ps2 
(20095 bp) 
Intergenic 
4 
 
46790936 
 
Gabbr2 
 
Tbc1d2 
(127855 bp) 
Gm568 
(230252 bp) 
Intronic 
4 
 
141306461 
 
Agmat 
 
Ddi2 
(27127 bp) 
Dnajc16 
(9643 bp) 
Intronic 
4 
 
145428809 
 
None 
 
Gm13238 
(908 bp) 
Gm13246-001 
(5498 bp) 
Intergenic 
4 
 
 
146141283 
 
 
Zfp600 
Gm13165 
Gm17452 
Gm13051 
(47261 bp) 
 
Gm13170 
(4242 bp) 
 
Intronic 
Non-coding 
4 
 
146599023 
 
Gm16889 
Gm17317 
Gm13163 
(29703 bp) 
Gm13147 
(5370 bp) 
Non-coding 
4 
 
146711210 
 
Gm16889 
Gm17317 
Gm13151 
(3367 bp) 
Gm13145 
(22407 bp) 
Non-coding 
5 
 
33068902 
 
Gm2420 
 
Yes1 
(79472 bp) 
Pisd 
(10047 bp) 
Non-coding 
6 
 
47698472 
 
None 
 
Y-RNA 
(11254 bp) 
AC166252.1 
(24856 bp) 
Intergenic 
6 
 
103264621 
 
None 
 
U6.880 
(452125 bp) 
Chl1 
(196249 bp) 
Intergenic 
7 
 
23614005 
 
None 
 
Gm4207 
(21673 bp) 
Vmn1r159 
(13072) 
Intergenic 
7 
 
46628130 
 
None 
 
U6.424 
(88627 bp) 
Gm5114 
(34534) 
Intergenic 
7 
 
148824812 
 
Muc6 
 
Ap2a2 
(5902 bp) 
Muc2 
(51456) 
Exonic 
8 
 
14306925 
 
Dlgap2 
 
SNORA17.403 
(33614 bp) 
C030037F17Rik 
(438404 bp) 
Intronic 
8 
 
19929891 
 
Gm172379 
2610005L07Rik 
6820431F20Rik 
(36881 bp) 
Gm15319 
(3351 bp) 
Non coding 
8 
 
73672924 
 
None 
 
Gm17576 
(105985 bp) 
Haus8 
(102100 bp) 
Intergenic 
8 
 
74324225 
 
None 
 
Fcho1 
(74610 bp) 
Gm5373 
(52846 bp) 
Intergenic 
10 
 
7233614 
 
None 
 
9230019H11Rik 
(6912 bp) 
Lrp11 
(76001 bp) 
Intergenic 
11 
 
31822731 
 
Cpeb4 
 
Gm12107 
(84517 bp) 
4930524B15Rik 
(42861 bp) 
Intronic 
11 
 
53954092 
 
None 
 
P4ha2 
(8938 bp) 
Gm12221 
(18336 bp) 
Intergenic 
12 
 
88821123 
 
None 
 
Snw1 
(7874 bp) 
Gm2022 
(12151 bp) 
Intergenic 
13 
 
3372770 
 
None 
 
Speer6d-ps1 
(184207 bp) 
2810429I04Rik 
(104779 bp) 
Intergenic 
13 
 
76730298 
 
Mctp1 
 
Gm10760 
(207822 bp) 
SNORA17.278 
(13782 bp) 
Intronic 
16 
 
36915248 
 
Golgb1 
 
4930565N06Rik
* (17973 bp) 
Hcls1 
(19821 bp) 
Exonic 
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18 
 
3005873 
 
None 
 
None 
(centromere) 
Vmn1r-ps151 
(21082 bp) 
Intergenic 
18 
 
40467890 
 
Kctd16 
 
2900055J20Rik 
(50552 bp) 
Rps19-ps13 
(418003 bp) 
Intronic 
19 
 
39341696 
 
Cyp2c53 
Cyp2c29 
Cyp2c66 
(80134 bp) 
Cyp2c38 
(122350 bp) 
Intronic 
Non-coding 
X 
 
131588748 
 
3632454L22Rik 
 
Zmat1 
(28917 bp) 
Gm6207 
(65752 bp) 
Non coding 
X 
 
166505941 
 
None 
 
Mid1 
(62273 bp) 
Gm15069 
(9891 bp) 
Intergenic 
 
Table 4.4 Persistent DMRs unique to cocaine self-administration.  
Chromosome (Chr) and location are derived from Ensembl Build 37 (NCBI37) with location 
defined as the middle of the DMR.  
 
Black: protein coding 
Blue: processed transcript 
Purple: Linc RNA 
Grey: transcribed processed pseudogene 
Orange: transcribed unprocessed pseudogene 
Pink: Unprocessed pseudogene 
Red: Miscellaneous RNA 
Green: miRNA  
Turquoise: snRNA 
Indigo: SNORA 
*: antisense 
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4.4.4 Abstinence-associated modifications of DNA methylation following cocaine 
self-administration  
28 genomic regions became differentially methylated during abstinence from cocaine self-
administration but not passive cocaine exposure (p<0.1 in IVSA 21 animals, p>0.1 in IVSA 
1, Yoked 1 and Yoked 21 animals, FDR-adjusted p-values relative to naïve animals, Table 
4.5). Moreover, 5mC enrichment at abstinence-associated DMRs is significantly different 
in IVSA 21 animals relative to IVSA 1 or Yoked 21 animals (follow-up Student’s t-tests, 
p<0.05). 8 abstinence-associated DMRs became demethylated during prolonged 
abstinence, while the rest became methylated. 13 of 28 DMRs overlap genes and 3 more 
are located within <10 kB of a gene.  Again, gene-associated DMRs predominantly occur 
within introns or non-coding loci; 5 of 19 gene-associated DMRs are located within exons 
or promoter regions. A greater percentage of abstinence-associated DMRs occur within 
10-100 kB of annotated genes (39% of abstinence-associated DMRs as opposed to 14% 
of persistent DMRs) which may indicate a more pronounced role for abstinence-associated 
DMRs in the regulation of enhancer or insulator regions. Once more, abstinence-
associated DMRs frequently co-localise with repetitive elements (16 of 28 DMRs overlap 
repetitive elements). Astonishingly, 24 of 28 abstinence-associated DMRs overlap or are 
located proximal to nuclear lamina domains (13 overlap and 11 are located within < 1 kB 
of nuclear lamina domains). The unusual association of abstinence-associated DMRs with 
lamina domains suggests extensive repositioning of the genome during abstinence, 
potentially with profound transcriptional consequences. 
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Chr Peak 
summit 
Overlapped 
gene 
Left gene 
(distance) 
Right gene 
(distance) 
Genomic 
feature 
1 
 
26744426 
 
None 4931408C20Rik 
(121 bp) 
n-R5s209 
(271552 bp) 
promoter 
1 
 
85243851 
 
C130026I21Rik 
Gm16028* 
Gm7069 
(33490 bp) 
Gm16026 
(19422 bp) 
Intronic 
Non-coding 
3 
 
22163381 
 
None RNaseP_nuc.3 
(12796 bp) 
SNORA17.487 
(145464 bp) 
Intergenic 
4 
 
20119038 
 
Nkain3 Ggh 
(125141 bp) 
Gm11872* 
(151815 bp) 
Intronic 
4 
 
60276939 
 
None Mup-ps3 
(20240 bp) 
Gm14311** 
(97572 bp) 
Intergenic 
4 
 
145029937 
 
Gm13277 Gm13224** 
(35635 bp) 
Gm13230 
(6706 bp) 
Non-coding 
chr4 
 
145761171 
 
None Gm13251 
(12155 bp) 
Rex2 
(120144 bp) 
Intergenic 
4 
 
146593852 
 
Gm16889 
Gm17317 
Gm13163 
(24532 bp) 
Gm13147 
(10541 bp) 
Non-coding 
4 
 
 
146624923 
 
 
Gm16889 
Gm17317 
Gm13147 
Gm13163 
(55603bp) 
 
Gm13158 
(16599 bp) 
 
Non-coding 
4 
 
146847085 
 
Gm16889 
 
Gm17317 
(15957 bp) 
Gm13152 
(19441 bp) 
Non-coding 
4 
 
147029598 
 
2610305D13Rik Gm13155** 
(30604 bp) 
Gm16211 
(13029bp) 
Intronic 
5 
 
15195434 
 
Speer7d-ps1 4930572O03Rik 
(32557 bp) 
Speer-4d 
(19855 bp) 
Non-coding 
5 
 
26425785 
 
5031410I06Rik Gm10471 
(9954 bp) 
Gm10220 
(16472 bp) 
3’ UTR 
5 
 
95153090 
 
None Gm6025 
(37712 bp) 
Gm3176 
(227009 bp) 
Intergenic 
(island) 
7 
 
12595989 
 
None Vmn1r-ps60 
(4430 bp) 
Vmn1r77 
(30659 bp) 
Intergenic 
8 
 
20036646 
 
None 2610005L07Rik 
(16254 bp) 
None Intergenic 
9 
 
120196465 
 
None Mobp 
(105863 bp) 
Myrip 
(16589 bp) 
Intergenic 
10 
 
7229820 
 
None 
 
9230019H11Rik 
(3118 bp) 
Lrp11 
(79778 bp) 
Intergenic 
10 
 
7233650 
 
None 
 
9230019H11Rik 
(6948 bp) 
Lrp11 
(75948 bp) 
Intergenic 
11 
 
55343509 
 
Glra1 Gm12236* 
(2292 bp) 
Gm12237 
(24933 bp) 
Intronic 
14 
 
43641447 
 
None Gm8068 
(17965 bp) 
Gm3102 
(14108 bp) 
Intergenic 
14 
 
43981432 
 
Gm9732 Gm8127 
(9086 bp) 
Gm17155 
(15276 bp) 
Intronic 
15 
 
75934238 
 
None Nrbp2 
(13795 bp) 
BC024139 
(15709 bp) 
Intergenic 
17 3082304 Pisd-ps2 Pisd-ps2 Scaf8 Non-coding 
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  (192 bp) (32668 bp) 
17 
 
29240998 
 
None Cdkn1a 
(3331 bp) 
Gm16194* 
(10092 bp) 
Intergenic 
18 
 
82390610 
 
None MiR5127 
(201791 bp) 
Gm17383** 
(117556 bp) 
Intergenic 
X 
 
32099759 
 
None Gm2940 
(145178 bp) 
Gm2946 bp 
(30027 bp) 
Intergenic 
X 
 
166584479 
 
None Gm15069 
(68276 bp) 
Gm15068 
(54108 bp) 
Intergenic 
 
Table 1.5 Abstinence-associated DMRs arising from cocaine self-administration 
Black: protein coding 
Blue: processed transcript 
Purple: Linc RNA 
Grey: transcribed processed pseudogene 
Orange: transcribed unprocessed pseudogene 
Pink: Unprocessed pseudogene 
Red: Miscellaneous RNA 
Green: miRNA 
Turquoise: snRNA 
Indigo: SNORA 
Light green: ribosomal (rRNA) 
*: antisense 
** known pseudogene 
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4.4.5 Verification of differential methylation by MBD qPCR 
A selection of the observed differences in methylation between naïve and self-
administering animals (Day 1 and 21) were selected for validation by MBD qPCR in an 
independent cohort of animals. An additional group that did not undergo relapse testing 
after 21 days of abstinence (IVSA 21 NR) was included to ensure that abstinence-
associated changes in DNA methylation were not simply the product of the relapse test. 
The mean cocaine intake did not differ between Day 1 (56 ± 1.8 infusions), Day 21 R (57 ± 
0.7 infusions) and Day 21 NR (55 ± 1.5 infusions) (F2,33 = 0.51, ns).  Select DMRs included 
three regions that were persistently differentially methylated following cocaine self-
administration and one that became differentially methylated during abstinence. Two of the 
persistent DMRs overlapped coding genes (KCTD16 and GOLGB1) and one was located 
proximal to SNW1, while the abstinence-associated DMR was located within an intron of 
GLRa1. Graphs of the normalised read distributions at these DMRs are provided in Figure 
4.3. All candidate DMRs were successfully validated by MBD qPCR (Figure 4.4), 
indicating that MBD Ultra-Seq and the statistical limitations employed reliably identify 
changes in DNA methylation induced by cocaine self-administration.  
 
While DMRs identified by the statistical means above validate reliably, DMRs covered by 
less than 5 mean normalised reads or with more stereotypical p-values (p<0.02-0.05 prior 
to FDR correction) show marked variation between individuals. Nevertheless, two DMRs 
within the latter category were validated by MBD qPCR (Figure 4.5) and merit inclusion. 
The first was located within Cadherin 13 (CDH13), a gene that is heavily implicated in 
addiction to multiple substances (Hart et al., 2012) (Figure 4.5a). The second DMR was 
located upstream of gm10375 (Figure 4.5b) and illustrates the rapid and dynamic 
regulation of DNA methylation in the hours that follow relapse and memory retrieval, 
indicating that the retrieval of cocaine-related memories during abstinence may induce 
modifications of DNA methylation.  
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Figure 4.3 Mean normalised reads surrounding validated DMRs 
Plots of mean normalised read counts from sequencing surrounding DMRs that have been 
validated by sequencing. (a) A plot of the normalised mean read counts surrounding a 
persistently methylated DMR located within an intron of KCTD16 (potassium channel 
tetramerisation domain containing 16), which was centred at chr 18: 4046790 (mm9 
reference genome) (b) A plot of the normalised mean read counts surrounding a 
persistently demethylated DMR located within an exon of GOLGB1 (Golgin b1) and 
centred at chr 16: 36915248 (c) A plot of the normalised mean read counts surrounding a 
persistently demethylated intergenic DMR located proximal to SNW1 (snw1 domain 
containing gene) and centred at chr 12: 88821123 (d) A plot of the normalised mean read 
counts surrounding an abstinence-associated DMR that was located within an intron of 
GLRa1 (glycine receptor subunit alpha 1) and demethylated during abstinence. P-values 
are relative to naïve animals and are FDR-corrected p-values derived from a Benjamini-
Hochberg correction following Student’s t-tests. Y-axis values are the mean number of 
aligned reads for each treatment group, X-axis values are location within the chromosome.  
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Figure 4.4 Validation of select DMRs by MBD qPCR 
In an independent cohort of animals, qPCR was performed to assess the relative levels of 
5mC enrichment at DMRs identified in Figure 4.4. (a) In accordance with sequencing 
results, the DMR located within KCTD16 was persistently methylated following cocaine 
self-administration, F3,16 = 2.73, p=0.07. (b) Similarly, the locus within GOLGB1 was 
demethylated following cocaine self-administration, F3,17= 3.57, p<0.05. (c) Demethylation 
was also replicated at the intergenic locus located proximal to SNW1, F3,17= 4.35, p<0.05. 
(d) Finally, demethylation of the GLRa1-associated DMR was reproduced following 21 
days of abstinence, F3,17 = 5.59, p<0.01. All values displayed as means	 ± SEM, p-values 
derived from Holm-Sidak post hoc tests relative to naïve, * = p<0.05.  
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Figure 4.5 Validation of DMRs that did not pass FDR-based statistical thresholds 
Two DMRs that did not pass initial FDR-based statistical thresholds were nevertheless 
replicated in a second cohort by MBD qPCR. Left panels display the mean normalised 
sequencing reads surrounding the DMRs, right panels illustrate the MBD qPCR results (a) 
Cocaine self-administration led to an increase in methylation at the locus located within 
CDH13 (Cadherin 13), F3,16 = 6.13, p<0.01 (right panel). (b) CpG methylation was 
increased at a locus upstream of gm10375 after 21 days of abstinence and relapse 
testing, F3,17 = 7.17, p<0.01 (right panel). This change in methylation was the product of 
epigenetic remodelling during the relapse test, as there was a significant difference 
between the degree of methylation in the animals subject to relapse testing and those that 
were simply sacrificed after prolonged abstinence (right panel). * = p<0.05, ** = p<0.01, 
Holm-Sidak post hoc values.  
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4.4.6 Cocaine self-administration produces enduring changes in DNA methylation 
One might predict that most modifications of DNA methylation induced by self-
administration would be transient, with a handful persisting during abstinence. However, 
only one locus (centred at chr 6: 3133868, not shown) was transiently differentially 
methylated in response to cocaine self-administration, but not passive cocaine exposure 
(p<0.1 in IVSA 1, p>0.1 in IVSA 21, Yoked 1 and Yoked 21 animals relative to naïve, FDR-
adjusted p-values, follow up Student’s t-tests IVSA 1 vs. IVSA 21, p<0.05, IVSA 1 vs. 
Yoked 1, p<0.05).  The dearth of transient changes in DNA methylation may be due to 
several factors: 1) most parsimoniously, animals underwent 12 days of self-administration 
and transient changes in DNA methylation may have long dissipated, 2) most changes in 
DNA methylation incurred by cocaine self-administration are persistent and short-term 
changes in gene expression are orchestrated by ephemeral epigenetic modifications, such 
as histone methylation and acetylation or 3) transient changes in DNA methylation occur in 
other regions of the brain following cocaine self-administration, such as the hippocampus, 
as was observed following fear conditioning (Miller et al., 2010). Nevertheless, the lack of 
transient IVSA-associated changes in DNA methylation is intriguing.  
 
4.4.7 Transcriptional consequences of cocaine-induced changes in DNA 
methylation 
Modifications of DNA methylation may exert a number of effects, but a primary function of 
altered DNA methylation remains the regulation of gene expression. In addition to 
propagating enduring changes in gene transcription, persistent experience-induced 
modifications of DNA methylation might prime the transcription of the affected locus upon 
subsequent neuronal (or memory) reactivation (see Chapter 2). According to this 
hypothesis, some persistent or abstinence-associated DMRs arising from cocaine self-
administration would have no transcriptional consequence until the cocaine-related 
memories are in a reactivated state. To test this hypothesis, half of the animals that 
underwent prolonged abstinence were subject to a relapse test after 21 days of 
abstinence, while the remainder were simply sacrificed at the same time point. The relapse 
test (and exposure to previously cocaine-paired cues and context) should reactivate 
cocaine-associated memories, while in the latter instance these memories are likely to 
remain dormant. The DMRs co-localising with GOLGB1 (Figure 4.6) and GLRa1 (Figure 
4.7) were accompanied by decreased gene expression, regardless of whether or not 
relapse testing occurred (GOLGB1: F3,26 = 5.42, p<0.01, Holm-Sidak’s post hoc, naïve vs. 
IVSA 1, IVSA 21 R and IVSA 21 NR all p<0.01, GLRa1: Welch’s F3,13.36 = 7.52, p<0.01, 
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Games-Howell post hoc, naïve vs IVSA 21 R and IVSA 21 NR, p<0.1). Conversely, 
despite increased DNA methylation in all groups, the expression of KCTD16 was altered 
only in animals that underwent a relapse test, F3,26 = 6.55, p<0.01, Holm-Sidak post hoc, 
naïve vs. IVSA 21 R, p<0.1, IVSA 21 R vs. IVSA 21 NR, p<0.05  (Figure 4.8), providing 
preliminary evidence of the priming of gene expression by learning-induced changes in 
DNA methylation. Unsurprisingly, the intergenic DMR located proximal to SNW1 had no 
effect on its expression, F3,26 = 0.07, ns (Figure 4.9). Finally, differential methylation within 
CDH13 was associated with an enduring change in the transcription of this gene, F3,26 = 
2.53, p=0.07, Holm-Sidak post hoc, naïve vs. IVSA 1, IVSA 21 R, IVSA 21 NR, p<0.1 
(Figure 4.10).  
 
A number of significant DMRs were unsuited to validation by MBD qPCR, as they were 
located within lengthy repetitive elements for which region-specific primers could not be 
designed. Nevertheless, several of these DMRs consort with genes that have been 
implicated in addiction, including MCTP1 (multiple C2 domains, transmembrane 1), 
CPEB4 (cytoplasmic polyadenylation element binding protein 4) and NKAIN3 (Na+/K+ 
transporting ATPase interacting 3). MCTP1 and CPEB4-associated DMRs were 
persistently methylated following cocaine self-administration (Figure 4.11a and b, left 
panels), while the DMR within NKAIN3 was methylated following prolonged abstinence 
from cocaine self-administration (Figure 4.11c, left panel). The persistent increase in DNA 
methylation within MCTP1 was associated with an enduring and significant decrease in 
the expression of MCTP1 (-001 isoform), F3,26 = 4.07, p<0.05, Holm-Sidak post hoc, naïve 
vs. IVSA 1, IVSA 21 R and IVSA 21 NR all p<0.05, while a similar increase in DNA 
methylation within CPEB4 was associated with a significant increase in the expression of 
this gene (-001 isoform), F3,26 = 5.96, p<0.01, Holm-Sidak post hoc, naïve vs. IVSA 1 and 
21 NR, p<0.01, naïve vs. IVSA 21, p<0.05 (Figure 4.11a and b, right panel). Interestingly, 
the expression of NKAIN3 was exclusively decreased in mice have undergone relapse 
testing after 21 days of abstinence, F3,26 =4.56, p<0.05,  Holm-Sidak post hoc, naïve vs. 
IVSA 21 R, p<0.05, IVSA 21 R vs. IVSA 21 NR, p<0.01 (Figure 4.11c, right panel), which 
provides further preliminary evidence of a complex relationship between learning-induced 
changes in DNA methylation, gene expression and the reactivation state of the memory.  
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Figure 4.6 Differential DNA methylation and expression of GOLGB1 
(a) The GOLGB1-associated DMR was located intragenically and overlapped an exon of 
this gene. (b) As previously shown (Figure 4.5), the DMR was persistently demethylated 
following cocaine self-administration c) Decreased DNA methylation was correlated with a 
significant reduction in the expression of GOLGB1 (all isoforms), F3,26 = 5.42, p<0.01. 
Holm-Sidak post hoc, * = p<0.05, ** = p<0.01, data displayed as means ± SEM. 	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Figure 4.7 Differential methylation and expression of GLRa1 
(a) The DMR associated with GLRa1 was located within an intron of this gene. (b) The 
DMR was significantly demethylated relative to naïve animals after 21 days of abstinence, 
as previously described in Figure 4.5 (c) Demethylation of the GLRa1-associated DMR 
was associated with a trend towards a significant reduction in the expression of GLRa1 (all 
isoforms) after 21 days of abstinence, Welch’s F3,13.36 = 7.52, p<0.01, Games-Howell post 
hoc. * = p<0.05, data displayed as means ± SEM. 	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Figure 4.8 Differential DNA methylation and expression of KCTD16 
(a) The DMR associated with KCTD16 was located within the sole intron of KCTD16. (b) 
As seen in Figure 4.5, cocaine self-administration resulted in a persistent increase in DNA 
methylation at the locus highlighted in (a) (c) A trend towards a significant decrease in 
gene expression was observed after 21 days of abstinence, F3,26 = 6.55, p<0.01. After 21 
days of abstinence, KCTD16 expression was decreased in animals that underwent a 
relapse test (IVSA 21 R) compared to those that were simply sacrificed (IVSA 21 NR), 
p<0.05. Holm-Sidak post hoc, * = p<0.05, data displayed as means ± SEM. 	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Figure 4.9 Differential intergenic DNA methylation and SNW1 expression 
(a) The intergenic DMR was located proximal to SNW1. (b) At this locus, cocaine self-
administration decreased DNA methylation, as previously seen in Figure 4.5. (c) 
Decreased DNA methylation was not associated with a significant change in the 
expression of SNW1, F3,26 = 0.07, ns. Holm-Sidak post hoc, * = p<0.05, data displayed as 
means ± SEM. 	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Figure 4.10 Differential DNA methylation and expression of CDH13 
(a) Persistent DNA methylation following cocaine self-administration was located within an 
intron of CDH13-001, but overlapped the first exon of CDH13-002. (b) The DMR located 
within CDH13 was persistently methylated following cocaine self-administration, as 
previously seen in Figure 4.6 (c) There was a trend towards the reduction of CDH13 
expression, F3,26 =2.53, p=0.07, Holm-Sidak post hoc, ** = p<0.01, data displayed as 
means ± SEM. 	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Figure 4.11 Expression of genes co-localising with DMRs that cannot be validated  
(a) Cocaine self-administration produced a persistent increase in DNA methylation at a 
locus within MCTP1 (left panel). Increased DNA methylation was correlated with a 
concomitant decrease in the expression of MCTP1 (-001 isoform), F3,26 = 4.07, p<0.05, 
Holm-Sidak post hoc (right panel). (b) Cocaine self-administration resulted in a persistent 
increase in DNA methylation within an intragenic region of CPEB4 (left panel). Increased 
DNA methylation was associated with a long-lasting upregulation of CPEB4 (001/201 
isoform) expression, F3,26 = 5.96, p<0.01, Holm-Sidak post hoc (right panel). (c) A 
significant increase in DNA methylation within an intron of NKAIN3 occurred after 21 days 
of abstinence (left panel). The increase in DNA methylation was associated with a 
decrease in the expression of NKAIN3 (all isoforms) after 21 days of abstinence and 
relapse testing, F3,26 =4.56, p<0.05, naïve vs. IVSA 21 R, p<0.05, IVSA 21 R vs. IVSA 21 
NR, p<0.01, Holm-Sidak post hoc. The expression of NKAIN3 was unaltered when mice 
were simply sacrificed after 21 days of abstinence. ** = p<0.01, * = p<0.05, data displayed 
as means ± SEM.  
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4.4.8 Regulation of alternative splicing by intragenic DNA methylation 
A chief function of intragenic methylation is the regulation of alternative splicing. In our 
paradigm, DMRs within CPEB4, CDH13 and MCTP1 were associated with the regulation 
of specific isoforms of the co-localising genes (Figure 4.12). DNA methylation within 
CDH13 correlated with the overall downregulation of the expression of this gene, F3,26 = 
2.53, p=0.07 (Figure 4.12a), however this appears to stem from the regulation of non-
coding isoforms as the expression of the protein coding isoform, CDH13-001 (Ensembl 37) 
was unaltered, F3,26 = 1.35, ns, following cocaine self-administration (Figure 4.12b). 
Similarly, the overall expression of CPEB4 increased following cocaine self-administration, 
F3,26 = 5.96, p<0.01 (Figure 4.12c), but the most common variant (CPEB4-001, Ensembl 
37) exhibited a different pattern of expression, F3,26 = 4.32, p<0.01; CPEB4-001 expression 
was unchanged relative to naïve animals in all groups, yet was differentially expressed in 
animals subject to a relapse test after 21 days of abstinence compared to those that were 
simply sacrificed (Holm-Sidak post hoc, p<0.01, Figure 4.12d). The splice variants that 
gave rise to the overall increase in the expression of CPEB4 remain to be elucidated. 
Finally, the persistent increase in methylation within MCTP1 was associated with an 
enduring decrease in the expression of MCTP-001, F3,26 = 4.07, p<0.05 (Figure 4.12f), but 
the overall expression of all overlapped protein-coding transcripts of this gene was only 
significantly different in animals that underwent a relapse test after 21 days of abstinence 
compared to those that did not, F3,26 = 3.62, p<0.05, Holm-Sidak post hoc, IVSA 21R vs 
IVSA 21 NR: p<0.05 (Figure 4.12e). Together, these data suggest that the intragenic 
modifications of DNA methylation produced as a result of cocaine self-administration 
regulate the expression of specific isoforms of associated genes.  
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Figure 4.12 Regulation of alternative splicing by intragenic DNA methylation 
 Intragenic modifications of DNA methylation arising during cocaine self-administration 
may contribute to the differential regulation of select splice variants (a) There was a trend 
towards the overall decreased expression of CDH13, F3,26 =2.53, p=0.07. However, this 
was likely due to the regulation of non-coding transcripts of CDH13 (see Figure 4.11) as 
the expression of the protein-coding transcript was not significantly altered following 
cocaine self-administration, F3,26 = 1.35, ns (see b). (c) Subsequent to self-administration, 
CPEB4 expression was increased, F3,26 = 5.96, p<0.01. (d) However, there was no 
significant change in the expression of the common isoform, CPEB4-001, relative to naïve 
animals, F3,26 = 4.32, p<0.01, though there was a significant difference in the expression of 
this isoform in animals subject to a relapse test at 21 days of abstinence compared to 
those that were not (p<0.01, Holm-Sidak). (e) When the collective expression of all 
protein-coding isoforms of MCTP1 was explored, the sole significant difference was again 
between animals subject to a relapse test at 21 days and those that were not, F3,26 = 3.62, 
p<0.05, Holm-Sidak post hoc, IVSA 21 R vs. IVSA 21 NR, p<0.05. (f) A persistent increase 
DNA methylation within an intron of MCTP1 was associated with a persistent decrease in 
the expression of MCTP1-001 (Ensembl 37), F3,26= 4.07, p<0.05.   
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4.5 Discussion 
In summary, voluntary cocaine self-administration (IVSA) induces modifications of the 
neuronal methylome that are distinct from those incurred by passive cocaine exposure. 
IVSA-associated changes in DNA methylation are predominantly persistent or arise over 
the course of abstinence and are therefore congruous with the enduring nature of memory. 
Moreover, differential methylation within genes is associated with concomitant changes in 
their expression. Surprisingly, persistent modifications of DNA methylation do not 
invariably yield enduring changes in the transcription of corresponding genes; in select 
cases altered transcription is exclusively evident following re-exposure to previously 
cocaine-paired cues and the self-administration context. Therefore, in some cases, 
learning-induced modifications of DNA methylation may remain transcriptionally silent and 
prime the transcriptional response to subsequent neuronal or memory reactivation, rather 
than ceaselessly modifying the expression of a gene.   
 
A significant advance of this body of work is the identification of modifications of DNA 
methylation that are uniquely attributable to voluntary cocaine-self administration, rather 
than simple cocaine exposure. To date, many investigations have explored the epigenetic 
consequences of repeated involuntary cocaine exposure (Feng et al., 2014, Maze et al., 
2011, Renthal et al., 2009), a paradigm that is disturbingly unrelated to the consumption of 
cocaine under native conditions, and in which cocaine exposure is actually aversive 
(Twining et al., 2009). In demonstrating that the modifications of DNA methylation 
associated with self-administration are unique, we hope to spur the adoption of a more 
ethologically valid model of cocaine-seeking in future epigenetic studies.    
 
While the self-administration model of cocaine consumption is appropriate to the study of 
learned drug seeking and cocaine-related memories, the simple self-administration of 
cocaine is not a reliable indicator of addiction. Several of the identified DMRs may 
contribute to addiction, but in order to establish this it will be necessary to demonstrate 
that these DMRs are equally specific to animals that continue to self-administer cocaine in 
the face of adverse consequences, perhaps by using the conflict model of cocaine-self 
administration (see Chapter 5, (Cooper et al., 2007). In addition, extended access to 
cocaine (ie. 6+ hrs of cocaine access) may result in further epigenetic modifications that 
are not observed following restricted (1-2 hr) access to cocaine (Ploense et al., 2015). 
Finally, further investigations will determine if these changes are common to other reward-
related learning paradigms.  
 
 
108 
 
IVSA-associated changes in DNA methylation likely stem from learned cocaine seeking 
and may therefore underpin the maintenance cocaine-related memories. Fittingly, the 
majority of these modifications of DNA methylation are persistent or develop as a 
consequence of forced abstinence; both types of modification may direct the maintenance 
of cocaine-related memories. Persistent IVSA-associated changes in DNA methylation 
may govern the maintenance of cocaine-related memories by orchestrating long lasting 
changes in gene transcription or by regulating transcriptional responses to incoming 
stimuli. Abstinence-associated changes in DNA methylation likely originate from the 
retrieval and reconsolidation of cocaine-related memories and beget their unusual 
persistence. Reconsolidation is the process by which memories are returned to long-term 
storage following retrieval and is dependent on de novo gene transcription and DNA 
methylation (Maddox & Schafe, 2011). Cocaine-related memories are readily retrieved by 
re-exposure to external cocaine-paired cues (discrete or contextual) and interoceptive 
cues (such as stress) (Saunders & Robinson, 2011) and may repeatedly undergo 
reconsolidation, producing de novo modifications of DNA methylation during abstinence. 
Befittingly, undergoing reconsolidation can increase the strength of memory trace 
(Tronson & Taylor, 2013) and consequently variations in DNA methylation produced by the 
reconsolidation of cocaine-related memories may contribute to their outstanding 
persistence. Moreover, DNA methylation is altered following memory retrieval at the DMR 
upstream of gm10375, providing tangible evidence of a retrieval/reconsolidation-induced 
change in DNA methylation.  
 
It is possible that the IVSA-associated modifications of DNA methylation do not perpetuate 
the initial transcriptional signature of cocaine-related learning but instead constitute 
homeostatic responses to the wide range of changes in gene transcription that occur as a 
result of cocaine self-administration and exposure. Homeostatic de novo methylation could 
oppose transcriptional changes induced by cocaine, either by blunting the expression of 
up regulated genes or by forcing the expression of those that are down regulated. 
However, homeostatic responses in DNA methylation may nevertheless result in long-
lasting changes in gene expression once the initial stimulus (ie. cocaine) is removed and 
potentially alter neuronal excitability. In some respects, memory is not only the 
perpetuation of an initial learning signal but also the conservation of the cell’s response 
that to that initial signal, including homeostatic responses.  
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The majority of IVSA-related modifications of DNA methylation are situated within or 
proximal to genes (both coding and non-coding) and predominantly within introns. As the 
bulk of neuronal activity-induced changes in DNA methylation also occur within introns 
(Guo et al., 2011a), this is relatively unsurprising. Equally expected is the relative 
enrichment of DMRs within repetitive elements. Approximately 42% of the mouse genome 
corresponds to repetitive elements (Church et al., 2009) and these are often heavily 
methylated, which facilitates the detection of differences by enrichment-based methods 
such as MBD Ultra-Seq. However, the abundance of abstinence-associated DMRs within 
or proximal to nuclear lamina-associated domains was surprising. A ring of 
heterochromatin is normally found beneath the nuclear envelope and the tethering of a 
genomic region to the nuclear lamina inhibits the transcription of genes within the region 
(Peric-Hupkes & Van Steensel, 2010). DNA methylation directly influences the association 
between genomic regions and the nuclear lamina as the methyl-CpG binding protein 
MeCP2 interacts with inner nuclear lamina-associated proteins (Guarda et al., 2009). 
Furthermore, neuronal activity influences the association of genes with the nuclear lamina 
(Walczak et al., 2013) and inappropriate regulation of genome-lamina associations has 
been implicated the development of neuropsychiatric disorders (Ito et al., 2014, 
Wilczynski, 2014). Repeated cocaine exposure results in a significant decrease in 
heterochromatin (Maze et al., 2011). Therefore, abstinence-associated changes in DNA 
methylation may alter genome-lamina associations and heterochromatin stability, though 
an explanation for the specific enrichment of abstinence-associated DMRs within lamina-
associated domains remains elusive.   
 
A number of gene-associated DMRs were located within genes that have been previously 
implicated in learning, memory and addiction and their potential biological functions merit 
elaboration. KCTD16 functions as an auxiliary subunit of the GABAB receptor, enhancing 
its sensitivity and accelerating responses to agonists (Schwenk et al., 2010) but 
paradoxically causing GABAB receptor activation to produce non-desensitizing responses 
in neurons (Gassmann & Bettler, 2012). Activation of the GABAB receptor, which is equally 
subject to persistent changes in methylation following cocaine self-administration, is 
associated with a reduction in cocaine self-administration (Roberts & Brebner, 2000) and 
therefore by altering the kinetics and sensitivity of this receptor, the differential methylation 
of both genes may modulate cocaine seeking. MCTP1 polymorphisms are associated with 
bipolar disorder (Scott et al., 2009) and MCTP1’s expression is altered during abstinence 
from several drugs of abuse (Le Merrer et al., 2012). CDH13 is a particularly striking 
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candidate as polymorphisms within this gene have been implicated in methamphetamine 
dependence (Uhl et al., 2008), alcohol dependence (Treutlein et al., 2009), nicotine 
dependence (Uhl et al., 2010), vulnerability to addiction (Johnson et al., 2011) and 
disorders of impulse control including ADHD (Arias-Vasquez et al., 2011), though no 
studies have explored the epigenetic regulation of this gene in cocaine seeking and 
addiction. Together with the other DMRs identified, these changes in DNA methylation 
have a clear potential to contribute to development of addiction and thanks to the 
malleable nature of epigenetic modifications, are promising targets for pharmacological 
interventions in the treatment of addiction. Nevertheless, as previously mentioned, it is first 
necessary to establish that these DMRs regulate addiction and not simple cocaine self-
administration. Moreover, many DMRs are located within repetitive regions and will require 
the application of new techniques for their verification. One potential technique for the 
validation of DMRs within repetitive regions is SMRT sequencing (PacBio), which can be 
used to sequence single molecules of DNA of up to 40,000 bp in length without 
amplification. However, this and other viable techniques remain in development and will 
necessitate further optimisation.  
 
Repeated exposure to cocaine generates ‘silent’ glutamatergic synapses that do not 
influence the basal efficacy of synaptic transmission but are pronounced sites of plasticity 
in response to subsequent stimulation (Lee & Dong, 2011). An analogous phenomenon 
may occur in the context of learning-induced changes in DNA methylation, whereby 
learning (or IVSA)-induced changes in DNA methylation do not necessarily produce long-
lasting changes in the transcription of co-localising genes, but instead prime their 
transcription in response to subsequent neuronal and memory reactivation. To this effect, 
in a subset of genes (KCTD16, CPEB4 and NKAIN3), the association between differential 
methylation and altered gene transcription was modulated by the re-activation of cocaine-
related memories through a relapse test, which suggests that the function of some 
changes in DNA methylation is indeed to prime transcription upon memory reactivation. 
KCTD16-associated data is particularly convincing as there is no difference in methylation 
in animals that underwent a relapse test after 21 days of abstinence and compared to 
those that were simply sacrificed; caution must be used when interpreting the NKAIN3- 
and CPEB4- related data as the possibility that DNA methylation is altered by the relapse 
test cannot be excluded. Further experiments will extend these correlative findings and 
conclusively demonstrate that the observed metaplastic priming of gene transcription is a 
direct consequence of memory reactivation and DNA methylation at a specific locus. It is 
 
 
111 
possible to establish that memory re-activation mediates the association between IVSA-
associated DNA methylation and gene expression by subjecting mice to a relapse test in 
the presence of pharmacological agents that prevent the retrieval of memory (such as 
propranolol, which prevents the retrieval of cocaine-associated memories in CPP (Otis & 
Mueller, 2011)). Moreover, by artificially reversing the IVSA-associated changes in 
methylation at a given DMR, one can establish its role in regulating transcription and 
cocaine seeking behaviour. Targeted DNA methylation or demethylation can be produced 
by engineered transcription activator–like effectors (TALEs), which bind to specific 
sequences of DNA and can be fused to demethylating enzymes such as TET1 (Maeder et 
al., 2013a) or methylating enzymes such as DNMT3a. The concurrent application of both 
techniques will demonstrate the importance of learning-induced modifications of DNA 
methylation in the metaplastic priming of gene expression, a phenomenon for which this 
body of work has provided preliminary evidence.  
 
Finally, IVSA-associated changes in intragenic DNA methylation are associated with the 
regulation of alternative splicing. Importantly, we demonstrated that the absence of an 
overall change in the expression of a gene does not exclude the possibility that individual 
splice variants are differentially regulated. The overall expression of MCTP1 is unchanged, 
yet the expression of a single isoform (MCTP-001) was differentially regulated. Opposing 
changes in the expression of specific isoforms of genes could obscure global changes in 
the expression of a given gene. Evidently, each isoform of a gene may produce proteins 
with vastly different functional capabilities and therefore it is critical that the expression of 
specific splice variants is determined. At the level of individual DMRs, exploring the 
expression of each splice variant of co-localising genes may be too time-consuming and 
expensive; it may be preferable simultaneously perform whole-transcriptome sequencing 
to broadly explore the regulation of alternative splice variants.  
 
Together, this body of work has identified persistent and abstinence-associated changes 
in DNA methylation in neurons of the mPFC that are unique to the voluntary cocaine self-
administration and which may underlie the maintenance of cocaine-related memories. 
Future experiments will functionally establish the role of these specific changes in DNA 
methylation in cocaine-seeking behaviour and memory maintenance and explore their 
function in the regulation of transcription.  
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CHAPTER 5 
 
Conclusions & Outlook 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113 
5.1 Summary of findings 
As hypothesized (Aim 1), mice persistently sought cocaine after 21 days of abstinence, 
indicating the presence of long-lasting cocaine-related memories on which this behaviour 
is contingent. IVSA-associated modifications of DNA methylation were identified by MBD 
Ultra-Seq, a next generation sequencing technique we developed to pinpoint genome-
wide region- and cell type- specific DNA methylation states in individual animals (Aim 2). 
As hypothesized (Aim 3), in neurons of the mPFC, the modifications of DNA modifications 
arising from cocaine self-administration are distinct from those that are incurred by passive 
cocaine exposure. Variations in DNA methylation produced by cocaine self-administration 
are surprisingly persistent, which is consistent with the hypothesis that these variations 
facilitate the maintenance of cocaine-related memories and enduring cocaine-seeking 
behaviour. Abstinence-associated changes in DNA methylation arise with curious 
frequency in nuclear lamina-associated domains, which is indicative of extensive re-
organisation of chromatin during abstinence. Both persistent and abstinence-associated 
DNA modifications preferentially co-localise with transcribed regions and may therefore 
function primarily in the regulation of transcription. However, as outlined in Chapter 2 and 
hypothesized in Aim 4, some IVSA-associated DNA modifications prime gene expression 
in response to the reactivation of cocaine-related memories rather than perpetuating 
changes in transcription, providing an in vivo example of genomic metaplasticity. 
 
5.2 Future directions 
The overarching objective of future experiments is to conclusively establish that IVSA-
induced modifications of DNA methylation mediate the maintenance of persistent cocaine-
related memories and cocaine-seeking behaviour. Broadly, this objective can be dissected 
into 3 tasks. First, we will identify DMRs associated with the maintenance of cocaine-
related memories by examining methylation within neurons selectively engaged by the 
memory trace. Moreover, we will manipulate DNA methylation at specified DMRs to 
functionally establish their role in continued cocaine-seeking behaviour during abstinence. 
Lastly, we will unambiguously demonstrate that enduring neuronal activity- or learning- 
induced modifications of DNA methylation do not necessarily prompt lasting changes in 
gene expression, but may instead represent a form of genomic metaplasticity that primes 
the transcriptional response to subsequent neuronal or memory reactivation.  
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5.2.1 Honing in on memory-related DNA methylation and gene transcription 
During cocaine-self administration, animals learn to associate behaviours, cues and 
contextual stimuli with cocaine availability, which gives rise to enduring cocaine-related 
memories that encode these learned associations and motivate cocaine-seeking 
behaviour. In contrast, passive cocaine exposure generates memories for the experience 
of cocaine, which are incapable of driving cocaine seeking. In identifying the modifications 
of DNA methylation that are uniquely produced by cocaine self-administration, we may 
have indirectly characterised the changes in DNA methylation that mediate the 
maintenance of cocaine-related memories. However, by examining the IVSA-associated 
changes in DNA methylation and gene expression in neurons selectively engaged by 
cocaine-related memories (ie. activated upon the retrieval of cocaine-related memories by 
self-administration or relapse testing), we can directly identify the modifications of DNA 
methylation that beget the maintenance of cocaine-related memories. In addition, future 
animals will be directly trained to self-administer cocaine, eliminating the possibility that 
any behavioural/epigenetic changes are due to the initial instrumental training with oral 
sucrose. 
 
Fluorescence-activated cell sorting (FACS) can be coupled to transgenic or viral vector-
mediated approaches to identify and capture recently activated neurons. In transgenic 
mice, recently activated neurons are labelled by a reporter protein that is expressed under 
the control of an endogenous promoter of neuronal activity-regulated genes (ie. c-fos, egr-
1 or Arc) (Eguchi & Yamaguchi, 2009, Smeyne et al., 1992). After memory reactivation 
FACS is subsequently used to isolate neurons expressing the reporter protein. However, 
within certain neuronal subtypes (ie. inhibitory GABA neurons) the endogenous promoters 
are differentially regulated in response to neuronal activity (Kawashima et al., 2014) and 
therefore this method may only capture recently activated neurons of a certain variety. A 
synthetic, virally introduced, activity-dependent promoter termed E-SARE (enhanced 
synaptic activity reactive element) can be used to overcome this bias and drive the 
expression of reporter proteins in all recently activated and transfected neurons 
(Kawashima et al., 2013). Expressing reporter proteins under the control of the E-SARE 
promoter is perhaps preferable as it greatly reduces region- and cell type- biases in the 
expression of the reporter protein. Future experiments will use an E-SARE-driven 
destabilised green fluorescent protein (GFP) and FACS to isolate neurons that are 
activated in response to the retrieval cocaine-related memories.    
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Though it is possible to isolate recently activated neurons from the mPFC, the quantity of 
DNA obtained from this limited population may restrict the methods that can be applied to 
identify IVSA-associated changes in DNA methylation. The present IVSA-associated 
modifications of DNA methylation were identified using gDNA derived from all NeuN+ 
neuronal nuclei of the mPFC (about 80,000 nuclei per animal). However, based on the 
number of neurons that mediate drug-seeking behaviour in other structures and drug-
taking paradigms (Bossert et al., 2011, Cruz et al., 2014), enduring cocaine-seeking 
behaviour is likely directed by 3-6% of neurons within the mPFC (or a total of 2400-4800 
neurons). Diploid neurons contain approximately 6 pg of DNA (Moroz & Kohn, 2013); 
unreasonably assuming the perfect extraction of all activated neurons and their gDNA 
from the mPFC, we would recover approximately 28 ng of DNA per animal. With further 
optimisation, MBD Ultra-Seq may be applicable, but alternative methods of sequencing 
must be considered. A promising alternative is the direct detection of DNA methylation by 
single-molecule real-time (SMRT) sequencing (Flusberg et al., 2010). Similar to Illumina’s 
HiSeq, SMRT sequencing uses parallelised DNA sequencing by synthesis, where DNA 
polymerases catalyze the incorporation of complementary fluorescent nucleotides to single 
stranded DNA. As each nucleotide is added, the fluorescent tag is cleaved to produce a 
fluorescent signal that indicates which nucleotide was incorporated. The kinetics of DNA 
polymerase are altered by the presence of epigenetic modifications, which results in 
differences in the duration and arrival times of the fluorescent pulses produced by 
nucleotide addition and reveals the presence of N6-methyladenosine, 5-methylcytosine, 
and 5-hydroxymethylcytosine. SMRT sequencing overcomes the need for PCR-based 
whole genome amplification of DNA prior to sequencing, which can introduce bias 
(Benjamini & Speed, 2012). However, it is not practical to use SMRT sequencing for the 
genome-wide discovery of 5mC in the 2.5 GB mouse genome, as it generates a maximum 
of 40,000 bp reads and a minimum of 25X coverage is recommended for the identification 
of 5mC (PacBio). Nevertheless, the 40,000 bp reads permit the identification of DNA 
methylation within repetitive regions and perhaps this technique could be coupled to MBD 
Ultra-Seq for the validation of locus-specific changes in DNA methylation within repetitive 
regions.    
 
One limitation of the current data is that gene expression was explored in mRNA derived 
from the entire mPFC. In future experiments, whole neurons will be isolated from the 
mPFC and gene expression will be analysed in the neurons engaged by cocaine-related 
memories. Several protocols have optimised the isolation of whole neurons and quality 
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RNA from adult brains (Fanous et al., 2013, Guez-Barber et al., 2012, Saxena et al., 
2012), but the simultaneous extraction of RNA and DNA from a small sample will require 
optimisation. Nevertheless, with further optimisation, it will be possible to perform genome-
wide DNA methylation profiling and whole-transcriptome sequencing on neurons 
selectively engaged by cocaine-related memories. Together, these novel techniques will 
more rigorously identify the variations in DNA methylation states and gene expression that 
support enduring cocaine- seeking behaviour and long-lasting cocaine-related memories.  
 
5.2.2 Establishing the function of specific DMRs in behaviour 
Overall, the appropriate regulation of DNA methylation is necessary for the expression of 
cocaine-seeking behaviour (Laplant et al., 2010, Tian et al., 2012) and memory 
maintenance (Miller et al., 2010). However, manipulating global levels of DNA methylation 
to demonstrate function is almost inconsequential after the identification of such specific 
changes in DNA methylation. Future experiments will establish the function of discrete 
IVSA-associated DMRs in the regulation of cocaine-seeking behaviour and memory.  
 
5.2.2.1 Targeting specific DMRs 
To demonstrate the function of specific DMRs in cocaine-seeking behaviour it is necessary 
to exclusively manipulate their persistence in neurons that are engaged by this behaviour. 
Two evolving technologies may enable the manipulation of specific epigenetic 
modifications at discrete genomic loci. The first is transcription activator-like effector 
(TALE) proteins, which can be engineered to bind precise locations in the genome by 
fusing several TALE repeat domains together. TALE repeat domains are approximately 34 
amino acids in length and vary by two amino acid residues, which causes them to bind 
specific DNA nucleotides. By fusing several TALE repeat domains that bind specific 
nucleotides with a defined distance between each binding site, one can create a TALE 
protein that binds to a single site in the genome. Moreover, TALE proteins can be fused to 
the catalytic domains of methylating or demethylating enzymes to force DNA methylation 
or demethylation at nucleotides proximal to their binding sites (Maeder et al., 2013a). 
Furthermore, as TALE proteins are expressed from viral vectors, it is possible to design an 
inducible TALE protein whose expression is restricted to recently activated neurons, by 
placing the vector under the control of an E-SARE promoter. A relapse test at an 
intermediate time point (ie. 10 days) would induce the expression of the TALE protein in 
the neurons engaged by cocaine seeking and TALE fusion protein(s) would subsequently 
force methylation/demethylation at the desired DMRs within these select neurons. The 
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effects of the methylation manipulations on cocaine-seeking behaviour and the expression 
of co-localising genes could be examined upon a second relapse test, thereby establishing 
the role of specific DMRs in cocaine-seeking behaviour. Nevertheless, designing TALE 
proteins remains very challenging. Moreover, there remains the question of whether one 
DMR contributes substantially to the regulation of behaviour. It appears unlikely that one 
DMR, within a handful of neurons, would significantly contribute to the maintenance of 
memory (and regulation of behaviour), as this would render memories incredibly sensitive 
to disruption. Instead, a network with regional and epigenomic redundancies may maintain 
memory and compensate for the inadvertent loss of discrete epigenetic changes. 
Therefore, it be necessary to simultaneously manipulate several DMRs to observe a 
behavioural effect. 
 
 A second approach to artificial epigenetic editing is the CRISPR/Cas9 system, which has 
been previously used for genomic editing (Cho et al., 2013). Here, CRISPR RNAs 
(cRNAs) are expressed and bind the endonuclease Cas9, changing its conformational 
state and causing it to scan the genome for endogenous protospacer adjacent motif (PAM) 
sites (5’-NGG). Upon binding to a PAM site, the cRNA/Cas9 complex prompts the 
unwinding of the DNA helix. To remain tethered to the DNA, a designated sequence-
specific region within the cRNA must be complementary to the DNA sequence proximal to 
the PAM site. If complementarity is present, the cRNA binds the DNA and the 
CRISPR/Cas9 complex causes double-stranded break in DNA at the complementary 
region. However, the substitution of two amino acids within Cas9 can inactivate its 
nuclease domains to form dCas9, which retains its function as a DNA-binding scaffold 
(Jinek et al., 2012). As with TALEs, it may be possible to create a fusion protein of dCas9 
and the catalytic domains of methylating or demethylating enzymes and force site-specific 
methylation or demethylation. Unlike TALE proteins, the CRISPR/Cas9 system does not 
necessitate the design of new proteins for each target and the expression of multiple 
cRNAs by distinct (Swiech et al., 2015) or a single (Kabadi et al., 2014) viral vector can 
target dCas9 to multiple genomic loci. However, compared to TALEs, cRNA-guided dCas9 
binds relatively promiscuously throughout the genome (Wu et al., 2014) and may cause 
undesirable de novo epigenetic modifications at non-targeted loci. Further, the expression 
multiple cRNAs, dCas9 and the catalytic domain of a methylating/demethylating enzyme 
will require co-transfection by multiple plasmids.  However, differences in transfection rates 
amongst the plasmids could result in the unequal expression of each vector and therefore 
each epigenetic modification may not be targeted to the same extent. Moreover, CpG 
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methylation and chromatin state may interfere with dCas9 binding (Wu et al., 2014). 
Nevertheless, as the CRISPR/dCas9 system evolves, its relative ease of use may favour 
its adoption in the manipulation of site-specific changes in DNA methylation, particularly as 
it enables the simultaneous manipulation of several DMRs.  
 
In conclusion, TALE and dCas9 fusions proteins under the control of E-SARE promoters 
may permit the site-specific manipulation of IVSA-associated DMRs within neurons that 
are selectively engaged by cocaine-seeking behaviour. Future investigations will enlist 
these approaches to directly examine the importance of specific DMRs in the maintenance 
of cocaine-related memories and cocaine-seeking behaviour. It is unlikely that a single 
DMR within a discrete neuronal population significantly regulates a complex behaviour or 
begets the maintenance of a memory, but it remains possible that by disrupting a single 
DMR/gene we may exert a ‘butterfly’ effect, whereby the disruption of one component of 
an adaptive pathway leads to its complete interruption and consequently exerts a 
significant effect on behaviour. More promisingly, both the TALE and CRISPR/dCas9 
system permit epigenetic remodelling at multiple loci.   
 
5.2.3 IVSA-associated DMRs, addiction and natural reward seeking 
Cocaine addiction may arise in part from the pathological usurpation of the neural 
pathways and adaptions normally enlisted by natural reward learning and memory 
(Hyman, 2005, Hyman et al., 2006). Therefore, in identifying the changes in DNA 
methylation associated with enduring cocaine-seeking behaviour and cocaine-related 
memories, we may have inadvertently distinguished the modifications of DNA methylation 
that beget addiction. However, the continued self-administration of cocaine in the absence 
of adverse consequences can hardly be considered indicative of cocaine addiction. A key 
feature of cocaine addiction in humans is compulsive cocaine seeking despite adverse 
consequences, which are absent from the standard self-administration paradigm, but 
present in the ‘conflict’ model of cocaine self-administration (Cooper et al., 2007). In this 
model, adverse consequences (such as electrified floor grid proximal to the cocaine-paired 
lever) are gradually introduced during cocaine self-administration until they completely 
deter cocaine-seeking behaviour. Cue-, context- or cocaine- induced relapse is examined 
in the presence of the maximal adverse consequence; animals that continue to seek 
cocaine despite the presence of adverse consequences are considered addicted. 
Ultimately, it will be necessary to employ this or a similar model, to identify the 
modifications of DNA methylation directly associated with addiction; until such time, the 
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epigenetic modifications identified are simply associated with cocaine seeking behaviour 
and potentially cocaine-related memories.  
 
A further avenue of investigation will distinguish the modifications of DNA methylation that 
drive cocaine-seeking behaviour from those that motivate natural reward (food, water) 
seeking, or the self-administration of other drugs, as an increasing amount of evidence 
suggests that the epigenetic modifications associated with natural reward consumption 
differs (Pol Bodetto et al., 2014, Romieu et al., 2008).  
 
Finally, it will be necessary to determine if the changes in DNA methylation associated with 
cocaine-related memories are region-specific (ie. localised to the mPFC), occur throughout 
activated neurons with the reward-related circuitry, or arise throughout the brain. A recent 
investigation (Massart et al., 2015) found persistent changes in DNA methylation in the 
nucleus accumbens following cocaine self-administration. However, as they used promoter 
microarrays to identify changes in DNA methylation, it is not possible to determine if 
candidates from this thesis overlap with those described in the paper.    
 
5.2.4 DNA methylation and the metaplastic priming of gene transcription 
This body of work has provided preliminary evidence that the reactivation state of memory 
influences the relationship between gene expression and DNA methylation. However, a 
conclusive demonstration of the priming of gene expression by enduring learning-induced 
changes in DNA methylation remains to be established. Future investigations will first 
examine the priming of gene expression by long-lasting neuronal activation-induced 
modifications of DNA methylation in cultured neurons, as this can be done in advance of 
the optimisation of whole neuron sorting. To begin, we will identify persistent modifications 
of DNA methylation that arise following neuronal depolarisation. Furthermore, we will 
pinpoint the persistent modifications of DNA methylation that are only associated with a 
change in gene transcription upon subsequent neuronal stimulation, by comparing 
expression within neurons that have not been re-stimulated, those that have, and neurons 
that have been re-stimulated in the presence of a pharmacological agent that blocks 
depolarisation. An association between gene expression and DNA methylation that is 
unique to neurons that have been activated would suggest a role for DNA methylation in 
genomic metaplasticity. Finally, neurons will be transfected with TALE/CRISPR/Cas9 –
DNMT/TET 1 fusion protein to reverse activation-induced changes in DNA methylation at 
the identified region, with expectation that subsequent stimulation will not produce a 
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change in the expression of the co-localising gene if the modification of DNA methylation 
was necessary to prime transcription. Together, these approaches offer a more conclusive 
demonstration of the metaplastic priming of gene transcription by neuronal activity-induced 
modifications of DNA methylation. Further, it may be possible to extend these findings in 
vivo, if recently activated whole neurons with good quality RNA can be isolated and 
learning-induced changes in DNA methylation can manipulated in select cell populations.  
5.3 Summary of future directions 
In sum, this body of work has yielded a novel hypothesis about how transcriptionally 
quiescent DNA methylation regulates the maintenance of memory, an innovative 
technique for the identification of region- and cell type- specific genome-wide changes in 
DNA methylation in multiple individuals, the first in vivo profile of exclusively IVSA-
associated changes in DNA methylation and preliminary evidence of the priming of gene 
expression by long-lasting changes in DNA methylation. Future experiments will identify 
modifications of DNA methylation and gene expression explicitly associated with cocaine-
related memories and demonstrate a functional role for these specific changes in cocaine-
seeking behaviour. Finally, the transcriptional consequences of neuronal activation-
induced changes in DNA methylation will be explored. Together these experiments 
present several technical challenges, but are necessary to conclusive demonstrate the 
role of learning-induced modifications of DNA methylation in the maintenance of cocaine-
related memories.  
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Brief Communication
Activation of BDNF signaling prevents the return
of fear in female mice
Danay Baker-Andresen, Charlotte R. Flavell, Xiang Li, and Timothy W. Bredy1
Psychiatric Epigenomics Laboratory, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia
There are significant sex differences in vulnerability to develop fear-related anxiety disorders. Females exhibit twice the rate
of post-traumatic stress disorder (PTSD) as males and sex differences have been observed in fear extinction learning in both
humans and rodents, with a failure to inhibit fear emerging as a precipitating factor in the development of PTSD. Here we
report that female mice are resistant to fear extinction, and exhibit increased DNA methylation of Bdnf exon IV and a con-
comitant decrease in mRNA expression within the medial prefrontal cortex. Activation of BDNF signaling by the trkB
agonist 7,8-dihydroxyflavone blocks the return of fear in female mice after extinction training, and thus represents a
novel approach to treating fear-related anxiety disorders that are characterized by a resistance to extinction and increased
propensity for renewal.
There are significant sex differences in terms of vulnerability to
develop fear-related anxiety disorders. Females exhibit twice the
rate of post-traumatic stress disorder (PTSD) as males (Olff et al.
2007), which cannot be explained by the severity of the experi-
enced trauma or comorbidity with other affective disorders
(Tolin and Foa 2006). Furthermore, sex differences have been ob-
served in fear extinction learning in humans and rodents, with a
failure to inhibit fear emerging as a precipitating factor in the de-
velopment of PTSD (Lebron-Milad et al. 2012; Ter Horst et al.
2012). In accordance with previous observations we have found
that there are significant sex differences in the extinction of con-
ditioned fear in mice. Male and naturally cycling female C57BL/6
mice (n ¼ 15–16/group, 9 wk of age) were first trained on a
cued-fear-conditioning task in which a 70-dB white noise (condi-
tioned stimulus [CS], 2 min) coterminated with mild foot shock
(unconditioned stimulus [US] 0.7 mA, 1 sec) on three occasions.
Twenty-hours later, micewere extinction trained in a new context
(30 nonreinforced, 2-min, 5-sec inter-trial interval, tone (CS) ex-
posures in context B). On Day 3, all mice were returned to context
B and tested (two CS presentations) for retention of memory for
fear extinction. There was no difference betweenmale and female
mice in the acquisition of cued fear (data not shown). However,
therewas a significant sex difference inmemory for the extinction
of conditioned fear (F(3,59)¼ 11.41, P, 0.0001; Tukey’s post hoc
test: fear conditioned without extinction training (FC-No EXT)
male vs. extinction trained (EXT) male, P, 0.0001; EXT male
vs. EXT female, P, 0.05), withmalemice exhibiting significantly
lower levels of freezing than females (Fig. 1). These data suggest
that female mice are resistant to the extinction of conditioned
fear; however, the neural mechanisms underpinning this effect
are not known.
Epigenetic mechanisms influence cognition andmemory by
regulating learning-induced gene expression (Day and Sweatt
2011). One such epigenetic mechanism is DNA methylation,
which has been implicated in experience-dependent plasticity
and in the formation and maintenance of fear-related memories
(Miller et al. 2010; Baker-Andresen et al. 2012). Activity-de-
pendent brain-derived neurotrophic factor (BDNF) signaling en-
hances neural plasticity and is necessary for the formation of
fear-related memories (Peters et al. 2010; Andero and Ressler
2012) with the epigenetic regulation of Bdnf expression being
shown to be critical for the acquisition and extinction of condi-
tioned fear (Bredy et al. 2007). Furthermore, dysregulation of
BDNF has been implicated in many neuropsychiatric disorders
(Boulle et al. 2012). Recently, significant sex differences in BDNF
signaling have been observed within the prefrontal cortex (Hill
and van den Buuse 2011), a region of the brain in which sexual
dimorphism in epigenomic function has also been reported (Xu
et al. 2008). However, it is not yet knownwhether there are sex dif-
ferences in the epigenetic regulation of Bdnf, which would subse-
quently contribute to the observed differences in fear-related
learning andmemory. To address this issue, wemeasured the level
of DNAmethylation surrounding the transcription start site (TSS)
of exon IVof the gene encoding BDNF bymethylated DNA immu-
noprecipitation (MeDIP) followed by quantitative PCR (qPCR)
(Fig. 2A). Briefly, genomic DNA was isolated from tissue samples
encompassing the prefrontal cortex by overnight proteinase K
treatment, phenol–chloroform extraction, ethanol precipitation,
and RNase digestion. Prior toMeDIP, genomicDNAwas randomly
fragmented by sonication into fragments of !500 bp in length,
with 1 mg fragmented DNA used for each MeDIP assay. MeDIP
was performed using a MeDIP assay kit (Active Motif) as per the
manufacturer’s instructions. Methylated DNA fragments were re-
covered by reverse cross-link followed by ethanol precipitation
and then quantified by qPCR using MEDIP-qPCR primers for
Bdnf exon IV (forward, 5′-GTGGACTCCCACCCACTTT-3′; reverse,
5′-TATTACCTCCGCCATGCAAT-3′).
In response to the extinction of conditioned fear, Bdnf ex-
pression is altered in an isoform-specific manner; Bdnf exon IV
expression increases in response to fear extinction and is marked
by learning-induced epigenetic modifications surrounding its
promoter (Bredy et al. 2007). Furthermore, reduced BDNF exon
IV expression is associated with deficits in inhibitory neurotrans-
mission in the prefrontal cortex (Sakata et al. 2009), thus adversely
affecting the formation andmaintenance of extinctionmemories
when occurring in the medial prefrontal cortex (ILPFC) (Akirav
et al. 2006), an area of the brain that is critically involved in fear
extinction. As opposed to examining the well-characterized pro-
moter region of Bdnf exon IV, we selected a locus immediately
downstream of TSS due to the presence of several binding motifs
for transcription factors, including Sp1, YY1, and CTCF, all of
which are known to interact with DNAmethylation in regulating
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transcriptional activity. As an indirect measure of the functional
relevance of variations in DNA methylation, we also measured
Bdnf exon IV mRNA expression within the ILPFC of naive male
and female mice. Briefly, RNA was isolated from samples encom-
passing the ILPFC of naive male and female mice using the
Trizol extraction method (Invitrogen). Total RNA (1 mg) was
used for cDNA synthesis using the Omniscript RT kit (Qiagen).
PCR was then performed using primers for Bdnf exon IV (for-
ward, 5′-GCAGCTGCCTTGATGTTTAC-3′; reverse, 5′-CCGTGGA
CGTTTACTTCTTTC-3′) and for phosphoglycerate kinase (Pgk)
as an internal control (forward, 5′-TGC
ACGCTTCAAAAGCGCACG-3′; reverse,
5′-AAGTCCACCCTCATCACGACCC-3′).
qPCRwasperformedusingaRotorGeneQ
(Qiagen) cycler using SYBR-green (Qia-
gen). The threshold cycle for each sample
was chosen from the linear range and
converted to a starting quantity by inter-
polation fromastandardcurve runonthe
same plate for each set of primers. Bdnf
exon IV mRNA levels were normalized
for each well to Pgk mRNA using the
DDCT method, and each qPCR was run
induplicate for each sample and repeated
at least two times. mRNA levels were ana-
lyzed by unpaired t-tests.
Our results revealed a significant
sex difference in DNA methylation and
mRNA expression. Naive female mice
exhibited significantly greater methyla-
tion (unpaired t-test, t ¼ 2.75, df ¼ 7,
P, 0.05) (Fig. 2C) relative to naive
males, which was accompanied by de-
creased levels of Bdnf exon IV mRNA ex-
pression (unpaired t-test, t¼ 2.04, df ¼ 6,
P, 0.05) (Fig. 2B). Together, these data
suggest a potential relationship between
sex differences in the epigenetic regula-
tion of Bdnf exon IV within the medial
prefrontal cortex and fear extinction in
mice. Therefore, we next asked whether
these differences could collectively be
overcome to promote the extinction of conditioned fear in female
mice.
A brief reminder CS after fear conditioning renders themem-
ory for that fear temporarily labile and sensitive to modification,
requiring re-stabilization or updating of the memory trace
through a process known as reconsolidation (Przybyslawski and
Sara 1997; Przybyslawski et al. 1999; Nader et al. 2000). Monfils
et al. (2009) capitalized on the labile nature of memory to intro-
duce a retrieval-extinction procedure to interfere with reconsoli-
dation and strengthen the formation of fear extinction memory
in rats. They observed a significant reduction in the fear response
that did not return as a function of spontaneous recovery, renew-
al, or reinstatement. These findings were subsequently replicated
in humans (Schiller et al. 2010), and in mice in which a single
nonreinforced CS prior to extinction training diminished the re-
newal of conditioned fear (Clem and Huganir 2010). However,
not all studies have demonstrated beneficial effects using this ap-
proach, and an exaggerated return of fear, dependent on the con-
text in which the fear memory is retrieved, has also been reported
(Chan et al. 2010). Based on these observations, we reasoned that
a retrieval-extinction protocol might be useful in promoting fear
extinction in females, which are otherwise resistant when exam-
ined in a standard fear extinction training protocol. Moreover,
as there are sex differences in the epigenetic regulation of cortical
BDNF expression and in basal levels of BDNF expression in other
structures of the fear extinction-related circuitry (Zhu et al.
2006), we hypothesized that fear extinction would be facilitated
through direct systemic activation of the downstream signaling
target of BDNF, the trkB receptor. 7,8-Dihydroxyflavone (7,8-
DHF) is a small molecule activator that binds to the trkB receptor
(Jang et al. 2010), thereby mimicking the effect of BDNF in the
brain. Systemic administration of 7,8-DHF has been shown to ac-
tivate trkB receptors, enhance learning and memory (Liu et al.
2010; Andero et al. 2011, 2012), and reverse memory deficits in
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Figure 1. Female mice exhibit impaired retention of fear extinction
memory compared to males. Twenty-four hours after a 30 CS extinction
session in context B, male mice (EXT male) freeze significantly less than
no-extinction controls (FC-No EXT male) when presented with two CS
in the extinction context, suggesting retention of the memory for extinc-
tion training. While no difference in the retention of fear is observed
between sexes (FC-No EXT male vs. FC-No EXT female), female mice
(EXT female) display a significant extinction impairment compared to ex-
tinguished males. (∗∗∗) P, 0.0001, (∗) P, 0.05.
Figure 2. Expression of Bdnf exon IV mRNA differs in naive males and female C57BL/6 mice and is
accompanied by differences in DNA methylation surrounding TSS. (A) DNA methylation levels were
measured at the TSS of exon IV of the gene encoding BDNF. A significant increase in methylation
was observed in females (C), along with a concurrent decrease in Bdnf exon IV expression (B), compared
to males. (∗) P, 0.05
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a preclinical model of age-related cognitive decline (Devi and
Ohno 2012; Zeng et al. 2012a, b). We therefore investigated
whether administration of 7,8-DHF, in combination with a mod-
ified version of the retrieval-extinction protocol, could aid in fur-
ther promoting extinction in female mice.
Female mice (n ¼ 8/group) were trained on a cued-fear-con-
ditioning task and 24 h later were exposed to a single retrieval
cue prior to extinction training in a new context (10 or 11 non-
reinforced tone exposures in context B, balanced for CS exposure
on retrieval). All mice were then returned to context B and tested
for retention of memory for fear extinction on Day 3 before being
tested for renewal of fear memory 24 h later in context A (Fig. 3A).
We found that a single exposure to a retrieval cue, prior to fear ex-
tinction training, led to significantly higher levels of within-
session freezing, and an exaggerated return of fear when the
mice were tested in the context in which fear was initially learned
(Fig. 3F), similar to the findings of Chan et al. (2010). In contrast,
there were no differences when tested in the extinction context B
(Fig. 3E). A single injection of 7,8-DHF (25 mg/kg, i.p., dissolved
in 10% DMSO in sterile saline), administered systemically 30
min prior to retrieval, led to a significant reduction in freezing
upon retrieval (unpaired t-test, t ¼ 2.88, df ¼ 14, P, 0.05) (Fig.
3C) and completely prevented the return of fear in context A
(F(3,31)¼ 3.03, P, 0.05; Tukey’s post hoc test; Vehicle Ret vs. 25
mg/kg 7,8-DHF Ret, P, 0.05) (Fig. 3F). This effect on renewal
was due in large part to the very strong effect of 7,8-DHF on
contextual memory, as indicated by the pre-CS freezing levels in
drug-treated mice (F(3,31) ¼ 4.66, P, 0.01; Tukey’s post hoc test;
Vehicle Ret vs. 25 mg/kg 7,8-DHF Ret, P, 0.05) (Fig. 3F).
Furthermore, this reduction in freezing was not due to a general-
ized increase in activity as there were no significant differences in
locomotion (distance traveled) either 30 min or 80 min post-
injection (Fig. 3B). Together these data suggest that 7,8-DHF pro-
motes a reduction in fear-related respondingduring and following
extinction training in female mice, consistent with results sug-
gesting that activation of BDNF signaling can induce extinction
in the absence of training (Peters et al. 2010).
This study generated threemain findings: (1) femalemice are
resistant to the extinction of conditioned fear; (2) there are sex dif-
ferences in the epigenetic regulation of Bdnf expression in the
medial prefrontal cortex; and (3) femalemice exhibit a significant
return of fear after extinction training in a retrieval-extinction
paradigm, effects that are completely blocked by targeted activa-
tion of BDNF signaling prior to memory retrieval and extinction
training. It is important to note that there is evidence to suggest
that sex differences in fear extinction are dependent on circulat-
ing gonadal hormone levels (Zeidan et al. 2011; Merz et al.
2012); however, naturally cycling mice were examined in this
study to closely mimic what occurs in the general population.
Moreover, regardless of cycle, we observed a significant sex differ-
ence in fear extinction that is associated with basal differences in
epigenetic regulation of Bdnfwithin the medial prefrontal cortex.
We cannot exclude the possibility that stage of estrous contribut-
ed to these effects (Spencer et al. 2010); however, our data on the
return of fear after exposure to a retrieval cue in female mice rep-
resent a third replication of this effect, making it unlikely that
these differences are strictly due to a hormonal influence on fear
extinction learning.
Few studies have considered whether there are sex differenc-
es in the epigenetic regulation of gene expression, although this is
an emerging concept (McCarthy et al. 2009). Using amousemod-
el that separates hormonal effects from sex chromosome-linked
gene effects, Xu et al. (2008) were the first to examine how genes
specifically encoded on sex chromosomes influence the way in
which the epigenome exerts an effect on gene expression. They
found that, regardless of gonadal phenotype, the expression pat-
tern of the H3K27me3 histone demethylase ubiquitously tran-
scribed tetratricopeptide repeat gene on X chromosome (Utx)
was highest in the cortex of femalemice.We have observed a sim-
ilar pattern of Utx expression specifically in the medial prefrontal
cortex in male and female mice (data not shown). Given the tight
association between H3K27me3 and DNA methylation, it is likely
that sex differences in the epigenome are broadly distributed
and contribute to the function of many genes and related behav-
iors. Our data on DNA methylation status of Bdnf exon IV give
but one prototypical example of how sex differences in the epige-
netic regulation of gene expression may influence fear-related
learning and memory. With respect to the influence of 7,8-DHF
on the return of fear, previous studies have indicated beneficial
effects of 7,8-DHF on fear extinction in paradigms where di-
minished capacities for extinction are observed, such as follow-
ing exposure to an acute stressor (Andero et al. 2011). These
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Figure 3. 7,8-Dihydroxyflavone prevents retrieval-induced renewal of fear. (A) Schematic representation of experimental protocol. (B) Analysis of dis-
tance traveled 30 and 80 min post-injection with either vehicle (10% DMSO in PBS) or 25 mg/kg 7,8-DHF reveals no effect of drug on locomotor activity.
(C) Treatment with 7,8-DHF 30min prior to retrieval significantly decreased the expression of fear in female mice. (D) Vehicle-treated animals subjected to
a retrieval cue (Vehicle Ret) demonstrate a resistance to extinction compared to drug-treated (25 mg/kg 7,8-DHF Ret) and nonretrieval groups (Vehicle
No Ret and 25 mg/kg 7,8-DHF No Ret). (E) No significant differences were observed at test in context B. (F) A significant retrieval-induced renewal of fear
was observed in the vehicle retrieval group compared to nonretrieval groups, an effect which was blocked in the 7,8-DHF Ret group. (∗) P, 0.05.
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observations were later extended by the demonstration of a bene-
ficial effect of 7,8-DHF on stress-induced spatial memory impair-
ments (Andero et al. 2012). Thus, exposure to a retrieval cue
prior to fear extinction training may represent an acute stressor,
which leads to a significant increase in the return of fear in female
mice, an effect that can be completely prevented by activation of
BDNF signaling.
In summary, femalemice are resistant to fear extinction, and
exhibit increased DNA methylation of Bdnf exon IV and a con-
comitant decrease in mRNA expression within the medial pre-
frontal cortex. Together these findings suggest the intriguing
possibility that sex differences in epigenetic regulation of gene ex-
pression may represent a general distinction between the male
and female brain that will impact a variety of behaviors. In the
case of BDNF signaling, targeting downstream trkB receptors to
block renewal in female mice offers a novel approach to treating
fear-related anxiety disorders characterized by a significant return
of fear.
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